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Regulation of Ca2* Influx by Cell Shape in Swiss 373 Cells
Abstract
It has been found that cell shape and Ca2+ influx are both important elements in regulating cell 
proliferation. When cells are prevented from spreading on a substrate, mitogen-stimulation is no 
longer able to promote proliferation and the influx component of the mitogen 
(bombesin)-evoked [Ca2+]i response is lost (SOCE; Pennington et alv 2007). Since 
cell-shape-dependent Ca2+ influx plays an important role in the regulation of cell cycle, the 
regulation of this influx has been investigated.
in fura-2 loaded Swiss 3T3 cells, using large (045pm) and small (022pm) adhesive islands to 
control cell shape and the presence of cell-shape-dependent Ca2* influx was confirmed. Influx 
occurred in cells on the large adhesive islands, but not in the cells on the small adhesive islands.
Also in fura-2-loaded fibroblasts, by substituting extracellular Ca2+ for Sr2+ and Ba2+, it was
suggested that the bombesin-evoked Ca2+ influx pathway shared Sr2+ and Ba2+ permeability
characteristics that were most similar to those of ETYA, an arachidonic acid (AA) analogue, rather
than to thapsigargin, an agonist evokes store-operated Ca2+ entry (SOCE; Foster, 2005). Due to
the variability in the behavior of Ba2+ and Sr2+ fluxes, it was difficult to further characterize
non-store operated Ca2+ entry (NSOCE) and SOCE using this approach. As a result, the
involvement of AA in the mitogen-evoked Ca2+ influx is first studied. Cytoplasmic phospholipase
A2(cPLA2} is a Ca2+-dependent enzyme that mediates agonist-dependent AA release in many cell
types. The activation of cPLA2 involves Ca2+-dependent translocation of the enzyme from the
cytosol to intracellular membranes and phosphorylation of the Ser505 residue (de Carvalho et a!.,
1996). Immunofluorescence was used to determine whether changes in cell shape affect the
distribution of phosphorylated cPLA2 (phospho-cPLA2; the activated form of cPLA2) in 3T3
fibroblasts. In addition, mitogen-activated protein (MAP) kinases inhibitors (FR180204 &
PD98059) which inhibit the phosphorylation of cPLA2 were also used to examine the role of cPLA2
in the bombesin-evoked Ca2+ influx pathway. The distribution of phospho-cPLA2 was examined
using a Leica AOBS scanning confocal microscope (excitation 488nm and emission 510-525nm).
The results showed that there is a significant increase in the intensity of phospho-cPLA2
iii
immunofluorescence after the stimulation by bombesin (lOOnM) in normal spreading Swiss 3T3 
cells. This increase in the intensity of phospho-cPLA2 immunofluorescence was not affected when 
the cell spreading was restricted using small adhesive islands (022pM). Both FR180204 and 
PD98059 showed little inhibition on the increase in the intensity of phospho-cPLA2 
immunofluorescence. Additionally, they failed to inhibit the bombesin-evoked Ca2+ influx when 
the [Ca2+]j responses were monitored using a PTI Ca2+ imaging system or a Flexstation plate 
reader. These findings suggest that cPLA2may not be required to activate the bombesin-evoked 
Ca2+ influx. Instead of cPLA2, iPLA2 may be important to this Ca2+ influx pathway since bromoenol 
lactone (BEL), an iPLA2 inhibitor, effectively blocked the bombesin-evoked Ca2+ influx. 
Ca2+-independent phospholipase A2 is reported to generate AA (Atsumi et al., 1998), but may also 
have other action that are critical to Ca2+ entry. It is believed to be a key component in the 
activation of SOCEs associated with (Ca2+ influx factor) GIF and stromal interacting molecule 1 
(STIMl)-Orai (reviewed by Bolotina, 2008).
The participation of AA in the bombesin-evoked Ca2+ influx is further studied using AA inhibitors 
including two cPLA2 inhibitors (cPLA2ot inhibitor & AACOCF3) and one DAG inhibitor (RFIC80267}. 
The results suggested that AA may still be involved in this Ca2+ entry. However, rather than cPLA2, 
it may be generated through the DAG pathway.
The involvement of SOCEs is investigated. The use of a widely applied SOCEs inhibitor, SK&F96365, 
indicated that SOCEs play a role in this bombesin-evoked Ca2+ influx. The effect of cell shape on 
the activity of STIM1, a key component in SOCEs activation (Liou etai, 2005), was then examined 
using mCherry- /YFP-STIM1 plasmids. Bombesin is able to induce the STIM1 puncta formation in 
unrestricted HeLa and Swiss 3T3 cells. However, bombesin is not as effective as thapsigargin in 
evoking STIM1 puncta. No clear bombesin-induced STIM1 puncta was observed in the 
shape-restricted Swiss 3T3 cells. The results indicated that the thapsigargin-induced STIM1 
puncta formation is not cell-shape dependent. Thapsigargin is effective in promoting STIM1 
puncta formation in shape-restricted cells. It remains a possibility that attenuation of puncta 
formation after stimulation by bombesin in the cell spreading-restricted cells underlines 
cell-shape-dependent Ca2+ influx.
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Chapter I
1.1 Introduction
Cell proliferation is necessary for controlled growth, development, tissue maintenance and tissue 
repair. This involves the faithful replication of genome, organellogenesis and highly coordinated 
partitioning of the chromosome and organelles. Regulation of cell proliferation is essential to 
allow appropriate growth and development. Extracellular signals {e.g. growth factors) and 
environmental events serve to regulate this process. Deregulation of cell cycle is a key event in 
the development of various diseases, such as cancer, cardiovascular diseases and hyperplasias. 
Hence, it is important to study the mechanisms of cell cycle regulation.
1.2 The cell cycle
The cell cycle is the series of events that lead to cell replication. In eukaryotes cells, the cell cycle 
consists of two consecutive processes: interphase and mitosis (M) phase. During the interphase, 
cells grow in size, accumulate the nutrients needed for the mitosis and duplicate their DNA. This 
interphase stage is made up of 3 phases: Gi, S and G2 (Figure 1.1, page 8). Cells increase in size in 
Gx phase and prepare for the DNA replication during S phase, while the G2 phase is a gap for the 
cell to prepare for mitosis (reviewed by Norbury and Nurse, 1992). Following the transition 
through G2 phase, cell undergoes the M phase, which begins with mitosis. Mitosis is traditionally 
divided into four distinct phases, sequentially known as prophase, metaphase, anaphase and 
telophase. During the mitosis, the duplicated DNA is distributed to a pair of identical daughter 
nuclei. Once mitosis is completed, the second major process of M phase-cytokinesis splits the cell 
into two daughter cells, each with one nucleus. Cells that have temporarily or reversibly stopped 
dividing are said to have entered a state of quiescence called the G0 phase (reviewed by Norbury 
and Nurse, 1992). The cell cycle is tightly regulated by series of checkpoints, such as DNA damage 
checkpoints and spindle checkpoints to detect possible defects. Once defects are detected, the 
cell cycle is arrested so that repair can take place (reviewed by Vermeulen et at., 2003). Various 
extracellular signals also play an important role in coordinating the cell cycle progression. The 
mechanisms of cell cycle regulation are explained in sections 1.2.1-1.2.5.
1.2.1 Regulation of the cell cycle by intracellular checkpoints
The transition from one cell cycle phase to another occurs in a precise order and is regulated by
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different cellular proteins. The key regulatory molecules are the cyclin-dependent kinases (CDKs). 
CDKs are serine/threonine protein kinases that are activated when associated with cyclins. 
Cyclins are a family of proteins that function as regulators of cell cycle progression (reviewed by 
Nigg, 1995; Murray, 2004). Multiple cyclins and CDKs have been identified. There are three 
interphase CDKs (CDK2, CDK4 and CDK6), a mitotic CDK (CDK1) and four main types of cyclins 
(cyclin A, cyclin B, cyclin D and cyclin E). When activated by a bound cyclin, CDKs activate or 
inactivate target proteins by phosphorylation to coordinate entry into the next phase of the cell 
cycle (Morgan, 1995). CDKs are constitutively expressed in cells whereas the concentration of 
cyclins varies at specific stages of the cell cycle, in response to various molecular signals (Figure 
1.2, page 9). When the concentration is low, the cyclins disassociate from the CDKs, which inhibits 
the enzymatic function of CDKs.
Different cyclin-CDK complexes function at different phases and they are negatively regulated by 
various CDK inhibitors (CKIs) to ensure the correct timing and sequence of key steps required for 
cell division (Figure 1.1. page 8). When a defect is detected at a checkpoint of the cell cycle, CKIs 
can arrest the cell cycle through different signaling pathways. They bind to the CDK alone or the 
cyclin-CDK complex to regulate CDK activities. Two CKI families have been discovered: the INK4 
family and the Cip/Kip family (reviewed by Sherr and Roberts, 1995). The INK4 family includes 
pie'NMa pi5INK4b (pl5), pl8INK4c (pl8), and pl9INK4d (pl9). The cip/kip family in contrast,
includes the gene products from p21Cipl/Wafl/sdl1 (p21), p27Kipl (p27) and p57KipZ (p57). The INK4 
family inhibits CDK4 and CDK6 activity during G1 phase specifically, whereas the Cip/Kip family 
can inhibit CDK activity during all phases of the cell cycle (reviewed by Sherr and Roberts, 1999).
After stimulation by a mitogenic signal, cyclin D is expressed and preferentially activates CDK4 
and CDK6. This enables cells to enter the Gi phase from G0( startingthe ceil cycle progression. The 
cyclinD-CDK4/6 complex then enables the cell to pass the checkpoint in Gi phase by 
phosphorylating and inactivating the retinoblastoma protein (Rb) (reviewed by Sherr, 1994). The 
Rb is a tumor suppressor pocket protein that is dysfunctional in many types of cancer. It prevents 
the cell from replicating damaged DNA by preventing progression through the cell cycle from Gi 
into S (reviewed by Massague, 2004). When Rb is in an activated state (unphosphorylated), it
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binds and inhibits transcription factors of the E2F family, and the resulting Rb”E2F interaction 
blocks the transcriptional activities of many important genes necessary for S phase (Dyson, 1998). 
Once Rb is phosphorylated by cyclinD-CDK4/6, it disassociates from E2F and enables the E2F 
dependent transcription of the cyclin E gene along with other components that support DNA 
replication (reviewed by Stevaux and Dyson, 2002). Cyclin E then activates CDK2 in late In 
addition, the cyclinE-CDK2 complex can further phosphorylate Rb, leading to the expression of 
additional genes necessary for DNA synthesis (Ohtani et al., 1995; Harbour et al., 1999). Both 
families of CKIs were reported to have a role in the Gi-S checkpoint. For instance, pl6 can arrest 
the cell cycle at the Gi phase by binding and inhibiting CDK4 and CDK6 to prevent the Rb 
phosphorylation (McConnell et al., 1999; Thullberg et al., 2000). P21 can arrest the cell cycle at 
the Gi checkpoints when activated through the ataxia-telangiectasia-mutated (ATM)-p53 
pathway triggered by damaged DNA. The ATM is one of a number of protein kinases that can 
recognize damaged DNA. Activated ATM phosphorylates p53, a tumor suppressor protein, which 
further leads to the activity of p21 (Siliciano et al., 1997; Gartel and Tyner, 1999). Another Cip/Kip 
protein p27 is found to be effective in antagonizing the activity of cyclinE-CDK2 which may not be 
present in quiescent cells or in early Gi. phase (Coats et al., 1996).
After the cell cycle enters S phase, cyclin E is degraded and cyclin A accumulates, which leads to 
an exchange of cyclin E with cyclin A in the CDK2 complexes (Girard et al., 1991). Following S 
phase, cyclin A separates from CDK2 and associates with CDK1 promoting the entry into mitosis. 
The mechanism of S phase checkpoint is still poorly understand, while in the G2/M phase, the cell 
cycle can be arrested by the ATM-dependent and other damaged DNA sensing manners, such as 
ATR (ATM and Rad3-related)-dependent pathway. For example, the human checkpoint kinase 2 
(Chk2) and Chkl which are activated by ATM and ATR respectively can phosphorylate and inhibit 
cdc25. Cdc25, a specific tyrosine phosphatase, its dysfunction can lead to the suppression of 
cyclin A/B-CDK1 complex and restraint of cell cycle in G2/M phase (Karlsson-Rosenthal and Millar, 
2006) In addition, the ATM-p53-p21 pathway is also capable of arresting the G2 phase by 
sequestrating CDK1 in the cytoplasm and by inactivating cyclinB-CDKl complexes, respectively 
(reviewed by Stewart et al., 2003).
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Finally, mitosis is regulated by cyclin B in complex with CDK1 (King et ai, 1994; Wheeler et ai, 
2008). There is a spindle checkpoint during M phase which monitors the microtubule structure 
and chromosome attachments of the mitotic spindle and delays chromosome segregation during 
anaphase until defects in the mitotic spindle apparatus are corrected. More details on the spindle 
checkpoint is reviewed by Musacchio and Fiardwick (2002).
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Figure 1.1-Regulation of checkpoints during cell cycle
The cell cycle progress of four distinct phases: Gx, S, G2 and M phases. Cells that have temporarily 
or reversibly stopped dividing are said to have entered a state of quiescence called G0 phase. 
Various positive and negative regulators are presented in this figure.
The figure is modified from 'G1 cell-cycle control and cancer' (Massague, 2004).
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Gjphase S phase G2phase M phase
Figure 1.2-Expression levels of cyclins during cell cycle
Expression levels of 4 main cyclins (cyclin A, cyclin B, cyclin D and cyclin E) change during the cell 
cycle progression are shown in the figure. Different cyclin/CDK complexes function in different 
cell cycle phases.
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1.2.2 The cell cycle and MAP kinase
Intracellular regulators are not sufficient to fully control cell cycle progression. Extracellular 
signals, which trigger and mediate these regulators, are required. Many cells remain in G0 phase 
for long periods of time. The commencement of a cell cycle is triggered by mitogens which 
activate intracellular signaling cascades. These mitogens act to overcome the intrinsic inhibition 
of the restriction points in the Gi phase (reviewed by Kahl and Means, 2003; Upskaia and Lompre, 
2004). Mitogens include a wide range of substances, such as growth factors, cytokines and many 
hormones (reviewed by Munaron et al., 2004). They induce a series of intracellular signals either 
by binding to membrane or intracellular receptors and activate protein kinase C (PKC) via G 
protein-coupled receptors, receptor tyrosine kinases (RTK), or Raf kinases via the 
mitogen-activated protein (MAP) kinases (Figure 1.3, page 11). MAP Kinases, also described as 
extracellular-regulated kinases (ERKs), belong to a family of serine/threonine protein kinases. In 
mammalian cells, there are mainly two highly homologous MAP Kinases: p42 and p44, also called 
ERK2 and ERK1 respectively. As shown in figure 1.3, the RTK activated by the mitogen activates a 
GDP binding protein called Ras, which subsequently associates with the serine-threonine kinase 
Raf. Raf kinase phosphorylates and activates MAP kinase kinase kinases and MAP kinase kinases 
generally referred as MEKs. MEKs downstream phosphorylate and activate MAP Kinases. 
Phosphorylated MAP Kinases could translocate into the nucleus and there interact with different 
transcription factors (Avruch et al., 2001). Previous works have shown that the Ras-regulated 
Raf-MEK-MAPK/ERK protein kinase cascade plays an important role in the control of cell 
proliferation and differentiation in both G0/Gi and Gi/S transitions (Lenormand et al., 1993; 
Pages et al., 1993). Ras itself induced several changes that promote Gi arrest, including induction 
of p21, pl5 and p!6 (Dajee et al., 2003). In addition, Ras was reported to induce nuclear factor 
(IMF)-kB activity, a transcription factor which can suppress CDK4 in Gi phase, through a pathway 
involving phosphoinositide 3-kinase (PI3K), Akt or PKC (Shirakawa and Mizel, 1989; Pan et al., 
1999; Madrid etal., 2001; Dajee etal., 2003) (Figure 1.3, page 11).
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Figure 1.3- MARK signaling pathways
Main MARK signaling pathways, including Ras-MEK/MAPK pathway and MAPK-PI3K-AKt pathway, 
are shown in the figure. The downstream of these signal cascades results in the activation of 
various transcription factors, such as c-Fos, c-JUN, CREB which in turn regulate the cell cycle 
progression.
The figure is modified from '3-Hydroxyanthranilic acid inhibits PDK1 activation and suppresses 
experimental asthma by inducing T cell apoptosis'fHayashi et al., 2007)
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1.2.2.1 Bombesin as a mitogen
Bombesin is an amphibian teradecapeptide first isolated from the skin of the European frog 
Bombina Bombina (Anastasi et al., 1971). The peptides of the bombesin family including 
gastrin-releasing peptide (GRP) and neuromedins are potent mitogens for a variety of cells 
(Wang et o/., 1996; Burdakov et al., 2001). The function of bombesin was widely studied, 
especially in Swiss 3T3 cells (Rozengurt and Sinnett-Smith, 1983; Rozengurt and Sinnett Smith, 
1987; Battey et al., 1991). The mitogenic response induced by bombesin depends on its binding 
to specific, high-affinity G protein receptors, which distinguish bombesin from other growth 
factors.
Bombesin plays a role in the regulation of cell proliferation. A complex set of events can be 
triggered by bombesin. It induces the activation of both mitogen-activated protein (MAP) kinase 
pathway and epidermal growth factor (EGF) receptor (Igishi and Gutkind, 1998; Santiskulvong et 
al., 2001). Bombesin evokes rapid activation of p42 and p44 in Swiss 3T3 cells (Withers et al., 
1995), that is completely dependent on PKC (Pang et al., 1993) It also activates p42 and p74 
through a PKC-independent pathway in Rat-1 cells (Charlesworth and Rozengurt, 1997). In 
addition, bombesin is able to stimulate DNA synthesis and cell division without the presence of 
other mitogens (Rozengurt and Sinnett-Smith, 1983). It can induce the expression of the nuclear 
transcription factors c-fos and c-myc (Rozengurt and Sinnett Smith, 1987).
It was reported that bombesin coupled with a Gq-like G proteins to elicit phospholipase C (PLC) 
mediated hydrolysis of phosphatidylinositolbisphosphate (PIP2). This leads to a Ca2+ release 
from intracellular stores and the activation of PKC (Wang et al., 1996; Rozengurt, 2007). The RyR 
receptors are also involved in bombesin-evoked Ca2+ response and may be required to produce 
cytosolic Ca2+ spiking (Burdakov et al., 2001). It was suggested that, along with cholecysokinin 
(CCK), bombesin shares the ability to transfer a local Ca2+ signal to a global Ca2+ transients 
(Takahashi et a!., 2000).
1.2.3 The cell cycle and Ca2* signaling
One of the critical cascades of these mitogen evoked signaling pathways is the increase of
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intracellular free Ca2+ ([Ca2+]i) which as a key second messenger further regulates the cell cycle 
progression. The increase of [Ca2+]j is due to both the Ca2+ release from intracellular stores and 
the influx of extracellular Ca2+through the plasma membrane. While the Ca2+ release is transient, 
the mitogen-induced Ca2+ influx is sustained and can last for 1 hour (Barbiero et al., 1995). Many 
reports support the essential role of Ca2+ in cell cycle (Takuwa et al., 1995; Whitaker and Larman, 
2001). It is reported that Gq/G! and Gi/S transitions are sensitive to the Ca2+ pool depletion 
(Means, 1994). On the other hand, the presence of extracellular Ca2+ is required during the cell 
cycle progression, especially at some critical points, such as the G0/Gi, Gi/S and G2/M phases 
(Barbiero et al., 1995; Bodding, 2001; Santella et al., 2005). For instance, when proliferating 
fibroblasts are cultured in medium containing a low Ca2+ concentration media, they cease cellular 
division at the Gi phase (Kahl and Means, 2003). It was also observed that blocking the Ca2+ influx 
with SK&F96365 results in the accumulation of cells in the G2/M phases (Barbiero etal., 1995).
Ca2+ elevation is transduced into cellular effects by either directly binding to target effectors or by 
binding to Ca2+ binding proteins, such as calmodulin (CaM). In mammalian cells, CaM is a highly 
conserved Ca2+ binding protein that contains four EF-hand Ca2+ binding motifs. The intracellular 
CaM level varies following cell cycle progression, and this affects the proliferative capacity of cells. 
It has been shown that CaM is required at two points of cell cycle: early after mitogen stimulation 
and near the G^S boundary (Chafouleas et al., 1982; Rasmussen and Means, 1987). There are 
numerous enzymes which are targets of the Ca2+/CaM complex which broadens the function of 
Ca2+. Among them, the Ca2+/CaM-dependent protein kinases (CaMKs) and the 
Ca2+/CaM-dependent protein phosphatase 2B, calcineurin are two identified essential enzymes 
that mediate cell proliferation. In the early Gi phase, inhibition of both CaMKs and calcineurin 
results in the accumulation of cells before the activation of cyclinD-CDK4. While at Gi/S boundary, 
CaMKs or calcineurin inhibitors could lead to p27 and p21 accumulation respectively, which 
arrests cell progression by blocking the expression of CDK2 (Kahl and Means, 2003). The 
mechanisms by which CaMKs and calcineurin regulate the cell cycle are complex and differ 
among cell types. So far, it has been demonstrated that the transcription factor adenosine 
S^S'-monophosphate (cAMP) response element-binding protein (CREB) and CREB binding
protein/p300 (CBP/300) signaling pathway is one of the models through which CaMKs participate
13
Chapter 1
in mediating proliferation. Following the increase of [Ca2^, the activated CaMKs phosphorylate 
CREB and CBP/300 which promotes the transcription activity of p53 and p21 expression. On the 
other hand, calcineurin is most well characterized in term of its function in nuclear factor of 
activated T cells (NFAT) signaling. NFAT translocates into nucleus and regulates the transcription 
of cell cycle-related genes such as cyclin A, cyclin D, CDK4 and Rb {Baksh et al., 2002; Caetano et 
al.t 2002; Neal and Clipstone, 2003). The translocation of NFAT is mediated by calcineurin and is 
dependent on the increase of [Ca2+]j. Besides, CaMKs and calcineurin have been reported to 
participate in the Ca2+ dependent MAPK-NFkB pathway which controls the cell cycle through 
transcriptional regulation of cyclin D1 during G0/Gi phase (See et al., 2004). In addition to CaM, 
other Ca2+ sensors have been identified including downstream regulatory element antagonist 
modulator (DREAM) and S100B which can directly modulate transcription through interaction 
with a DNA promoter element or a transcription factor (Ikura et al., 2002). For example, S100B, a 
Ca2+-binding peptide, is suggested to interact with the p53 and inhibits both p53 by PKC (Delphin 
et al., 1999). DREAM is an EF-hand Ca2+-binding protein that represses transcription of c-fos 
genes (Mellstrom and Naranjo, 2001).
Despite a great deal of research into how Ca2+ controls the cell cycle, the bigger picture remain 
unknown. It is no doubt that Ca2+ is involved in more than one cell cycle regulation pathway since 
the mechanisms vary at different cell cycle transitions. Moreover, different cell types may have 
distinct Ca2+ dependent mechanisms.
1.2.4 The cell cycle and cell adhesion
In addition to mitogens and Ca2+, cell adhesion to the extracellular matrix (ECM) is another 
equally important regulator for normal cell cycling. It is known that most normal mammalian cells 
start to proliferate only when they are attached to a substrate (Folkman and Moscona, 1978). For 
instance, the ECM has been proved to play a key role in modulating capillary endothelial (CE) cell 
sensitivity to soluble mitogens and, thereby, trigger and control their cell proliferation (Ingber, 
1990).
The molecular mechanism of this adhesion-dependent growth control is still unclear. The
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interaction of ceils with the ECM is a dynamic process. The primary subcellular structures that 
mediate the regulatory effects of ECM adhesion on cell behaviour are the focal adhesions (FAs) 
(Chen et ol., 2003). Focal adhesions are macromolecular complexes that form regions where the 
surface of the cells come closest to the substrate. They regulate cell adhesion to the ECM by 
coupling integrins to the actin cytoskeleton. Integrins represent a family of heterodimeric cell 
surface proteins receptors that bind to ECM proteins, such as fibronection (FN; Ruoslahti, 1991). 
Cells have been observed to lose the ability to hyperphosphorylate Rb when they are coated on 
low FN density substrates (Ingber, 1990).
The key function of integrins is to promote cell adhesion and to transduce signals to the nucleus 
and enable gene expression by activating the intracellular pathways (Schwartz and ingber, 1994). 
It was found that integrins could stimulate multiple early mitogen-induced events associated with 
transition from G0 to Gi phase of the cell cycle. These include expression of immediate early 
growth response genes (Huang and Ingber, 1999). Such adhesion-dependent control on the cell 
cycle process is believed to occur through the integrin-mediated activation of MAPK/ERK 
pathway which regulates the cell cycle (Morino et al., 1995). The integrin binding appears to 
promote the transferring and propagation of signals to ERK pathways (Clark and Hynes, 1996; Lin 
ef al., 1997).
Studies using fibroblasts revealed that the adhesion to ECM controls entry into S phase as well. 
Unanchored fibroblasts remain arrested in mid-Gi phase, whereas the same cells pass through 
this restriction point and enter S phase when allowed to reattach and spread on an ECM 
substrate. A decrease of the level of cyclin E or cyclin D and an increase of CDK inhibitor p27 and 
p21 was observed in different studies (Zhu etal., 1996; Resnitzky, 1997; Huang and Ingber, 1999).
1.2.5 The cell cycle and cell spreading
Along with adhesion to the ECM, changes in cell spreading are also essential to cell cycle. The
maintenance of cell shape and its spread relies on the attachment of integrins and the
arrangement of the cytoskeleton. The cytoskeleton is composed of three major types of protein
filaments, including microfilaments, microtubules and intermediate filaments. The
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microfilaments are polymers of actin. They constitute the actin cytoskeleton together with a large 
number of actin-binding and associated proteins. The actin cytoskeleton is essential for the 
modulation of cell shape (Hay, 2005).
There are mainly two ways to manipulate the cell shape and control the spreading in studies on 
cell shape. One method is to restrict spreading using a non-adhesive polymer called poly 
(2-hydroxyethyl methylacrylate) (polyHEMA). Varying concentrations of polyHEMA have been 
used (Folkman and Moscona, 1978). Cells attached but did not spread on thick layers of high 
concentration polyHEMA while they attached and spread on a thin layer of low concentration 
polyHEMA. This method has been modified by growing cells on a defined area of 
palladium-substratum surrounded by non-adhesive polyHEMA over which the cells cannot spread 
(Ireland et a!., 1987). These areas of palladium-substratum are called adhesive islands. Another 
widely used method to prevent cell spreading is to disrupt the actin cytoskeleton using drugs, 
such as cytochalasins and jasplakinolide (Huang and Ingber, 2002).
It has been shown that restricting cell spreading with adhesive islands of 022|im and 045|im 
prevents S phase entry (Ireland et al., 1987; Pennington et al., 2007). While ECM and growth 
factor signals trigger the cell to pass through the G0/Gi phase, they are not sufficient to promote 
the progression to S phase when the actin cytoskeleton is disrupted (Huang and Ingber, 1999).
In summary, restricting the cell spreading by culturing the cells on small adhesive islands or 
disrupting the cell cytoskeleton by drugs prevent S phase entry, but how cell shape controls the 
cell growth remains obscure. So far, it has been found that preventing cell spreading failed to 
increase cyclin D levels or down-regulation of p27and the cells are arrested in late Gi before Rb 
checkpoint (Huang et al,, 1998).
1.3 Ca2* signaling
The intracellular Ca2+ ([Ca2+]i) is a critical signal that regulates various cellular activities from the
rapid responses such as contraction and secretion to long-term regulation of transcription,
growth, and cell division, as reviewed by Potier and Trebak (2008). Changes of [Ca2+]i level are
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tightly controlled by complex interactions among ion channels, transporters, pumps and binding 
proteins. The resting level of [Ca2+]i is normally maintained in the range of around lOOnM. To 
maintain this low concentration, Ca2+ is actively pumped from the cytosol and accumulated in the 
intracellular stores, such as the endoplasmic reticulum (ER) or sarcoplasmic reticulum (SR), and 
sinks such as mitochondria. Signaling occurs when Ca2+ is stimulated to enter from the outside 
through the plasma membrane or to be released from the ER/SR. The level of [Ca2+]j normally 
rises to 500-1,OOOnM after the stimuli. Most of the increased [Ca2+]i binds to buffers, whereas a 
small proportion binds to the effectors that activate and mediate a large number of cellular 
processes (Berridge etaL, 2003).
The properties of Ca2+ signals are quite diverse and can be local or global, transient or sustained. 
Local Ca2+ signals occur when the Ca2+ concentration is elevated within restricted microdomains 
at the mouth of channels or when larger subcellular Ca2+ signals span several micrometers 
(Bootman et ai, 2001). They can be generated by opening the channels located either in the 
plasma membrane or in the Ca2+ store membrane as long as the stimulus is sufficiently small 
(Cancela etai, 2002). For instance, Ca2+ "blips" are signals that are caused by the opening of the 
inositol 1,4,5-trisphosphate receptors (IPaRs) while "quarks" are the result of the opening of 
ryanodine receptors (RyRs) (reviewed by Webb and Miller, 2003). More details of the IP3Rs and 
RyRs are described in section 1.4. Local Ca2+ signals can last for up to 200ms and have an 
amplitude less than 30nM depending upon the cytosolic environment, spread for no more than a 
couple of micrometers (reviewed by Laude and Simpson, 2009). The amplitude of Ca2+ signaling 
events including Ca2+ "puffs" or "sparks" form from the coordinated Ca2+ release from a 
population of IP3Rs or RYRs respectively. These two events can spread no more than 6^m, 
possess a typical amplitude of up to 200nM and last for no longer than 500ms (reviewed by 
Laude and Simpson, 2009). Since such signals can remain localized and activate effectors within a 
particular region, it is believed that local Ca2+ signals serve to activate specific targets to regulate 
different events via Ca2+ passage through different channels (Bootman et al., 2001; Taylor et ai, 
2009).
Local Ca2+ signals can transform into global Ca2+ signals in different ways. A higher agonist
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concentration is one of the causes. For example, low concentration of acetylcholine (ACh) or CCK 
generates local Ca2+ signals whereas higher concentration causes global Ca2+ signals (Cancela et 
al., 2002). In addition, Ca2+-induced Ca2+ release (CICR) is another way to transform a local Ca2+ 
signal into a global wave (Cancela et al, 2002). One of the global Ca2+ signals, a Ca2+ wave, was 
observed to be generated by the recruitment of various local Ca2+ signals, starting from a 
restricted region of the cell. This then propagates, leading to a global Ca2+ wave (Boittin et al., 
1999; Dumollard et al., 2002). Ca2+ waves can then pass through the cell and spread to other cells 
if they are connected.
Ca2+ oscillations are another well studied global Ca2+ signal which has been seen in many, if not all, 
types of cells (Fewtrell, 1993). The term oscillation refers to all fluctuations in Ca2+ whether these 
appear as regular fluctuations about a mean value (sinusoidal oscillations) or occur as discrete 
transients arising from a constant resting level (transient oscillations; Berridge, 1990). There are 
numerous speculations about the role of oscillations, especially in the non-excitable cells. A 
widespread theory is that oscillations permit a smoothly graded input to be translated into a 
digital all-or nothing signal in which the information is robustly encoded in the timing rather than 
the amplitude of pulses. Oscillations allow Ca2+ signals to regulate various processes via timing 
and frequency in different patterns (Lewis and Cahalan, 1989; Bhakta et al., 2005).
The generation and modulation mechanisms of oscillations have been extensively studied. In the 
excitable cells, oscillations usually arise from the Ca2+ entry from outside through the 
voltage-gated channels. In non-excitable cells, oscillations can be generated in 
receptor-controlled models mainly relying on the IP3Rs (Berridge, 1990).
All these Ca2+ signals are important parts of the Ca2+ homeostasis system, which is sustained by 
extracellular Ca2+ influx along with Ca2+ release from intracellular stores. They will be discussed in 
section 1.4 to 1.6.
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1.4 Intracellular Caz+ release 
1.4.1 Ca2+ stores
Various intracellular Ca2+ stores play both a structural and dynamic role in Ca2+ homeostasis. Due 
to a large number of immobile Ca2+ binding sites in the cytosol, the diffusion of cytosolic Ca2+ 
([Ca2+]c) is slower than other second messengers. The elevation of [Ca2+]c by the influx from the 
outside is insufficient to fulfill all its diverse functions. The existence of widely distributed and 
rapid by mobilizable intracellular Ca2+ stores facilitate the diffusion of Ca2+ and, moreover, permit 
the generation of local Ca2+ signals. These may be initiated at a distance from the plasma 
membrane. More importantly, the Ca2+ stores sequester Ca2+ to keep a low level of [Ca2+]c after 
the Ca2+ transient has occurred (Pozzan et al., 1994). So far, the most prevalent Ca2+ stores or 
sinks are ER/SR, mitochondria and Golgi.
The ER contains the rapidly exchanging Ca2+ pools in non-excitable cells while the SR functions in 
muscle cells (Pozzan et at., 1994). They accumulate Ca2+ via the sarcoplasmic/endopiasmic 
reticulum Ca2+ ATPase (SERCA) pumps and release it through IP3Rs and RyRs. The ER/SR is 
physically continuous and spatially and functionally heterogeneous. Many Ca2+ binding proteins 
are unevenly distributed in ER. These include calsequestrin and calretiulin which function as 
major Ca2+ buffers. The concentration of Ca2+ inside the ER varies from micromolar to near 
miilimolar concentration. Generally values of at least 100pm are seen when the store is Ca2+ 
loaded and a number of reports suggest that concentration of Ca2+ inside the ER is between 400 
and 800pm (reviewed by Laude and Simpson, 2009).
Mitochondria sequester Ca2+ via a low-affinity, high-speed uniporter powered by the 
mitochondrial membrane potential. It was reported that the mitochondrial Ca2+ uptake was 
stimulated by IP3-evoked Ca2+ release, capacitative Ca2+ entry (Section 1.6), and Ca2+ leaking from 
the ER. The amplitude of [Ca2+]j signals is also a determinant of mitochondria Ca2+ accumulation 
(Collins eta!., 2001). Due to these special properties, mitochondria can dampen and prolong the 
[Ca2+Ji responses (reviewed by Laude and Simpson, 2009).
The Golgi is another lP3-sensitive Ca2+store. This IP3-mediated Ca2+ release is slower than that
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from the ER (Pinton et ol., 1998). It accumulates Ca2+ via SERCA pumps and also the secretory 
pathway Ca2+ATPase (SPCA; Pinton et a!., 1998). In addition (reviewed by Rizzuto and Pozzan; 
2006), other various compartments such as acidic endosomes, lysosomes and secretory granules 
can accumulate Ca2+ as well.
1.4.2 Different Ca2* release mechanisms
It has been revealed that ER/SR can release Ca2+ through various different membrane channels. 
The IP3Rs and RyRs are two major Ca2+ channels regulating Ca2+ release from ER/SR. These two 
receptors are sensitive to different messengers. For example, IP3Rs can be activated by IP3 while 
the RyRs can be triggered by cyclic adenosine diphosphate ribose (cADPR). Significantly both also 
operate by Ca2+-induced Ca2+ release (CICR). This is the primary trigger of Ca2+ release via RyRs 
(Endo, 1977). In addition, nicotinic acid adenine dinucleotide phosphate (NAADP) has been 
reported to cause Ca2+ release in a distinct way. All these multiple messengers modulate Ca2+ 
release in different ways and produce specific Ca2+ signals responding to different stimuli. There is 
also believed to be a hierarchy of Ca2+ release in which trigger events initiate further release 
(Bootman et al., 1997; Huser and Blatter, 1997).
1.4.2.1 IP3 sensitive Ca2+ release
IP3R is a tetramer of about 260 kilodalton (kDa) subunits. The receptor is expressed in abundance 
in the ER (reviewed by Tsien and Tsien, 1990). At least three different isoforms have been 
identified in mammalian cells, and there may exist in heterotetramers (Dawson, 1997).
The IP3R enables Ca2+ influx due to its sensitivity to IP3.The role of IP3 on Ca2+ release was first 
reported in 1980s (Streb eta!., 1983). Since then, many cell types were observed to demonstrate 
IP3-induced Ca2+ release. IP3 is generated as a consequence of an agonist binding to cell surface 
receptors resulting in activation of G-proteins or certain tyrosine kinases. They in turn activates 
enzyme PLC, which catalyzes the hydrolysis of PIP2 into IP3 and diacylglycerol (DAG; Lee and Rhee, 
1995) (Figure 1.5, page 41). IP3 triggers the Ca2+ release by activating the IP3Rs in ER. In addition, 
IP3 can cause Ca2+ release from the Golgi and some other secretory granules as well (Pinton et al., 
1998).
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IP3R as a Ca2+ release channel in the ER Ca2+ store is regulated by a number of ligands; including 
the most important ones IP3 and Ca2+. These ligands regulate the IP3R activity mainly by 
modifying the sensitivity of the channels to Ca2+ regulation.
The IP3-gated Ca2+ release plays a crucial role in the generation of Ca2+ signals including 
oscillations and waves (Berridge, 1990). IP3R exhibits very complicated properties. Generally, Ca2+ 
regulates steady-state IP3R channel gating with a biphasic concentration-dependence: Ca2+ at low 
concentrations activates the channel, whereas at higher concentrations, Ca2+ inhibits the channel 
(reviewed by Foskett et al., 2007). This biphasic effect of [Ca2+]c on IP3Rs provides the key to 
understanding the oscillatory behaviour. Most IP3Rs become more sensitive to IP3 as the [Ca2+]c is 
modestly increased, which leads to CICR. While the [Ca2+]c increases further, IP3Rs are then 
inhibited. It is argued that IP3Rs are ideal for CICR, since in the presence of IP3, a small increase of 
[Ca2+]c is able to trigger Ca2+ release via the IP3Rs (Foskett et al., 2007). A possible mechanism for 
these effects is that: a IP3R is inhibited by Ca2+without IP3 bound, but after IP3 binding the 
inhibitory Ca2+-binding site is concealed and a stimulatory Ca2+-binding site is exposed, allowing 
Ca2+ to promote channel opening (Adkins and Taylor, 1999; Taylor and Laude, 2002).
IP3Rs work in a complex way. In addition to ligands, they are also regulated by phosphorylation by 
various kinases. As reviewed by Foskett et al. (2007), these kinases include cAMP-dependent 
protein kinase (PKA), cyclic guanosine 3,5-monophosphate (cGMP)-dependent protein kinase 
(PKG), Ca2+/CaM-dependent kinase II (CaMKII), PKC and various protein tyrosine kinases (PTKs).
1.4.2.2 RyRs sensitive Caz+ release
The RyRs were first identified in skeletal muscle cells (Endo, 1977). So far, three mammalian RyRs
subtypes have been defined (RyRl, RyR2 and RyR3). The RyRs are expressed in a variety of tissues
(Fill and Copello, 2002). The RyRl protein is the predominant isoform in skeletal muscle cells
while the RyR2 protein is the most abundant isoform in cardiac muscle cells and the RyR3 is
expressed more widely, but especially in the brain (Zucchi and Ronca-Testoni, 1997; Fill and
Copello, 2002). They may co-exist with IP3Rs in the same cells.
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The study of the RyRs has focused on its role in muscle cells. In striated muscles, RyRs are 
responsible for regulating Ca2+ release from the SR in order to trigger contraction, this occurs 
through a mechanism called "excitation-contraction coupling" (Rossi and Sorrentino, 2002). RyRs 
are also thought to be involved in CICR with a bell-shaped relationship with Ca2+ (Chen et ai., 
1992), which will be discussed in the next paragraph.
Evidence shows that the RyR channels are poor Ca2+ selective channels with high conductance, 
which can be activated by various endogenous and exogenous regulators. For instance, it is found 
that cADPR and caffeine can activate RyR channels, while, ruthenium red is a well known RyR 
channel inhibitor (Rossi and Sorrentino, 2002). In addition, other regulators, such as Ca2+ itself, 
CaM and ryanodine have biphasic effect on RyR channel activity at different concentrations (Rossi 
and Sorrentino, 2002). Like Ca2+, the RyR channels are activated by low [Ca2+]c (nM-pM) and 
inhibited by high [Ca2+]c (pM-mM).
Among these modulators, cADPR plays an important role in regulating RyRs to induce CICR in 
many cell types (Galione et at., 1991). Cyclic adenosine diphosphate ribose is a metabolite of 
nicotinamide adenine dinucleotide (NAD). It was first found to act as a powerful intracellular Ca2+ 
release agent in sea urchin eggs (reviewed by Churchill et al., 2002). The cADPR-induced Ca2+ 
release can by blocked by chemical analogues, such as 8-amino- cADPR or 8-bromo- cADPR 
(Galione and Churchill, 2002). The precise mechanism of how cADPR activates RyRs is still unclear. 
It may bind directly to RyRs or through a separate cADPR-binding protein, such as FK506-binding 
proteins (FKBPs) (Galione and Churchill, 2002). The cADPR elevated [Ca2+]j during activation lasts 
longer that IP3 elevated. Hence, it is suggested that IP3 may induce a short-term Ca2+ signaling 
while the major role of cADPR may be the generation of more prolonged Ca2+ signals (Galione 
and Churchill, 2002).
1.4.2.3 NAADP sensitive Ca2+ release
NAADP is another Ca2+ mobilizing messenger discovered in sea urchin eggs (Chini et al., 1995;
Aarhus et al., 1996). It is believed to induce Ca2+ release distinct from that activated by IP3 or
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cADPR. It is found that the NAADP-sensitive Ca2+ release is unaffected by pharmacological agents 
of all known Ca2+ release mechanisms that affect either IP3Rs or cADPR receptors, including 
heparin, ruthenium red, procaine and 8-IMH2-cADPR (Aarhus et ai.f 1996; Yamasaki et at., 2005). 
Nevertheless, NAADP-induced Ca2+ release can be selectively blocked by a disparate group of 
channel blockers, such as D600, verapamil, and SK&F96365 (Galione and Ruas, 2005). In addition, 
studies showed that the NAADP-evoked Ca2+ release from unique stores which are distinct from 
those sensitive to IP3 and cADPR in sea urchin eggs (Lee and Aarhus, 2000). The NAADP-sensitive 
stores can still persist under the stimulation of thapsigargin, a SERCA pump inhibitor (Thastrup et 
ai, 1990), while both IP3 and cADPR sensitive stores are discharged (Genazzani and Galione, 
1996). Some data suggests that the NAADP-sensitive Ca2+ store was probably an acidic organelle 
or lysososome-related (Galione and Ruas, 2005). However, there are reports that NAADP might 
also activate ryanodine receptors on the ER (Dammermann and Guse, 2005). All these findings 
remain controversial. More studies are required to identify the NAADP receptors and their 
location. Recently, it was found that two-pore channels (TPCs), novel members of the superfamily 
of voltage-gated ion channels, comprise a family of NAADP receptors, with TPC1 and TPC3 being 
expressed on endosomal and TPC2 on lysosomal membranes (Calcraft eta!., 2009).
NAADP is a very potent messenger. In mammalian cells, it is able to induce Ca2+ release at nM 
level whereas pM concentrations of IP3 or cADPR are needed to evoke such responses in the 
same cell. Curiously, increasing the NAADP produces no further Ca2+ response. Conversely, 
NAADP in the pM range is highly effective in desensitizing the NAADP-sensitive Ca2+ release 
mechanism. This "bell-shaped" concentration response curve for NAADP appears to be a 
hallmark of NAADP-mediated Ca2+ release in mammalian cells (Galione and Ruas, 2005). 
Sub-threshold concentrations of NAADP for Ca2+ release are able to fully inactivate 
NAADP-evoked Ca2+ release to a subsequent challenge by a higher, normally effective 
concentration (Galione and Churchill, 2002).
Studies show that NAADP can evoke localized signals, which may be amplified into global signals 
by recruiting lnsP3Rs and RyRs through CICR mechanisms (Cancela et ai, 2000; Churchill and
Galione, 2001; Yamasaki et ai, 2005). The existence and interaction of the diverse Ca2+ mobilizing
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messengers, including IP3, cADPR and NAADP, in a single cell system ensures that cells can 
respond to given extracellular signals. In addition, those multi messengers permit local Ca2+ signal 
occurs in different regions within the cell and with different characteristics (da Silva and Guse, 
2000).
1.5 Ca2+ sequestration and efflux
After stimulation, the [Caz+]i needs to return to resting level and then be kept at this low level 
when the cell is at rest. This can be achieved by either pumping Ca2+ to the external environment 
or sequestering the Ca2+ into the intracellular stores.
Ca2+ is transferred across the plasma membrane mainly through the plasma membrane Ca2+ 
pump (PMCA pump). PMCA pump belongs to the P-type class of ion-motive ATPase. This type of 
pump forms a phosphorylated intermediate during the reaction cycle. In the high-affinity 
conformation (El), Ca2+ binds to the cytosolic domain of the enzyme, followed by the 
phosphorylation of the catalytic aspartic acid by adenosine triphosphate (ATP). The 
phosphorylated enzyme changes the El conformation to a low Ca2+ affinity conformation E2, 
which exposes Ca2+ to the extracellular side and promotes Ca2+ release prior to the hydrolytic 
cleavage of the phosphorylated intermediate. After the cleavage of the intermediate, the pump 
returns to the El conformation (Carafoli and Brini, 2000). In addition, Na+/Ca2+ exchangers also 
eject Ca2+ and these do so with a higher transport capacity particularly in excitable cells (Di Leva 
et al., 2008). The distribution of PMCA pump varies among different cell types. In some cell types, 
the pump is located in small plasma membrane invaginations called caveolae. While in other cell 
types, the pump is distributed diffusely throughout the plasma membrane (Monteith etal., 1998). 
Two of the basic PMCA isoforms, PMCA1 and PMCA4 are distributed ubiquitously in animal 
tissues and other two PMAC2 and PMCA3 isoforms are mainly restricted to nervous cells (Carafoli 
and Brini, 2000).
The PMCA pump can be inhibited by orthovanadate (V03(0H)2) and by La3+. It has a low affinity to
Ca2+ at the pM [Ca2+]c level. It was found that the affinity of the pump for Ca2+ can be increased
through a number of mechanisms, for example, by lowering its Kd to values as low as about
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200nM. CaM is also one of the activators for PMCA pump. Technically, Ca2+/CaM relieves an auto 
inhibition of the pump. In addition, PMCA pump can be regulated by various kinases, such as the 
PKC, cAMP-dependent protein kinase, and cGMP-dependent protein kinase (Monteith et a!., 
1998). On the other hand, most of the [Ca2+]j is sequestered in the intracellular stores. After the 
Ca2+ stores are depleted, they can be replenished by extracellular Ca2+ via different uptake 
pathways, such as the capacitative Ca2+ influx pathway (Putney et al., 2001). Furthermore, the 
repeated Ca2+ release and refill from ER/SR directly results in Ca2+ oscillation.
ER/SR reuptakes Ca2+ through the SERCA pumps which are widely distributed in ER/SR. SERCA 
pump belongs to the P-type pump as well. The activation of SERCA pump requires the chemical 
energy produced from the conversion of ATP into adenosine diphosphate (ADP) as does the 
PMCA. it transports Ca2+ ions across the membrane from the cytosol to the ER, against a 
concentration gradient (Higgins et al., 2006). Besides the function of transporting Ca2+ into stores, 
it is also found that due to the delay in the binding and release of Ca2+, the SERCA pump 
contributes in buffering Ca2+ (Higgins etal., 2006).
Apart from ER/SR, mitochondria and other intracellular organelles buffer Ca2+ as well. It has been 
found that mitochondria and some acidic organelles uptake Ca2+ through the H+ electrochemical 
gradient created by H+-ATPases as the driving force for Ca2+ accumulation (Pozzan et al., 1994). 
Moreover, it was reported that mitochondria can also recycle Ca2+ to ER/SR and prevent the 
depletion of neighbouring ER regions (Arnaudeau etal., 2001).
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Figure 1.4-Two major Ca2+ entry pathways in non-excitable cells
Common models for two major Ca2+ entry pathways in non-excitable cells are shown in the figure. 
One is called SOCE, which involves the activation of SUM and Orai proteins. TRP channels are 
likely to participants in SOCE. Another pathway is the NSOCE. The most characterized NSOCE is 
the AA-regulated Ca2+ entry pathway. STIM, Orai and TRP proteins may also play a role in this 
pathway.
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1.6 Diverse Ca2* entry pathways
Resting cells generally have a low plasma membrane permeability to Ca2+. An increase in 
membrane permeability to Ca2+ can be achieved by opening Ca2+ permeable ion channels. A 
variety of different Ca2+ permeable channels have been found located in the plasma membrane. 
Cell Ca2+ entry has been given various and sometimes confusing different names. For a long time, 
there has been no universal admitted classification of these Ca2+ entry pathways. This was due to 
the lack of precise knowledge about the activation mechanisms of Ca2+ influx and in some cases 
the absence of information on their molecular identity.
Ca2+ channels have either been characterized by how they are activated or by the 
electrophysiology characteristics of Ca2+ entry. The most clear defined one is the 
voltage-operated/gated Ca2+ entry (VOCE) pathways, which are found, mostly, in excitable cells. 
The voltage-operated Ca2+ channels (VOCCs) have been extensively studied (reviewed by Lacinova, 
2005). Furthermore, there are many other voltage-independent Ca2+ entry pathways that exist in 
both excitable and non-excitable cells. They are opened in response to different external signals, 
majority of which are agonist dependent. These voltage-independent, agonist-dependent Ca2+ 
entry pathways can be further divided into two broad defined categories, (i) The store-operated 
Ca2+ entry (SOCE) is also called capacitative Ca2+ entry (CCE) and is triggered by the emptying of 
the intracellular Ca2+ stores. The Ca2+ channels activated in this entry pathway are so called 
store-operated Ca2+ channels (SOCCs) (figure 1.4, page 26). (ii) The non store-operated Ca2+ entry 
(NSOCE) or non-capacitative Ca2+ entry (NCCE). This type of pathway is named opposite to SOCE, 
since it was first noticed as a kind of Ca2+ influx that was independent on store depletion 
(Shuttleworth and Thompson, 1996). The most characterized and typical NSOCE is the one 
mediated by the activation of arachidonic acid (AA) which has been observed in a variety of 
different cell types (Mignen and Shuttleworth, 2000) (figure 1.4, page 26). The channels are 
normally named as arachidonic acid-regulated Ca2+ (ARC) channels.
SOCE and NSOCE are sweeping definitions. These Ca2+ entry pathways have other names
according to different classification criteria. For instance, the AA-induced Ca2+ entry is referred to
as a type of receptor-operated Ca2+ entry (ROCE), in which a group of channels activated by
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agonists acting on a range of receptors. On the other hand, owing to the growing understanding 
on the mechanisms of SOCE, there is emerging evidence that the receptor-operated Ca2+ 
channels (ROCCs) and SOCCs may be closely related (reviewed by McFadzean and Gibson, 2002). 
There has been a controversy about the identification of SOCE, which will be discussed in section 
1.6.2. In addition to those widely distributed voltage-gated or agonist-operated Ca2+ entry 
channels described above, there are other Ca2+ channels presented in some cell types such as 
mechanically-operated Ca2+ channels (MOCCs) or the tonically-actived Ca2+ channels (reviewed by 
Tsien and Tsien, 1990).
Many of these channels have been demonstrated to belong to the large transient receptor 
potential (TRP) ion-channel family (reviewed by Berridge et ai, 2003). This family consists of 
three groups: the transient receptor potential canonical (TRPC) family, the transient receptor 
potential vanilloid (TRPV) family and the transient receptor potential meiastatin (TRPM) family. It 
is reported that the TRP channels tend to have low conductance and therefore can operate over 
much longer time scales without swamping the ceil with too much Ca2+. They are essentially 
important in controlling slow cellular processes such as smooth-muscle contractility and cell 
proliferation (reviewed by Venkatachalam and Montell, 2007). In the following paragraphs, 
primary types of Ca2+ entry pathways which play a vital role in cellular progresses will be 
discussed.
1.6.1 Voltage-operated Ca2+ entry
Voltage-operated Ca2+ channles are the ion channels that are activated by changes in membrane 
potential. At physiological or resting membrane potential, VOCCs are normally closed. They are 
then opened at depolarized membrane potentials.
They are mostly present in excitable cells including nerves and muscle. Activation of particular 
VOCCs enables a rapid Ca2+ entry into the cell, which depending on the cell type, results in 
muscular contraction, excitation of neurons, up-regulation of gene expression, or release of 
hormones or neurotransmitters (reviewed by Lacinova, 2005).
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VOCCs are formed as a complex of several different subunits: oil, a26; [31-4, and y {reviewed by 
Tsien and Tsien, 1990; Jagannathan et ai., 2002). The ctl subunit forms the ion conducting pore 
while the associated subunits have several functions including modulation of gating. There are 
several different classifications of VOCCs. The most widely used one is to divide them into two 
subgroups regarding their activation threshold, low-voltage-activated (LVA) and high-voltage 
activated (HVA). LVA Ca2+ channels, which are also called T-types, are activated with relatively 
small depolarisation (between -80 and-60 mV). The T-type Ca2+ channels are characterized by 
their low voltage of activation, rapid inactivation, and slow deactivation. In contrast to LVA, the 
HVA Ca2+ channels are activated at relatively depolarized potentials (>-40mV) and have slow 
kinetics of current decay. They can be further classified into L-type, N-type, P/Qtype, and R types 
(reviewed by Tsien and Tsien, 1990; Jagannathan eta!., 2002; Lacinova, 2005).
The L-type is the first defined and most characterized HVA Ca2+ channel, which is widely 
expressed in diverse cell types, especially in the excitable cells. They are responsible for Ca2+ 
entry in the heart and also play a significant role in neurons, smooth muscle cells and certain 
endocrine cells. They have quite high conductance and slow time- or voltage-dependent 
inactivation (reviewed by Treinys and Jurevicius, 2008). One hallmark of all L-type channels is 
their sensitivity to 1,4-dihydropyridine (DHP) which encompasses a wide class of drugs that either 
have an inhibitory (e.g. nifedipine, nisoldipine, isradipine) or activatory [e.g. Bay K 8644) action 
on this L-type channel (Hess and Tsien, 1984; Belkacemi etaL, 2005).
The other three types of HVA Ca2+ channels differ significantly from L-type channels in their 
sensitivity to co-conotoxin which is one of a group of neurotoxic peptides isolated from the 
venom of the marine cone snail and spiders. The channel sensitive to w-conotoxin, kept the name 
N-type channel, while the channel sensitive to to-Aga toxin was named P/Q-type Ca2+ channel. 
The channel resistant to these toxins were named R-type Ca2+ channel (reviewed by Lacinova, 
2005).
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1.6.2 Store-operated Caz+ entry
SOCE is primarily responsible for the refilling of the Ca2+ stores such as ER/SR and the 
maintenance of the stable Ca2+ level inside the ER/SR (Putney, 2001). In contrast to the transient 
increase of [Ca2+]j resulting from the discharge of ER/SR, the Ca2+ that enters the cells via SOCE 
supplies a sustained elevation of [Ca2+]j level. This is crucial for specific signaling events (Smyth et 
al., 2006), especially those in non-excitable cells. Since SOCE can affect many aspects of cell 
biology, it is vital to understand the molecular aspects of SOCE. As a result, we may fully 
appreciate its contribution to normal physiological as well as pathophysiological states.
The existence of SOCE was first proposed by Jim Putney (1986). Since then, numerous studies 
have been carried out to investigate the mechanisms of SOCE. The first SOCC to be well 
characterized was from mast cells and its characteristic Ca2+ current was named as Ca2+ 
release-activated current (CRAC; Hoth and Penner, 1992). Initially, because of its extremely small 
conductance, the CRAC current (Icrac) could not be resolved on the single channel level, but the 
whole-cell ICrac was recorded in non-excitable cells (Bolotina and Csutora, 2005). ICRAC is not the 
only store-operated current, yet it is the most well studied SOCE. CRAC channels are remarkably 
selective for Ca2+ although they can conduct Ba2+ and Sr2+ as well (Parekh and Putney, 2005). 
Whilst Icrac remained characteristic archetypal SOCE pathways, other non-selective forms of 
SOCE were also observed.
The study on SOCE was once mired in difficulties. The key feature of SOCE is that it is the fall in 
Ca2+ content within the ER/SR and not the subsequent rise in [Ca2+]|, such as Ca2+ itself or other 
downstream signals, that activates the channels. It was difficult to distinguish the SOCE from 
other types of Ca2+ entry pathways. The application of some specific pharmacological inhibitors of 
SERCA pumps, which are responsible for pumping Ca2+ into the lumen of the ER/SR from the 
cytoplasm, has been invaluable in the study of SOCE function and regulation. Thapsigargin is the 
most common used agent to induce SOCE in experimentation, since it triggers store-depletion 
without direct activation of cell signaling pathways. Several agents are known to inhibit this 
thapsigargin-evoked Ca2+ influx, such as econazole, SK&F96365, 2-aminoethoxydiphenylborne
(2-APB) and the vanilloid capsaicin. Like all Ca2+ influx pathways, store-operated channels are
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inhibited by divalent and trivalent cations, probably via a block by slow permeation. Trivalent 
cations like La3+ and Gd3+ are particularly effective, blocking the channels fully in a low 
concentration range {Parekh and Putney, 2005). After more than 20 years' study, two major 
questions about SOCE questions remained enigmatic: (i) how does the ER/SR inform the SOCCs 
located in the plasma membrane of its emptying and (ii) the molecular identity of the SOCCs.
1.6.2.1 Models ofSOCEs
There were two general hypotheses for the communication between internal ER/SR and the 
plasma membrane SOCCs. The first involved the action of a diffusible messenger or a Ca2+ influx 
factor (CIF) that is released from the ER/SR to trigger the SOCCs in the plasma membrane upon 
ER/SR Ca2+ depletion. This diffusible messenger model was first put forward by Putney and 
colleagues in 1989 (Takemura et ai, 1989). Later, evidence for the existence of such a factor was 
demonstrated by Randriamampita and Tsien (1993), who isolated CIF an acid-extractable factor 
from thapsigargin-treated lymphocytes. The ability of CIF in activating Ca2+ influx has been 
demonstrated in several different cell types. The mechanism by which CIF triggers Ca2+ influx 
remains unclear, although more recent work suggested an important role of Ca2+-independent 
phospholipase A2 (iPLA2) in this CIF model. It has been found that IPLA2 is required for the 
activation of SOCE in various cell types (Smani et ai, 2003). Then, CIF is demonstrated to be able 
to activate iPLA2 by the displacement of inhibitory CaM from iPLA2 and that the lysophospholipid 
generated by iPLA2 is then responsible for directly activating SOCCs (Bolotina and Csutora, 2005). 
Based on these important findings, a novel model CIF-iPLA2-SOCE was proposed (reviewed by 
Bolotina, 2008). Despite these studies, the exact mechanism by which CIF activates SOCE is still 
an enigma. It remains uncertain whether CIF or other diffusion messengers is necessary for some 
types of SOCEs.
The second hypothesis was originally referred to as conformational coupling model. This idea was
first introduced by Irivne (1990) and further developed by Berridge (1990) involved
protein-protein interaction. This model suggested that the IP3Rs located on the ER membrane are
physically attached to the store operated Ca2+ channels in the plasma membrane, and that a
conformational change of the IP3Rs upon ER Ca2+ depletion opens SOCCs. This hypothesis was
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revised by Patterson et al. (1999) and has became known as the secretion-like coupling model 
that suggested that the IP3Rs are separated from SOCCs when the stores are full and that they 
move close to SOCCs in response to the store depletion (Patterson et at., 1999). However, other 
research provided strong evidence that the interaction of Ca2+ influx channels with the IP3Rs is 
not required for the activation of lCRAC (Sugawara et al., 1997). Though the function of IP3Rs in 
conformation coupling was challenged, it does not exclude the idea that there may be other 
proteins that act as a link between ER and SOCCs.
1.6.2.2 SUM and Oral in SOCEs
Recently, the advent of large scale RNAi-based screens brought a great breakthrough in 
identifying the molecular constituents of SOCE that identified the functional role of two proteins 
in SOCE (Liou et at., 2005). The first one is stromal interacting molecule (STIM) that was first 
found in Drosophila S2 cells (Roos et al., 2005). Mammals have two STIM proteins, STIM1 and 
STIM2, whose knockdown reduced SOCE (Liou et al., 2005). It is now clear that STIM1 is a 
necessary component of lCRAC-activation and SOCE while some research indicates that STIM2 may 
also participate in the SOCE (Parvez et al., 2008). STIM1 is a single-pass transmembrane protein 
residing primarily in the ER (Manji et al., 2000). It contains several conserved regions, including 
an EF-hand and a sterile alpha motif (SAM) domain in the N-terminus directed towards the lumen 
of the ER. In the cytosolic STIM1 C-terminus, there are two coiled-coil regions overlapping with 
the ezrin-radixin-moesin (ERM)-like domain, and a lysine-rich region are essential for ICrAc 
activation (Frischauf et al., 2009).
Although it is clear that STIM1 is required for the lCRAc and other store-operated entries, the 
mechanism by which it acts is still being elucidated. So far, the most accepted model involves a 
marked change in the distribution of STIM1 in the ER membrane, from a generally diffuse 
distribution to the formation of clusters of the proteins at sites either within or immediately 
adjacent to the plasma membrane (Zhang et al., 2005). When the ER Ca2+ stores are filled, the 
EF-hand domain which is suggested as the sensor of ER Ca2+ has bound Ca2+ while STIM1 is a 
dimer stabilized by the coiled-coiled interactions. Once the ER Ca2+ store is depleted, the EF-hand
domain releases bound Ca2+ which leads to quick STIM1 oligomerization mediated by the SAM
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domain. These clustered STIM1 proteins immediately translocate to form puncta, close to the 
plasma membrane (Wu et al., 2006). This conveys the message that ER store has been depleted. 
Some studies indicate that this ER-resident STIM1 migration might be guided by the microtubules 
(Smyth et al., 2007). Further investigation needs to be carried out on this possibility.
Another functional protein component identified in SOCE was named as Ca2+ release-activated 
Ca2+ channel protein 1 (Oral or CRACM). There are three member types in the Orai family: Orail, 
Orai2 and Orai3 all of which are expressed in mammalian cells. They are predicted to be 
membrane spanning proteins with 4 transmembrane domains located in the plasma membrane 
with their C and N termini located in the cytoplasm. All three Orai proteins possess a conserved 
putative coiled-coil domain in the C-terminus while only the N-terminus of Orail consists of a 
proline/arginine-rich region (Frischauf et al., 2009). Orail is suggested to be the major regulator 
of SOCE, whereas OraiB can complement partially and Orai2 has a lesser role (Gwack et al., 2007). 
Orail is regarded as the pore-forming subunits of CRAC channels (Prakriya et al., 2006). Upon 
store-depletion, Orail proteins require STIM1 co-expression to form a clustered localization in 
the plasma-membrane at sites in close proximity to STIM1 puncta. The STIM1 and Orail complex 
has been identified during the SOCE by co-immunoprecipitation and by Forster resonance energy 
transfer (Yeromin et al., 2006). Several reports have demonstrated a remarkable amplification of 
Icrac when Orail is coexpressed with STIM1 (Peinelt etal., 2006). However, either Orail orSTIMl 
expressed alone cannot result in an increase of SOCE (Xu et al., 2006). Hence, this interaction 
between STIM1 and Orail is necessary for the activation of Icrac- The two other members of the 
Orai family, Orai2 and Orai3, display similar, but smaller store-operated Ca2+ influx currents after 
co-expression with STIM1 (DeHaven etal., 2007; Lis etal., 2007).
The question as to the molecular interaction of STIM1 and Orail is still unclear. Evidence suggests 
that the C terminus of STIM1 contains the domain that is responsible for the opening of Orai 
channels. Recently, this domain has been found to be seated in the ezrin/radixin/moesin (ERM) 
coiled-coil region, which was named by three independent teams as STIM1 Orai activating Region 
(SOAR)(Yuan et at., 2009) or CRAC Activating Domain (CAD) (Park et al., 2009) or Orai Activating
Small Fragment (OASF)(Muik et al., 2009). According to these findings, this Orai activating region
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has been narrowed down to approximately 100 amino acids from STIM1 in the region of 344 to 
442. Strong evidence demonstrates that it is this fragment in STIM1 that binds directly to Orai 
and triggers Orai protein clusters. Moreover, either the C terminus of STIM1 or this short 
fragment alone has been proven sufficient to constitutively activate ICrac independently of 
store-depletion (Zhang et al., 2008). In turn, the domain of Orai protein is responsible for the 
binding with STIM1 has been generated. Orail deletion mutants devoid in their whole N or C 
terminus have been conducted (Muik et al., 2008; Frischauf et al., 2009). Deletion of either 
terminal failed to induce Ca2+ influx. Hence, both N and C terminus of Orai are necessary for the 
activation of ICrac channels. However, mutation of the Orail C terminus completely abrogates the 
coupling with STIM1. This observation suggests that the C terminus of Orai protein plays a 
dominant role in coupling to STIM1 independently of the N terminus. Presently, it has been 
revealed that a conserved putative coiled-coil region in the C terminus of Orai proteins mediates 
the coupling with STIM1 (Muik et al., 2008; Frischauf et al., 2009). This putative coiled-coil 
domain is a common motif involved in homo-as well as heteromeric protein-protein interactions 
(Woolfson, 2005; Muik et al., 2008). Mutation at this coiled-coil region of Orail with point 
mutations from leucine to serine (Orail L273S), which is expected to destabilize coiled-coil 
structure, was observed to fully disrupt the interaction with STIM1 in HEK293 cells (Muik et al., 
2008). The same single mutation in Orai2 or Orai3 proteins resulted in similar inhibition of 
binding with STIM1, though this was not completely abolished (Frischauf et al., 2009). In 
conclusion, STIM1 and Orai protein directly interact with each other at their C terminus 
coiled-coil domains.
Now we understand how the protein STIM can bind with Orai, then follows the question of how 
many STIM and Orai molecules are required to activate SOCE. The understanding of Orai 
stoichiometry differs based on different research approaches. In biochemical experiments, it is 
suggested that the Orai complex is a dimer in both resting and in SOCE, while in functional 
measurements of expressed tandem Orai multimers, it is indicated that Orai exists in a tetramer 
during SOCE (Penna et al., 2008). Recently, a newly developed method has been utilized to 
investigate the structure of Orai protein, which can detect the number of GFP (green fluorescent
protein)-tagged Orai subunits per channel by counting the number of photobleaching steps (Ji et
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al.f 2008; Penna et aL, 2008). Collectively, these experiments show that Orai Is present stably as 
dimer in the plasma membrane in resting cells, but when the SOCE is induced, Orai is found 
predominantly as a tetramer forming active channels. Similar photobleaching approach reveals 
that two STIM1 molecules are required to activate the tetrameric Orai channel (Ji et aL, 2008).
1.6.2.3 TRPC in SOCEs
Apart from STIM and Orai proteins, the mammalian TRP superfamily, particularly those from 
TRPC family, have long been proposed as the candidates for the conduction of SOCE. TRPC 
channels are non-selective, Ca2+ permeable cation channels containing six transmembrane 
domains. There are seven types of TRPCs named from TRPC1 to TRPC7. All TRPC channels are 
activated by receptor stimulation and conduct receptor operated cation currents while several 
TRPCs have been suggested to function as SOCCs. Among these TRPCs, the case for TRPC1 as a 
subunit of SOCCs is the most widely investigated one (Liu et aL, 2003; DeHaven et aL, 2009; 
Salido etal., 2009).
The functional role of TRPC1 in SOCE is supported by a series of studies. It has been observed in 
different cells, such as HEK293 cells, that overexpression of TRPC1 enhances thapsigargin- or 
DAG-induced SOCEs, while overexpression of TRPC mutations or TRPC knockouts results in a 
reduced SOCE current (Ambudkar et aL, 2007; Ong et aL, 2007; Liao et aL, 2009). This evidence is 
further upheld since overexpression of Orai is reported to increase SOCE current in the cells 
stably expressing TRPC but not in the control cells. This suggests an interaction between TRPCs 
and Orai proteins in SOCE (Liao et aL, 2009). On the other hand, STIM1 has shown the ability to 
regulate all TRPC channels, except TRPC7 (Yuan etal., 2007). The interaction of STIM1 with TRPCs 
requires the ERM domain to bind TRPCs directly as well as the polybasic lysine {K)-rich domain to 
open the channels, which both located at the C terminus of STIMl (Huang et aL, 2006).
Despite numerous supporting findings, the involvement of TRPCs in SOCEs is still a controversy 
challenged by other research reports. For instance, several investigators have failed to observe 
store-operated behaviour of TRPCs even in the same cellular models mentioned above (Salido et
aL, 2009). However, owing to a series of recent results, these discrepancies between studies in
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favour and against the participation of TRPCs in SOCEs may be reconciled. First, it is validated that 
some TRPCs can function in a STIM 1-dependent and STIMl-independent manner as different 
types of ion channels. It was shown that TRPC1, TRPC4 and TRPCS when regulated directly by 
STIM1 performed as SOCCs under all conditions. In comparison, TRPC3 and TRPC6 function as 
SOCC function mediated by STIM1 indirectly through the heteromultimerization with other TRPCs 
when they are expressed at low level (Zeng et al., 2008). The STIM1 mediated 
heteromultimerization is suggested to be necessary for TRPCs to form SOCCs. Besides, this STIM1 
indirectly regulates TRPCs. It is reported that translocation of TRPC1 to the plasma membrane 
does not occur in the absence of other TRPC isoforms, such as TRPC4 or TRPCS (Zeng et al., 2008; 
Salido et al., 2009). Thus, investigations may fail to assess the role of TRPCs in SOCE when they 
were overexpressed or when other TRPC isoforms were absent.
As with TRPCs ion channel subunits, Orai proteins have recently been implicated to also possess 
the ability to conduct ion current in different manners not restricted to SOCEs. It was observed 
that mutation Orail not only inhibited SOCE but also ROCE. Moreover, Orail is suggested to 
heteromerize with Orai2 or Orai3 to form the SOCCs under the regulation of STIM1 (Frischauf et 
al., 2009).
Collectively, though STIM1 is not the only factor to activate TRPC or 'Orai channels, it is obligatory 
for TRPCs and Orai proteins to perform as SOCCs. Respecting the additional finding that TRPCs 
and Orais can conduct SOCE current independently of each other, discrete store operated Ca2+ 
signals could be generated depending on whether STIM1 couples to TRPCs or Orai channels or to 
the TRPCs and Orai channel complexes (Zeng et al., 2008). SOCCs formed as a heteromultimeric 
complex by different combination modes among TRPC and Orai isoforms with STIM molecules is 
suggested to meet the diverse demands of various ion currents in different cells. The SOCCs 
formed by TRPCs are suggested to be less selective Ca2+ channels while the Orai formed channels 
or the TRPC-Orai complex channels are believed to conduct highly selective Ca2+ currents, such as 
Icrac- Receptors may also independently activate the TRPCs and Orai channels to tune their Ca2+ 
signals and it is possible that STIM1 determines which type of Ca2+ influx pathway ROCE or SOCE 
mediates Ca2+ entry (Zeng et al., 2008).
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A recent report proposed a SUM regulated heteromeric Orai/TRPC model to explain how STIM1 
convert TRPCs from ROCs to SOCCs. It is implicated that upon the stimulation-induced SOCE, Orai 
molecules rapidly release from TRPCs with the concomitant activation of TRPC channels to 
conduct ROCE. As the intracellular Ca2+ store is depleted, the aggregated STIM1 forms puncta and 
triggers the migration of both Orai and TRPC to the same microdomains. This then causes 
complexes of Orai, TRPC and STIM1 to form which acts as SOCCs located in lipid draft domain 
(LRD) (Alicia et at., 2008; Liao et al., 2009). Plasma membrane LRDs are domains containing high 
concentration of cholesterol and sphingolipids known to function as centers for the assembly of 
signaling complexes. This facilitates both specificity and efficiency of signaling events by 
positioning functionally associated molecules in close proximity to each other (Gajate et al., 
2009). It has been shown that LRDs are required for activation of TRPCl-mediated SOCE. 
Disruption of LRD inhibits both TRPC1 and STIM1 translocation leading to the decrease of SOCE 
(Gajate et al., 2009). Hence, the proposed role of LRDs is to bring STIM molecules in the ER and 
TRPCs in the plasma membrane, along with Orai, sufficiently close to each other to activate Ca2+ 
influx. Further studies will be required to establish the function of LRDs in SOCE.
Although there has been rapid and significant progress since the initial discovery of STIM and 
Orai's role in SOCE, what we have known is only part of the regulation mechanism of SOCE. Other 
than STIM, Orai and TRPCs, there may be additional molecular components to the mechanism. 
The CIF pathway is suggested to co-exist with the STIM-Orai protein-protein coupling model. This 
assumption is derived from the report that knockdown or overexpression of STIM1 results in 
corresponding impairment or amplification of CIF production (Potier and Trebak, 2008).
1.6.3 Arachidonic acid activated Caz* entry
As it is mentioned above, there are alternative, non store-operated Ca2* entry pathways that 
co-exist mostly in non-excitable cells. These have been argued to provide the predominant route 
of Ca2+ entry particularly at lower, more physiologically relevant levels of stimulation. In particular, 
the activation of these NSOCEs was observed, under most conditions, to result in Ca2+ oscillations
(Shuttleworth and Thompson, 1996; reviewed by Shuttleworth, 2009). In virtue of the properties
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of the oscillatory Ca2+ signals, the function of the non-store operated Ca2+ signals is believed to 
enable cells to regulate a diverse range of effects and responses in more precise and appropriate 
manners, and therefore represent the relevant responses to a range of different agonists 
(reviewed by Shuttleworth, 2009).
The most classic NSOCE, AA regulated Ca2+ entry, was first discovered in the 1990s (Shuttleworth, 
1996). The ARC channels have a highly Ca2+-selective conductance whose activation is specifically 
dependent on the receptor-mediated generation of low levels of intracellular AA. They display 
conductance values similar to CRAC channels and are inhibited by external La3+ and Gd3+. 
Nevertheless, lARC can be distinguished from ICrac by the absence of any fast-inactivation during 
brief pulses to negative potentials, insensitivity to low external pH and to 2-APB, and a 
significantly higher monovalent (Na+) to Ca2+ current ratio (reviewed by Shuttleworth et al., 
2007).
1.6.3.1 STIM and Oral in arachidonic acid activated Ca2* entry
Although the ARC currents have been demonstrated in various cell lines such as HEK293 and HeLa 
cells (Mignen and Shuttleworth, 2000; Mignen etal., 2007), further insight into the nature of the 
ARC channels was impeded by the lack of any clear indication of their molecular identity. This 
situation lasted until the very recent when, unexpectedly, it was found that STIM and Orai 
proteins are not limited to SOCEs but play a key role in regulation of ARC channels as well 
(Mignen et al., 2007; Mignen et al., 2008). These studies revealed that STIM and Orai proteins 
mediate ARC channels in a completely distinct model from that regulates SOCCs.
It is reported that the mobilization of STIM1 in the ER to sites close to the plasma membrane is 
not required for the activation of ARC channels. Moreover, instead of the heavily studied ER 
STIM1 being responsible for the modulation of SOCCs, the pool of STIM1 residing in the plasma 
membrane has been suggested be responsible for the regulation of ARC channels (Mignen et al., 
2007). The plasma membrane STIM1 is orientated with its N-terminal domain which exposed to 
the extracellular medium. Exposure of intact cells to an N-terminal STIM1 antibody markedly
reduced currents through the ARC channels by almost 70% (reviewed by Shuttleworth et al.,
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2007) . Based on the similar biophysical properties of the conductance represented by the ARC 
channels and the CRAC channels and the finding that they are both mediated by STIM1, the 
possibility of the involvement of Orai proteins in lARC was examined. The results showed that both 
Orail and Orai3 appear to contribute to the ARC channels pore whilst the formation of CRAC 
channel pore only requires Orail (Mignen etal., 2008).
Consequently, these findings suggest that the ARC channel could be considered as a STIM1 
mediated Orai-based channel like CRAC channels but that they are regulated in a different 
manner. The precise mechanism of how plasma membrane STIM1 regulates the ARC channels is 
still unclear. Given that the presence of low concentrations of AA is predicted to activate ARC 
channels, two possibilities arise to explain the action of STIMl on the ARC channels. Firstly, STIM1 
may be the target of AA. The interaction between STIMl and AA could somehow enable STIMl to 
activate the ARC channels. Secondly, AA could open ARC channels directly when the channels are 
associated with STIMl (reviewed by Shuttleworth etaL, 2007).
Although AA has been revealed to directly regulate various ion channels, no consistent sequence 
has been identified to be a possible candidate domain for binding with Orai channels (Meves,
2008) . Besides, there is no further evidence of the interaction of AA and plasma membrane 
STIMl. On the other hand, the ARC channels are proposed to be formed by Orail and OraiB 
(reviewed by Shuttleworth, 2009). Studies of the structure of OraiB reveal that OraiB possesses 
an extended extracellular loop that is not seen in either Orail or Orai2. In addition, compared 
with Orail, OraiB lacks both the arginine-rich domain and the two flanking porline-rich sequences. 
Moreover, OraiB has a much high probability of the putative coiled-coil domain in the C-terminus. 
The function of all these unique features of OraiB remain to be investigated, but they may explain 
ARC channels regulation (reviewed by Shuttleworth, 2009). Far more questions need to be solved 
before we could understand how ARC channels works.
1.6.3.2 Arachidonic acid
AA is a 20-carbon polyunsaturated fatty acid in mammalian cells. It cannot be synthesized by
mammalian cells and is absorbed from the diet. After AA biosynthesis, it is esterified into the
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phospholipids located on the cell membranes (SigaL 1991). Evidence indicate that the ARC 
channel is specifically dependent on AA for activation rather than any of the AA metabolism 
products called eicosanoids (Mignen et a!., 2008). It was demonstrated that concentrations of AA 
at 2 to lOpiM could lead to the activation of ARC channel (Mignen et al., 2008). There are three 
major pathways that lead to the release of AA through the activation of phospholipases, including 
phospholipase A2 (PLA2), PLC/DAG lipase and phospholipase D (PLD) (Figure 1.5, page 41). Among 
them, only PLA2 is able to cleave AA from the sn-2 position (Balsinde etal., 1999). Therefore, the 
PLA2 activation is regarded as the primary pathway through which AA is liberated from 
phospholipids.
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Extracellular
stimulation
enzyme
Figure 1.5-AA generation pathways
Various extracellular stimulation can active PI-PLC, PC-PLC, PLD or PLA2 enzymes, which further 
trigger four AA production pathways respectively, as shown in the figure.
This figure is modified from 'Contribution of different phospholipases and arachidonic acid 
metabolites in the response of gallbladder smooth muscle to cholecystokinin' (Alcon et al., 2002).
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1.6.3.3 Release arachtdonic acid by PLA2 
1.6.3.3.1 PLA2 superfamily
The PLA2s are a large enzyme superfamily that plays diverse functional roles and undoubtedly 
many of them can participate in the release of AA. The superfamily of PLA2s currently consists of 
15 groups and many subgroups and includes five distinct types of enzymes, namely the cytosolic 
PLA2s (cPLA2), the secreted PLA2s (sPLA2); the Ca2+-independent PLA2s (iPLA2), the 
platelet-activating factor acetlhydrolases (PAF-AH), and the lysosomal PLA2s (reviewed by Gijon 
and Leslie, 1999). The PLA2 superfamily has grown continuously since it was classified in 1994. 
These five types of enzymes are assigned based on different catalytic mechanisms as well as 
functional and structural features.
The cPLA2s are large cytosolic proteins with variable sizes from 61-114 kDa. The 85-kDa cytosolic 
cPLA2cx has been extensively studied for its dominant role in regulation the agonist-induced AA 
release (reviewed by Kudo and Murakami, 2002). So far, cPLA2a is the only PLA2 identified which 
is specific for the phospholipid bearing AA. The cPLA2a has an IM-terminal C2 domain or called 
Ca2+-dependent phospholipid binding (CaLB) domain, which is critical for Ca2+-dependent 
association with phospholipids membranes (reviewed by Burke and Dennis, 2009). The catalytic 
domain of cPLA2a contains many active site residues including Ser228, Ser505,AspS49, and Asp200 
(reviewed by Burke and Dennis, 2009). The mechanism of cPLA2 activation and regulation will be 
discussed later.
Although cPLA2 is primarily responsible for AA release, both IPLA2 and sPLA2 have demonstrated 
the capacity to mobilize AA (reviewed by Schaioske and Dennis, 2006). The sPLA2s are small 
secreted proteins. They are characterized by their low molecular weight (13-15 kDa), histidine in 
the catalytic site, Ca2+ bound in the active site, as well as 6 conserved disulfide bonds, with 1 or 2 
variable disulfide bonds (reviewed by Lambeau and Gelb, 2008). All of these sPLA2s have 
experimentally observed phospholipolysis enzymatic activity at sn-2 position (Murakami et a!., 
1999). Studies show that some of them have the capacity to regulate the release of AA in distinct 
ways (Schievella etai, 1995).
42
Chapter 1
The iPLA2 enzymes are characterized by not requiring Ca2+ for catalytic activity. The classical iPLA2 
exists in an aggregated form and occurs in several splice variants (reviewed by Burke and Dennis, 
2009). This enzyme, similar to the cPLA2, uses a serine in the active site to catalyze the cleavage 
of the sn-2 ester bond. However, it does not show AA specificity (Lambeau and Gelb, 2008). The 
function of iPLA2 in the cell physiology processes has been shown to be very complex. So far, it is 
suggested that this iPLA2 enzyme plays a role in phospholipid remodeling, AA-release resulting in 
eicosanoid formation, protein expression, acetylcholine-mediated endothelium-dependent 
relaxation of the vasculature, secretion, cell apoptosis and cell proliferation (Gijon and Leslie, 
1999). Additionally, as mentioned above, iPLA2 might participate in the SOCEs through 
co-operating with GIF (Smani et al, 2003). Recently, it is argued that GIF- iPLA2 may play an 
important role in SOCEs as an essential compound of signal conduction between STIMl and Orai 
channels in SOCEs (Bolotina, 2008).
1.6.3.3.2 Regulation of cPLA2
The cPLA2 is a widely distributed enzyme that is ubiquitously expressed in most cells and tissues. 
It is no doubt that the 85-kDa cytosolic cPLA2ct is the primary regulator in agonist-induced AA 
liberation from phospholipids (Qiu et al., 1998; Gijon and Leslie, 1999). The cPLA2 activity is 
stimulated by a wide variety of cytokines and mitogens such as interleukin-1, tumor necrosis 
factor (TNF), macrophage colony-stimulating factor (CSF), epidermal growth factor, ATP, 
interferonv (IFNV), and endothelin (reviewed by Leslie, 1997). It is subject to complex mechanisms 
of regulation at both the transcriptional and post-transcriptional levels.
At the transcriptional level, cytokines and growth factors can increase cPLA2 messenger RNA and 
protein in a variety of cell types (Sigal, 1991; Shimizu etal., 2008). The main regulation of cPLA2 in 
the posttranslational level is by the increase of [Ca2+]| level and phosphorylation following various 
stimuli. Both of the two mechanisms are required for the activation of cPLA2 to release AA.
The cPLA2 is cytosolic in resting cells but it is translocated to the intracellular membranes when 
the [Ca2+]j increases. Micromolar Ca2+ binding to the cPLA2 C2 domain increases its affinity for
membranes allowing access to the AA containing phospholipids substrates. It has been identified
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that the C2 domain of cPLA2 contains four acidic groups including Asp37, Asp43, Asp93, Glu100 that 
are required for binding with Ca2+ (reviewed by Leslie, 1997).
It is documented that Ca2+ plays a role in delivering the catalytic domain of cPLA2 to interact with 
the membrane through a hydrophobic mechanism. Studies discovered a tryptophan (W464) on 
the membrane binding face of the catalytic domain that stabilizes cPLA2 and prolongs membrane 
binding even after the decrease of [Ca2+]i (reviewed by Murakami and Kudo, 2002). A patch of 
basic residues (K488, K541, K543, K544) in the cPLA2 catalytic domain has been identified as the 
sites to interact with PIP2, which increases catalytic activity in vitro (reviewed by Tucker et at., 
2009).
The exact site of cPLA2 relocation remains unknown although it has been studied for decades. It 
appears to be cell specific. In the majority of studies, cPLA2 has been reported to translocate to 
the nuclear envelope, endoplasmic reticulum and Golgi (Leslie, 1997). How cPLA2 is selectively 
transferred to these sites is not known. It is observed that the subcellular localization of cPLA2 
can be effected by cell density (Zhao et ai., 2002). Ca2+-dependent translocation of cPLA2 to the 
plasma membrane has not been observed in most cells. However, cPLA2 localizes to cell-cell 
junctions in confluent endothelial cells and is transiently recruited to the plasma membrane by 
NADPH oxidase in the caveolae (Shimizu et ai, 2008). It has been demonstrated that in the 
human monocytes, cPLA2 and AA is required for the regulation of NADPH oxidase which normally 
located in the caveolae of the plasma membranes (reviewed by Murakami and Kudo, 2002). 
Interaction of cPLA2 with plasma membrane microdomains such as caveolae should be explored 
further as a possible regulatory mechanism in cPLA2 activation (reviewed by Burke and Dennis, 
2009).
Although important, the Ca2+ dependent cPLA2 relocation is not sufficient for full activation of 
cPLA2. Agonist induced phosphorylation is another necessary element. Several functionally 
important phosphorylation sites including Ser505, Ser727, Ser515 Ser437 and Ser454, in the catalytic 
domain of cPLA2 have been identified (reviewed by Tucker eto/., 2009).
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Residue Ser505 is identified as a consensus site for phosphorylation by MAPKs including ERKs, p38 
MARK and JNK (Lin et ai, 1993). In vitro, MAPKs mediated phosphorylation of Ser505 of cPLA2 
resulting in an up to 2 to 3-fold increase in the catalytic activity (reviewed by Kudo and 
Murakami, 2002). In addition, Ser727 can be phosphorylated by MAPK-activated protein kinase 
MNK1 or another related kinase (reviewed by Burke and Dennis, 2009). Ser515 is another 
important phosphorylation site on cPLA2. Several studies suggest that CaMKII prefers to 
phosphorylate Ser515 of cPLA2 to induce the AA release (Sigal, 1991; Farooqui and Horrocks, 2005). 
Another two sites, Ser437 and Ser454 of cPLA2 are also phosphorylated in spodoptera frugiperda 
(Sf9) cells (Borsch-Haubold et al., 1998). However, it is not clear whether they are important for 
the cPLA2 activation and which types of kinases are involved in this phosphorylation event 
(reviewed by Kudo and Murakami, 2002). In general, however, phosphorylation per se is 
insufficient for, but rather plays an augmentative role in cPLA2 mediated cellular AA release, since 
it was demonstrated that phosphorylated cPLA2 fails to release AA in the absence of an increase 
in [Caz+]i (reviewed by Kudo and Murakami, 2002).
1.6.3.4 Release arachidonic acid by PLC or PLD
Two other main phospholipase enzymes, PLC and PLD, participate in the generation of AA from 
phospholipids (Balsinde et al., 1999) (Figure 1.5, page 41). Rather than cleave the phospholipid 
directly to release AA like PLA2, the phosphoinositide specific PLC (PI-PLC) first splits membrane 
phospholipid PIP2 into two second messages including DAG and IP3(Smrcka etal., 1991). DAG can 
then be cleaved to generate AA via a DAG-lipase (Kennerly et al., 1979). Besides, another PLC the 
phosphatidylcholine specific PLC (PC-PLC) can generate DAG directly from PC (Alcon etal., 2002).
In a similar way, PLD can hydrolyze PC to phosphatidic acid (PA) and choline. PA can then be acted
upon by phosphatidic acid phosphohydrolase to yield DAG which can produce AA (reviewed by
Nakanishi and Rosenberg, 2006; Hyde and Missailidis, 2009). On the other hand, both PLC and
PLD have been reported to facilitate AA release through a PLA2 pathway. For example, studies
show that the PLC reaction substrate, PIP2, is able to promote the binding of cPLA2 to lipid
vesicles in a Ca2+ independent manner, which dramatically increases the cPLA2 activity (Mosior et
al., 1998). Similarly, PLD has been reported to facilitate the cPLA2 activation as well (Ueno et al.,
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2000).
1.6.3.5 Arachidonic acid metabolism
AA is the precursor in the production of eicosanoids. Eicosanoids are important cell signaling 
molecules play a central role in the cellular signaling cascades. They exert complex control in 
essential functions such as inflammation and immunity. It has recently been identified that their 
abnormal activation is associated with some cancers (reviewed by Nakanishi and Rosenberg, 
2006). Given these findings, understanding the cascades of AA metabolism is critical to the study 
of cancer and inflammatory disease (Mignen etal., 2003).
AA can be metabolized to eicosanoids via three pathways, namely the cyclooxygenase (COX) 
pathway, the lipoxygenase (LOX) pathway and the cytochrome P450 (CYP450) pathway. So far, 
three isoforms of the membrane bound enzyme COX have been identified, COX-1, COX-2 and 
COX-3. In the COX pathway, AA is converted into three main products: prostaglandins (PGs), 
prostacyclin l2 and thromboxane A2 (reviewed by Nakanishi and Rosenberg, 2006). There are nine 
PGs that have been identified. PGA2, PGD2, PGE2 and PGF2 are the major products in this AA 
metabolism. They bind a subfamily of cell surface seven-transmembrane receptors, 
G-protein-coupled receptors, performing variety of functions in different types of cells (reviewed 
by Tucker et al., 2009). Another important product of COX pathway is the generation of 
thromboxane. It is a vasoconstrictor and a potent hypertensive agent, and it facilitates platelet 
aggregation.
In the LOX pathway, AA leads to the formation of the leukotrienes, lipoxins and hepoxilins. 
Leukotrienes act principally on a subfamily of G protein coupled receptors. They function in 
various physiological processes including asthmatic, allergic reactions and inflammatory 
responses. The enzyme CYP450 converts AA into epoxyeicosatrienoic acids (EETs). EETs are 
signaling molecules that act as short-range hormones in cardiovascular system and kidney. They 
cause Ca2+ release from the intracellular stores and increase the cell proliferation (reviewed by 
Watanabe et al., 2003).
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1.7 Ca2+ signaling and cell spreading
Among the cell cycle regulatory elements, what caught our attention is an interaction between 
Ca2+ and the cell shape. The Ca2+ signal is affected by the state of the actin cytoskeleton, as 
mitogen-induced Ca2+ mobilisation in NIH 3T3 cells is abolished by cytochalasin D. This agent 
disrupts the actin cytoskeleton (Ribeiro et ol., 1997). However, the SOCE in NIH 3T3 cells was 
reduced by actin cytoskeleton disruption (Ribeiro et ai., 1997). Another drug, jasplakinolide, 
which can induce polymerization of monomeric actin, was observed to prevents SOCE but has 
little effect on the receptor activated Ca2+ store depletion (Patterson et ai, 1999). Thus, the actin 
cytoskeleton does not appear to play an obligate role perse in the SOCE pathway. The role of the 
microtubule cytoskeleton in SOCE has also been investigated as well. However, several studies 
have reported that nocodazole, a drug which causes depolymerization of the microtubular 
cytoskeleton, fails to inhibit SOCE or ICrac in rat basophilic leukemia (RBL) and chicken DT40 B 
lymphoma (DT40) cells (Bakowski et ai., 2001; Baba et al., 2006). Nevertheless, microtubules are 
reported to play a facilitatory role in organizing STIM1 for optimal Ca2+ sensing and/or 
communication with Orai channels (Smyth et al., 2007). Recent research has also shown that 
restricting cell spreading in Swiss 3T3 cells, by using adhesive islands to control cell shape, blocks 
the mitogen-evoked Ca2+ influx (Pennington et al., 2007).
1.8 Objectives of the research
The strict control of the cell cycle progression is the key guarantee of normal cell physiology 
activities. The cell cycle phase to phase transitions are mainly regulated by different cyclin-CDK 
combinations and CKIs (Brooks, 2005). In addition, mitogenic stimuli are required for the 
transition of G0 to Gi phase and also for the Gj progressing to S phase. Mitogens function through 
various intracellular signal pathways, such as the MAPKs or ERKs pathway plays a critical role in Gi 
progression (Pages eta!., 1993).
Moreover, it was found that the [Ca2+]i response which could be evoked by mitogens is another 
key regulator in the cell cycle control. For example, both the intracellular Ca2+ store depletion and 
the presence of extracellular Ca2+ are necessary for the transitions between G0/Gi and Gi/S
phases (Takuwa et al., 1995; Santella et al., 2005). Ca2+ with its binding proteins mediates the cell
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cycle by affecting various regulators, such as p27, p21, CDK2 and CDK4 at different transitions 
(Rasmussen and Means, 1987).
In addition to the Ca2+ signaling, cell adhesion and cell spreading are influential to the cell cycle 
regulation as well. Cell adhesion to ECM permits the entry from G0 to Gi (Folkman and Moscona, 
1978). The adhesion facilitates the signal transferring from the ECM proteins to the intracellular 
pathways, such as MARK pathway, which fulfils the regulation of the cell cycle (Zhu and Assoian, 
1995). On the other hand, the normal spreading cell shape and intact cytoskeleton are suggested 
to be the critical regulators in the transition from to S phase (Huang and Ingber, 1999). It was 
reported that restriction of the CE cell spreading prevents the increase of cyclin D and the down 
regulation of p27 arresting in Gi phase (Huang et al., 1998).
Although it has been widely accepted that both Ca2+ signaling and cell shape can mediate cell 
cycle progression, the regulation mechanisms are not fully understood. A relationship between 
these two elements, Ca2+ signaling and cell shape has been reported. For instance, it was 
observed that disruption the actin cytoskeleton by cytochalasin D result in the inhibition of ATP 
or platelet-derived growth factor evoked [Ca2+]i responses in NIH 3T3 cells (Ribeiro et al., 1997), 
while jasplakinolide was observed to prevent SOCE in A7r5 cells (Patterson et al., 1999). More 
importantly, a recent study revealed that, in Swiss 3T3 cells, restricting the cell spreading with 
polyHEMA adhesive islands not only prevents the cell cycle progression but also blocks the 
mitogen (bombesin)-evoked Ca2+ influx (Pennington et al., 2007). Such findings imply a possible 
role of Ca2+ that accounts for the cell shape regulation of cell cycle progression.
Based on these findings, the aim of this study is to identify the mechanism of this cell 
shape-dependent and bombesin-evoked Ca2+ influx. PolyHEMA islands (022pm and 045pm) have 
been used to restrict the spreading of Swiss 3T3 cells (Ireland et al., 1987; Pennington et al., 
2007). It is well known that there are two major Ca2+entry pathways existed in non-excitable cells. 
These include SOCEs and AA regulated Ca2+ influx. A previous study in our laboratory has 
suggested that this bombesin-induced Ca2+ influx is more likely to be activated through the 
regulation of AA, since it was observed that bombesin acted like 5,8,11,14-eicosatetraynoic acid
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(ETYA), a non-metabolizable analogue of AA, but not thapsigargin in Ba2+ and Sr2+ influxes (Foster, 
2005). Therefore, the AA-induced Ca2+ influx has been studied first.
As described in section 1.3.8.3, the cPLA2 pathway is the primary way to generate AA. Since the 
translocation of cPLA2 to intracellular membranes with the increase of [Ca2+]| is suggested to rely 
on the actin cytoskeleton (Cybulsky et aL, 2004), altering the cell spreading by adhesive islands is 
likely to affect the activation of cPLA2 which may account for the absence of Ca2+ influx in 
restricted cells. As a result, the involvement of cPLA2 activation in the bombesin-evoked Ca2+ 
influx was studied. The study focused on the phosphorylation of cPLA2, as it is another key 
prerequisite for the cPLA2 activation. Immunofluorescence was utilized as the main approach.
On the other hand, the possible role of SOCEs in this bombesin-evoked shape dependent Ca2+ 
influx pathway cannot be ruled out. Referring to the various models of SOCEs described in section 
1.3.7, alteration of the cell shape might affect the link between ER and SOCCs. Furthermore, 
STIM1, as the pivotal molecular component in SOCEs, is guided by microtubules to translocate to 
puncta (Smyth et al., 2007). Hence, the involvement of SOCEs was investigated using SOCE 
inhibitors. In addition, the formation of STIM1 puncta was examined to identify SOCEs.
Once the mechanism of this cell shape required Ca2+ influx is revealed, it might be possible to 
explain how the cell shape inhibits the bombesin-induced Ca2+ influx in the cell on small islands 
and why the cell failed to enter S phase in the cell cycle.
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Part 1: Methods
2.1 Cell culture
2.1.1 Cell culture in flasks
Swiss 3T3 cells were cultured in Dulbecco's modified Eagle's medium containing 10% fetal calf 
serum (PCS) and 1% antibiotic/mycotic (10% FCS-DMEM) and maintained in a humidified carbon
dioxide (C02) incubator at 37°C. The media was replenished 2-3 times per week and the cells
were passaged when they were approximately 80% confluent. When passaging, the media was 
removed and the cells were washed with 5ml PBS (136.8mM NaCI, 2.68mM KCI, 6.21mM 
Na2HP04 and 1.47mM KH2PO4). In order to remove the cells from the surface of the flask, they
were treated for 5 minutes (at 37°C) with 0.05% trypsin-0.02% EDTA using 1 and 3 ml volume for
a 25cm3 and 75cm3 flask respectively. Subsequently, the flasks were gently tapped in order to 
dislodge the cells. Then, each flask was supplemented with 5-10ml 10% FCS-DMEM to stop the 
digestion by 0.05% trypsin-0.02% EDTA. The cell suspension was centrifuged at 140xg for 5 
minutes. The supernatant was removed and the cell pellet was resuspended in 5 or 10ml 10% 
FCS-DMEM and divided into flasks. Cells were cultured in 25ml 10% FCS-DMEM for a 75cm3 flask 
and 5ml for a 25cm3 flask.
2.1.2 Plating cells onto coverslips/ islands
To plate the cells on coverslips, cells were removed from the surface of the flasks and centrifuged 
as described in section 2.1.1. Cells were resuspened in 15ml 10% FCS-DMEM. The cell suspension 
was then plated into a UV sterilized 6-well plate containing one coverslip in each well. Each 
coverslip was covered with 1ml of this cell suspension and 1ml of FCS-DMEM media.
To restrict the cell shape, 3-4 days old Swiss 3T3 cells were plated onto sterilized coverslips 
coated with either small or large palladium islands that were placed in 6-well plates in 10% 
FCS-DMEM following the same protocol as described above. The density of cells added to the 
coverslips need to be controlled. For the small islands, it was approximately 4 x 105 cells/ml, while 
for the large island it was 2 x 10s cells/ml.
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Cells on coverslips or islands were allowed to attach in the presence of serum for 3-4 hours until 
attached and then kept in serum free (SF)-DMEM for 16 hours before each experiment.
2.1.3 Cryopreservation of cells
After the Swiss 3T3 cells were cultured in flasks for 3 to 4 days, they were removed from the 
surface of the flasks and centrifuged following the protocol described in section 2.1.1. The cell 
pellet was resuspended with fresh made freezing medium made up with 10% DMSO and 90% FCS. 
Subsequently, the cell suspension was divided into cryovial tube (1ml each tube). All the cryovial
tubes were placed into a Mr. Frosty and kept in a -80°C freezer. Cells were left in the -80°C 
freezer overnight and were then transferred to the liquid nitrogen dewar.
To re-grow the cells that were kept in liquid nitrogen, cells were thawed using a water bath
pre-heated to 37°C. The thawed cells were placed into a 25cm3flask contained 5ml pre-warmed
FCS-DMEM. The media was changed with fresh FCS-DMEM when the cells had adhered to the 
flask.
2.2 Coverslip preparation
2.2.1 Preparation of adhesive islands
Round glass coverslips (022pm) were first cleaned. They were immersed in chromic acid for 
about 15 minutes and rinsed under fast flowing water. After that, the coverslips were placed into 
racks and immersed in distilled water for 1.5 hours while the water was changed every half an
hour. After the washing, they were dried at 60°C.
2.2.2 PolyHEMA coating
A 12% (w/v) polyHEMA stock in 95% ethanol was prepared. The solution needed to be incubated 
at 37°C overnight to ensure that the polyHEMA was completely dissolved. Before the next step,
the stock solution was centrifuged at 2500rpm for 30 minutes to pellet any un-dissolved 
polyHEMA. The polyHEMA stock was stored in the dark at room temperature until required. A 1%
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(w/v) solution of polyHEMA was prepared freshly by diluting the 12% polyHEMA stock with 95% 
ethanol. Each coverslip was evenly covered with 40|il of 1% polyHEMA. The coated coverslips
were dried for 90 minutes at room temperature and at 60°C for another 90 minutes.
2.2.3 Palladium coating
Palladium was then deposited onto the surface of these polyHEMA-coated coverslips by using an 
Edwards 12E6 vacuum coating unit (Figure 2, page 56). In this system, palladium wire (0.125mm 
in diameter and 11mm in length) was first twined around a tungsten filament that could be 
placed between the two electrodes of the coating unit. The palladium wire could be evaporated 
using 40 watts for 20-30 seconds (16A at 2.5V). Evaporated palladium deposited on coverslips 
through photolithographically etched copper foils to form different sizes of islands. Three types of 
foil islands masks were used. Two could form either large (045[im) or small (022pm) islands on 
coverslips, another one could form mixed sizes of islands (from 010pm to 045pm) a long with 
large areas for normal spreading cells on each coverslip.
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Belljar under 
vacuum
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cover slips
Figure 2-The process of making polyHEMA surrounded palladium coated adhesive islands
The figure shows the process of making adhesive islands. Glass coverslips were first coated with 
poly-HEMA, and then palladium was deposited onto these coverslips in a vacuum system.
The figure is adopted from the Foster's thesis (2005).
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2.3 Experiments with a PTI deltascan based imaging system 
2.3.1 Prepare the cells for Ca2+ imaging
Cells need to be transferred onto glass coverslips (022pm) or adhesive islands 1 day before the 
experiments using PTI Ca2+ imaging system. For the normal spreading cells, experiments were 
performed on both non-confluent and confluent cells. Normally, the non-confluent cells were 1-2 
days cultured while the confluent and quiescent cells were 4-5 days cultured before plated onto 
coverslips. For the restricted cells, 3-day old Swiss 3T3 cells were used and transferred onto 
islands.
A 6-well plate containing one glass coverslip or a palladium coated coverslip with islands in each 
well was sterilized under UV light for 30 minutes. After that, cells were transferred onto the 
sterilized coverslips following the protocol described in section 2.1.2. After 3-4 hours' culture in 
10% FCS-DMEM, the cells were changed to SF-DMEM to avoid cell proliferation. They were 
cultured for 16 hours serum free before the experiments.
2.3.2 Loading cells with fura-2
Fura-2-acetoxymethyl ester (Fura-2 AM) is a membrane-permeable derivative of the ratiometric 
Ca2+ indicator used to measure [Ca2+]j by fluorescence. After fura-2 diffuses inside the cell, its 
acetoxymethyl easter group is hydrolyzed by cellular esterases. Removal of the esters regenerates 
"fura-2", the pentacarboxylate Ca2+ indicator. Fura-2 fluorescence was excited at wavelengths of 
340nm and 380nm reflecting the excitation peaks in Ca2+-saturated and Ca2+-free conditions, 
respectively. The emission intensity 510nm from each excitation wavelength (340 and 380nm) 
was measured and used to generate a ratiometric measure of [Ca2+]i. In addition, 340/380nm 
ratio can be used to monitor Sr2+, Ba2+ fluxes and 340/360nm ratio can be used for Mn2+ quench 
protocol.
HEPES buffered saline (HBS), which contains 145mM NaCI, 5mM KCI, ImM MgS04, ImM 
NaH2P04 and lOmM Hepes, was prepared and supplemented with lOmM glucose prior to each 
experiment. Loading buffer was made by preparing HBS containing 2pM fura-2 and 0.012%
pluronic F127, 0.1%w/v BSA and 200pM sulphinpyrazone (SPZN). Each coverslip with cells was
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immersed with 1ml loading buffer at 37°C for 45-60 minutes in the dark. After loading, the cells 
were rinsed in Ca2+ free HBS to remove excess dye and kept in HBS (Ca2+ free or containing ImM 
Ca2+) at 37°C until use.
2.3.3 Ca2+ measurement
The PTI Ca2+ imaging system was coupled to a Nikon Diaphoto inverted microscope. Cells are 
excited at 340nm and 380nm using a PTI Deltascan light source. The light is then directed to the 
cells using a Nikon m400 dichronic mirror. The emitted light is able to pass through the dichronic 
mirror and be detected by a photonic science intensified charge-coupled camera after passing 
through a 510nm band pass filter. The 340nm and 380nm signals are then converted by a 
software into 340nm/380nm ratiometric traces and used to indicate the changes in [Ca2+]i.
The coverslip with cells was placed in a purpose built water-jacketed chamber with the cells 
immersed in a 1ml volume of HBS.
2.3.4 Ca2* calibration
The intracellular Ca2+ concentration can be calibrated by converting the ratio (F340/F380) to 
[Ca2+]i using an equation derived by Grynkiewicz et a!. (1985). It requires five parameters 
including the ratio of the fura-2 fluorescent signals at 340nm/380nm (R), the maximum ratio 
(Rmax )in saturating Ca2+, the minimum ratio (Rmin) in zero Ca2+, dissociation constant (Kd) for 
fura-2 in Ca2+ and the ratio of maximum and the fluorescence of the Ca2+ free dye at 
380nm/fluorescence of the Ca2+ bound dye at 380nm (P).
[Ca2*]FKd|3(R-Rmin)/(Rml»-R)
In order to get the Rmax, ionomycin (3pM) was added to cells in HBS which induced a rise in [Ca2+]i. 
While the Rmin was obtain by adding EGTA (lOmM) to cells in HBS again in the presence of 
ionomycin.
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2.4 Experiments with the flexstation microplate reader
2.4.1 Flexstation reader
The Molecular Devices Flexstation is a benchtop scanning fluorometer and integrated fluid 
transfer workstation capable of conducting endpoint, kinetic, lambda scan and well scan 
experiments in a multi-well plate format {6, 12, 24, 48 and 96-well) and fluidics transfer 
experiments in 96-well format. The Flexstation Reader was used to monitor the [Ca2+]i response 
in Swiss 3T3 cells by measuring fura-2 fluorescence. A set of eight wells of a 96-well plate were 
read in a single column simultaneously. The machine monitors all the wells in a column over a 
time course, during which up to three compounds can be added robotically. Multiple columns are 
read sequentially for additional run times.
2.4.2 Preparing cells for the flexstation
2-3 days old Swiss 3T3 cells were first plated onto 96-well plates with half of the plate 48 wells 
used. The cell concentration was carefully controlled, from 5xl04 to 7.5xl04 cells per well. Each
well was added with lOOpI cells suspension in 10% FCS-DMEM. After cultured at 37°C for 3-4
hours, 10% FCS-DMEM was aspirated and the cells were washed 3X in MBS with ImM Ca2+. 
Subsequently, SF-DMEM was added into each well (100pl). Cells were cultured for 6-16 hours 
before the Flexstation experiment.
2.4.3 Loading cells with fura-2
Fresh Ca2+ loading buffer was prepared as described in section 2.3.2. The SF-DMEM was removed 
from the assay plate of cells with a multichannel pipette and then 100pl loading solution was
added into each well instead. The plate was placed in a 37°Cincubator for 45 minutes in the dark. 
After the cells were loaded with fura-2, the loading buffer was replaced with FIBS either with 
ImM Ca2+ or EGTA or Ca2+ free (80pl per well) depending on what the experiment was carried 
out.
2.4.4 Preparing the compound plate
The compound plate was prepared 30 minutes before starting the Flexstation. All the compounds
59
Chapter 2
were made at 5X the final desired concentration by diluting stock with Ca2+ free or ImM Ca2+ 
contained HBS. Each compound was added into corresponding column, 300|il per well, according 
to the time point at which it should be added to the assay plate. The prepared the compound
plates was kept on ice and transferred into a 37°C incubator to warm up 10 minutes prior the 
experiment.
2.4.5 Experimentation
The Flexstation plate reader was usually started at least 30 minutes in advance, since the 
machine needed to warm up to 37°C. Then, both the assay plate and the compound plate were
put into the Flexstation microplate reader and reading initiated. The first addition point was 
always set at 20 seconds after starting a run in order, to record a baseline before additions. 
Subsequent addition time points varied in different assays. The data was recorded and analyzed 
by SoftMax Pro software.
2.5 Immunofluorescence
2.5.1 Staining the phospho-cPLA2 in normal spreading cells
3-4 days old Swiss 3T3 cells were plated onto UV sterilized coverslips (0 22pm) in a 6-well plate in 
10% FCS-DMEM as described in section 2.1.2 and allowed to grow as normal till 60% confluent.
Medium was removed from the cells and washed 3X in PBS. In order to fix the cell, 1ml 100% 
methanol was added to each well of a 6-well plate at room temperature for 10 minutes. After 
that, cells were washed 3X in PBS. Ten percent chicken serum in PBS was added into each well to 
block the cells for 1 hour at room temperature.
The primary antibody was diluted 1 in 100 in PBS containing 1% of the same chicken serum that 
used for blocking and 1% triton X100. Forty microliters of this primary antibody solution was
placed on to each of the coverslips and they were incubated overnight at 4°C. Each coverslip was 
covered with parafilm to prevent the primary antibody solution from drying.
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The next day, cells were rinsed 3X in PBS allowing 10 minutes for each wash. The second antibody 
was diluted 1 in 500 in PBS containing the same 1% chicken serum and 1% triton X100. Then, the 
cells were incubated with 40[d of secondary antibody solution and each coverslip covered with 
parafilm for 1 hour at room temperature in dark. Cells were then washed 3X in the same way 
with PBS to remove the excess second antibody. Finally, coverslips were placed on glass slide and 
mounted with VECTASHIELD with the edge sealed with nail varnish.
2.5.2 Staining the phospho-cPLA2 in shape restricted cells
Cells were transferred onto coverslips with adhesive islands according to the protocol mentioned 
in section 2.1.2. After about 16 hours, the cells were washed 3X in PBS. Following that, the cells 
were fixed with 100% methanol for 5 minutes at room temperature. The fixation time is reduced 
to 5 minutes in order to protect the polyHEMA from dissolving by methanol. After that, the 
primary and secondary antibody was used in a same way as described in section 2.5.1. Finally, 
the stained cells were mounted with VECTASHIELD as before.
2.5.3 Confocal microscopy
Confocal microscopy is an optical imaging technique used to increase micrograph contrast and/or 
to reconstruct three-dimensional images by using a spatial pinhole to eliminate out-of-focus light 
in specimens that are thicker than the focal plane.
Images of the stained cells were acquired using an inverted Leica SP2 AOBS laser scanning 
confocal microscope that allowed 458, 476, 488, 496, 514, 574, 594 and 633 laser line excitation. 
The FITCwide program was chosen for cells stained with the Alexa Fluor 488 chicken anti-rabbit 
IgG. The laser line 594 was used to excite the cells stained with the Alexa Fluor 596 chicken 
anti-rabbit IgG. Emission band width was adjusted to give optimal signal with no overlap into 
other channels. The scan speed was set as 400Hz per second. A scan format of 1024x1024 was 
used. The image was obtained from a frame average of 6. The gain and offset settings were 
always kept the same during each experiment to allow determination of relative intensities. The 
63x oil immersion objective was normally used.
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2.6 Plasmid transfection 
2.6.1 Preparing the plasmid
The plasmids: mCherry-STIMl and YFP-STIM1 were obtained from the laboratory stock prepared 
following standard plasmids preparation protocol by colleagues. I have prepared the GFP-cPLA2 
plasmid using a similar protocol, which is described in Appendix 1.
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Part 2: Materials
name supplier
Swiss 3T3 fibroblast A gift from professor Pennington
Dulbecco's modified Eagle's medium (DMEM) Invitrogen
Trypsin-EDTA Invitrogen
Fetal Calf Serum Invitrogen
antibiotics&antimyotics Invitrogen
Bombesin CalBiochem
Thapsigargin Calbiochem
ETYA CalBiochem
fura-2 AM Invitrogen
Pluronic F127 Sigma Aldrich Chemical Company
Sulphinpyrazone Sigma Aldrich Chemical Company
CaCI2 solution BDFI Laboratory Suppliers
BaCI2 Sigma Aldrich Chemical Company
SrCI2 Sigma Aldrich Chemical Company
LOE908 Tocris
SK&F 96365 CalBiochem
cPLA2a inhibitor CalBiochem
AACOCF3 CalBiochem
RHC80267 CalBiochem
PoiyHEMA Sigma Aldrich Chemical Company
Ethanol Sigma Aldrich Chemical Company
phospho-cPLA2 antibody(Ser 505)-R rabbit Santa Cruz Biotechology
Anti-rabbit immune-globulin 488 or 596 Invitrogen
YFP-STIM1 plasmid A gift from Professor Bob Burgoyne
mCherry-STIMl Plasmid A gift from Professor Bob Burgoyne
JetPRIME Polyplus
GeneJuice Novagen
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Chicken Serum Sigma Aldrich Chemical Company
Goat Serum Sigma Aldrich Chemical Company
Triton lOOx Sigma Aldrich Chemical Company
Methanol Sigma Aldrich Chemical Company
ERK inhibitor FR180204 CalBiochem
PD98059 CalBiochem
Bromoenol Lactone (BEL) CalBiochem
Flasks(25cm3 and 75cm3) Sarstedt
6-well and 96-well tissue culture plate Corning
Cover glass VWR
64
Chapter 3
Chapter 3
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3.1 Introduction
The main aim of the thesis is to investigate cell shape-dependent Ca2+ influx induced by the 
mitogen: bombesin. Swiss 3T3 cells were chosen because cell-shape regulation of Ca2+ influx and 
proliferation was first characterized using this type of cell (Ireland et a!., 1987; Pennington et al., 
2007). Before undertaking a more detailed investigation of the cell-shape-dependent Ca2+ influx, 
a series of experiments were performed to confirm that the bombesin-evoked [Ca2+jj responses 
in Swiss 3T3 cells were consistent with earlier observations. In addition, the influence of cell 
density on bombesin-evoked [Ca2+]i responses was studied with both confluent and 
non-confluent cells, because earlier experiments suggested that cell density might affect the 
[Ca2+]i responses (Evans etai, 1984; Otun etai, 1992).
Two additional agonists, ETYA and thapsigargin, were used to test the [Ca2+]i response. ETYA has 
been used to induce AA regulated Ca2+ entry as it is an analogue of AA. However, the ability of 
ETYA in inducing ARC influx is less effective than AA itself (Mignen et al., 2008). While ETYA 
induces a NSOCE, thapsigargin is the typical agonist for inducing SOCEs. Both agonists were used 
to test the existence of ARC channel and SOCC activity in Swiss 3T3 cells.
In addition, palladium coated islands surrounded by non-adhesive polyHEMA were used to 
restrict the cell shape. The bombesin-induced [Ca2+]| response was then examined in 
shape-restricted cells. Previous studies have reported that the bombesin-induced Ca2+ influx was
inhibited in cells on small islands (022pm) (Pennington et al., 2007). Similar experiments were 
repeated to confirm the existence of such cell-shape-dependent Ca2+ influx.
3.2 Methods 
3.2.1 Cell culture
Swiss 3T3 cells were cultured in flasks and then transferred onto glass coverslips according to 
standard protocol as described in section 2.1. The confluent cells were cultured for 4-5 days until 
they were closely packed while the non-confluent cells were cultured for 1-2 days in flasks before 
transferred onto coverslips (Section 2.3.1). For the experiments using shape-restricted cells, cells
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were transferred onto either large (045|tm) or small (022|am) islands according to standard 
protocol as described in section 2.1,2.
Cells on coverslips or islands were grown for 3-4 hours until attached in FCS-DMEM and then 
kept in SF-DMEM for 16 hours before each experiment.
3.2.2 Ca2+ imaging
During the experiment, cells on glass coverslips or islands were loaded with 2pM fura-2 as 
described in section 2.3.2 and immersed in HBS containing either ImM Ca2+ or ImM EGTA. Cells 
were stimulated with agonists: lOOnM bombesin, 2pilVl thapsigargin or lOOnM/lpM ETYA to 
induce [Ca2+]j responses in different experiments. The changes of fura-2 fluorescence were 
monitored using the Ca2+ imaging system (Section 2.3.3). More details of the each experiment are 
described in section 3.3.
3.3 Results
3.3.1 Bombesin-induced [Ca2*]; response
Figure 3.3.1A (a) shows two typical bombesin-induced [Ca2+]j responses in a normal spreading 
confluent or non-confluent Swiss 3T3 cell in HBS containing ImM Ca2+. In total, 4 experiments 
were carried out using confluent cells while 5 experiments were performed in non-confluent cells. 
The results indicated that lOOnM bombesin could consistently induce a [Ca2+]| response, although 
the amount of Ca2+ influx varied among cells. All the confluent cells in each experiment showed a 
[Ca2+]i response (n=42 cells). However, it is not the case in non-confluent cells. In 2 out of 5 
experiments, approximately half of the non-confluent cells failed to response to bombesin, 
therefore, only 26 out of 31 non-confluent cells showed a bombesin-induced [Ca2+]j response.
Similarly, figure 3.3.IB (a) shows two typical bombesin-induced [Ca2+]j responses in a normal 
spreading confluent or non-confluent Swiss 3T3 cell in HBS containing ImM EGTA. Results are 
representative of 22 and 23 experiments for confluent and non-confluent cells respectively. 
Consistent with what is indicated in figure 3.3.1A, in 8 out of 23 experiments, approximately half
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of the non-confluent cells showed a Ca2+ release. Therefore, 13 out of 130 non-confluent cells 
failed to response to bombesin, whereas all the 312 confluent cells showed a Ca2+ release. This 
further confirms that lOOnM bombesin is an effective agonist to induce [Ca2+]| response in Swiss 
3T3 cells although it is relatively less efficacious in the non-confluent cells.
The bombesin-evoked Ca2+ release and Ca2+ influx in either confluent or non-confluent quiescent 
Swiss 3T3 cells are compared in figure 3.3.1A (b) and figure 3.3.IB (b). The statistical analysis 
suggested that the stimulation by bombesin caused a significantly bigger Ca2+ influx and a much 
smaller Ca2+ release in non-confluent cells than that in the confluent cells.
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Figure 3.3.1A-Bombesin-induced Ca2+ influx
Quiescent Swiss 3T3 cells were cultured, unrestricted on glass coverslips in SF-DMEM for 16 
hours before experiments, (a) Typical Ca2+ responses to bombesin (lOOnM) are shown in the 
presence of ImM Ca2+ in confluent cells (black) or non-confluent cells (red). The [Ca2+]i was 
measured using fura-2, at 37°C. (b) Mean data of increased [Ca2+]| at both the peak and plateau 
of the responses caused by the addition of bombesin (lOOnM) were indicated in solid bars. The 
A[Ca2+]i is measured as the [Ca2+]i at the peak or plateau, which is 400 seconds after the peak, 
minus the baseline [Ca2+]j before the addition of bombesin. Error bars shown are ± S.E. of (N) 
number of indicated cells. *P<0.05, when A[Ca2+]i value of (N) number of cells were subjected to 
t-test.
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Figure 3.3.1B-Bombesin-induced Ca2+ release
Quiescent Swiss 3T3 cells were cultured, unrestricted on glass coverslips in SF-DMEM for 16 
hours before experiments, (a) Typical Ca2* responses to lOOnM bombesin are shown in the 
presence of ImM EGTA in confluent cells (black) or non-confluent cells (red). The [Ca2+]j was 
measured using fura-2, at 37°C. (b) Mean changes in [Ca2+]i at the peak and plateau of the 
responses caused by the addition of bombesin (lOOnM) were indicated in solid bars. The black 
bars represent the data of confluent cells and the red bars show the data of non-confluent cells. 
The A[Ca2+]j is measured as the [Ca2+]j at the peak and series time points of plateau, which are 
from 1 minute to 8 minutes after the peak, minus the baseline [Ca2+]j before the addition of 
bombesin. Error bars shown are ± S.E. of (N) number of indicted cells. *P<0.05, when A[Ca2+]| 
value of (N) number of cells were subjected to t-test.
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3.3.2 Thapsigargin-induced Ca2+ influx
Figure 3.3.2 shows two typical thapsigargin-evoked [Ca2+]i responses in Swiss 3T3 cells. The 
results indicate that thapsigargin (2pM} does not induce a consistent [Ca2+]i response and the 
responses vary among cells even in the same experiment. In total, 12 separate experiments {n=97 
cells) were repeated.
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Figure 3.3.2-Thapsigargin-induced Ca2+ influx
3-day-old quiescent Swiss 3T3 cells were cultured, unrestricted on glass coverslips in SF-DMEM 
for 16 hours before experiments. Two [Ca2+]i responses are shown to thapsigargin (2pM) which 
was added at 200 seconds in the presence of ImM Ca2+ in HBS. The [Ca2+]j was measured using 
fura-2, at 37°C. The figure is representative of the variation seen in 12 separate experiments.
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3.3.3 ETYA-induced Ca2+ influx
Figure 3.3.3 shows typical ETYA-induced [Ca2+]j responses in Swiss 3T3 cells. Cells showed an 
elevation in [Ca2+]j on addition of lOOnM ETYA in 2 (n=17 cells, figure a) out of 13 experiment 
(n=94 cells). The proportion of responsive cells increased to 10 (n=65 cells, figure b) out of 23 
experiments (n=168 cells) when the concentration of ETYA was increased to IpM. Consequently, 
ETYA rarely evoked a [Ca2+]| response at lOOnM and elicited a response in about 50% of 
experiments at IpM.
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Figure 3.3.3-ETYA-induced Ca2+ influx
3-day-old quiescent Swiss 3T3 cells were cultured, unrestricted on glass coverslips in SF-DMEM 
for 16 hours before experiments. Two [Ca2+]i responses are shown to lOOnM (a) and IpM (b) 
ETYA added at 200 and 150 seconds, respectively, in the presence of ImM Ca2+ in HBS. The [Ca2+]j 
was measured using fura-2, at 37°C. Figure (a) represents typical [Ca2+]i responses to lOOnM 
ETYA seen from cells in the 2 experiments when clear responses were seen. In a further 11 
experiments, no response to lOOnM ETYA was observed. Figure (b) represents typical [Ca2+]i 
responses to IpM ETYA seen from cells in the 10 experiments when clear responses were seen. 
In a further 13 experiments, no response to lOOnM ETYA was observed.
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3.3.4 The effect of cell shape on bombesin-induced Ca2+ influx
Figure 3.3.4 shows typical [Ca2+]j responses to lOOnM bombesin in a cell on either a small island 
(a) or a large island (b). In the cell on the small island, the [Ca2+]i returns to resting level quickly 
after the initial Ca2+release without a plateau, which indicates that the Ca2+ influx is inhibited in 
shape-restricted cells. In total, 3 separate experiments were performed.
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Figure 3.3.4-Cell-shape-dependent Ca2+ influx induced by bombesin
3-day-old quiescent Swiss 3T3 cells were cultured and restricted on either small (a) or large (b) 
islands in SF-DMEM for 16 hours before experiments. A [Ca2+]| response is shown to bombesin 
(lOOnM) added at 180 seconds in the presence of ImM Ca2+ in HBS. The [Ca2+]| was measured 
using fura-2, at 37°C. Each figure is representative of 3 separate experiments.
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3.4 Discussion
The data presented in this chapter confirms that the [Ca2+]i responses in Swiss 3T3 cells could be 
monitored with the indicator, fura-2.
In normal spreading Swiss 3T3 cells, stimulation of lOOnM bombesin consistently indicated a 
[Ca2+3j response including a transient Ca2+ release from the intracellular store and a sustained Ca2+ 
influx. Moreover, the Ca2+ responses to both thapsigargin and ETYA were also observed. This is 
consistent with the existence of SOCCs and ARC-tike channels in Swiss 3T3 cells.
in addition, the effect of cell density on bombesin-evoked [Ca2+]j responses was studied. The 
results indicate that the sustained Ca2+ influx to bombesin is larger in non-confiuent ceils than 
that in confluent cells. Also, the confluent cells show a bigger Ca2+ release than non-confluent 
cells whereas the Ca2+ sequestration is quicker. Both confluent and non-confluent cells have a 
similar resting level of fura-2 fluorescence, with the range of ratio 340/380 from 0.45 to 0.55. 
Hence, the differences in increased [Ca2+]j between confluent and non-confluent cells due to 
bombesin (figure 3.1.1 & figure 3.1.2) is convincing. The mechanism of the cell density influence 
on bombesin-evoked [Ca2+]j response is unclear. However, it was reported that after 5 days 
cultured confluent endothelial cells possess significantly lower levels of AA when compared to 
freshly harvested non-confluent cells (Evans eta!., 1984). Since it is known that AA could induce 
Ca2+ influx, if the generation of AA in Swiss 3T3 cells is affected in a similar way to that in 
endothelial cells as reported, a higher level of AA in non-confluent cells may explain why they 
show a bigger Ca2+ entry. No dear evidence was found to explain whether the SOCE Is cell density 
dependent. However, it is observed that there are no significant differences in 
thapsigargin-induced Ca2+ release and influx in confluent and non-confluent endothelial cells 
(Otun et al.t 1992). On the other hand, it is known that the shape of confluent cells is more 
restricted than non-confluent, as they are more tightly packed and rounded. Such cell shape 
differences may be another possible explanation for the different bombesin-evoked [Ca2+]j 
responses in confluent and non-confluent cells, although the degree of cell-cell contact and 
adhesion may also be important.
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Furthermore, the study in shape restricted cells confirmed that the bombesin-evoked Caz+ influx 
is influenced by cell shape, which is consistent with the observation in previous studies 
(Pennington et al., 2007). In addition, the Bombesin-evoked Ca2+ response in cells on islands are 
more similar to the response in confluent cells than that in non-confluent cells. Therefore, 
restriction of cell shape may make cells act in a way similar to when they are confluent. This cell 
shape-dependent bombesin-induced Ca2+ influx is discussed in the following chapters.
In summary, the experiment results in this chapter indicate that:
1. Bombesin (lOOnM) is an effective agonist to evoked [Ca2+]j responses in Swiss 3T3 cells.
2. Thapsigargin (2pM) and ETYA (lOOnM) are able to induce [Ca2*], responses in Swiss 3T3 cells.
3. The bombesin-induced [Ca2+]j responses are cell density dependent. The bombesin-evoked 
Ca2+ release is bigger in the confluent cells than that in the non-confluent cells. 
Bombesin-evoked a bigger Ca2+ influx in the non-confluent cells than in the confluent ones.
4. The bombesin-evoked Ca2+ influx is inhibited by cell shape restriction using adhesive islands.
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Chapter 4
Ba2+ and Sr2+ influxes in Swiss 3T3 cells
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4.1 Introduction
According to the evidence presented in chapter 3 and earlier studies (Pennington et ai., 2007), 
cell-shape-dependent Ca2+ influx induced by bombesin was observed in Swiss STB cells. In order 
to help characterize which Ca2+ entry pathways are involved, extracellular Ca2+ can be substituted 
by other divalent cations.
Ca2+ channels have been reported in many types of cells to be permeable to Sr2+ and Ba2+, as well 
as Ca2+ (Nachshen and Blaustein, 1982; Hughes and Schachter, 1994; Liu et ai, 1995). Moreover, 
it is known that these divalent cations can enter cells via multiple pathways. For instance, Ca2+ 
and Ba2+ enter rat A7r5 smooth muscle cells through either passive pathways or receptor 
operated pathways (Hughes and Schachter, 1994). It was reported that arginine vasopressin 
(AVP)-evoked Sr2+ entry in A7r5 cells is through a non-capacitative pathway mediated by AA 
(Broad et al., 1999). In addition, both Sr2+ and Ba2+ influxes were seen through passive pathways 
in Ca2+free solution in HEK293 cells without any extracellular stimuli (Zhu etal., 1998). Moreover, 
further Sr2+ and Ba2+ influxes were observed when the transient receptor potential 3 (Trp3) 
protein is expressed in HEK293 cells after stimulation with carbachol (CCh) (Zhu et al., 1998). 
Besides, IP3-sensitive intracellular stores can accumulate both Ca2+ and Sr2+ but not Ba2(Liu etal., 
1995).
A previous study in our laboratory has observed that thapsigargin is able to induce the Ba2+ and 
Sr2+ influx in Swiss 3T3 cells while ETYA and bombesin only induce the influx of Sr2+ (Foster, 2005). 
Since bombesin acted more like ETYA rather than thapsigargin, it was suggested that AA might 
participate in the bombesin-induced Ca2+ influx (Foster, 2005). In my research, similar 
experiments were performed in order to confirm this suggestion. In addition to monitoring the 
Ba2+ and Sr2+ responses in normal spreading cells, the responses to agonists in shape restricted 
cells were studied as well. If Ba2+ or Sr2+ enters cell through a pathway which is shape-dependent, 
then the influx should be blocked or reduced in cells on small islands.
Mn2+ quench has also been widely used to monitor Ca2+ influx by recording fluorescence with
340nm excitation, where Mn2+decreased and Ca2+ increased the signal (Sage etal., 1989;
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Simpson etal., 1995; Du etaL, 2000). An excitation wavelength of 360nm allows the selective 
study of Mnz+ entry without interference in the signal caused by changes in [Ca2+]j (Sage etal., 
1989; Simpson etal., 1990). However, Mn2+ cannot be used to distinguish different forms of Ca2+ 
entry. Also, as described above, with Mn2+ quench, the signal decreases in the presence of 
agonist following the Mn2+ influx. As a result of these limitations, Mn2+ is not used in my study.
The experiments presented in this chapter are aimed at studying the cell shape-dependent Ca2+ 
influx by using Ba2+ and Sr2+ as Ca2+ substitutes, with objective of determining if particular influx 
pathways are affected by cell shape.
4.2 Method
4.2.1 Cell culture
Swiss 3T3 cells were cultured in flasks according to standard protocol as described in section 
2.1.1. Cells were transferred onto glass coverslips 1 day before the experiments. For the 
experiments on Sr2+ influx in confluent and non-confluent Swiss 3T3 cells, the same protocol was 
used as described in section 3.2.1. For the experiments using shape restricted cells, cells were 
transferred onto either large (0 45pm) or small (0 22pm) islands according to standard protocol 
as described in section 2.1.2.
Cells on coverslips or islands were grown for 3-4 hours until attached in FCS-DMEM and then 
kept in SF-DMEM for 16 hours before each experiment.
4.2.2 Ca2+ imaging
Prior to each experiment, cells were loaded with 2pM fura-2 for 45min at 37°C in the dark as
described in section 2.3.2. They were immersed in HBS containing ImM Ca2+ before being placed 
in the heated chamber on the microscope stage. Ca2+ free or ImM EGTA containing HBS was used 
as extracellular medium when the cell responses is recorded. During the experiments, agonists 
including bombesin, thapsigargin or ETYA were added to stimulate the cell following the addition 
of either Ba2+ or Sr2+. The changes of fura-2 fluorescence were monitored using the Ca2+ imaging
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system. Details of individual experiments are described in section 4.3.
4.3 Results
4.3.1 Bombesin-induced Sr2+ and Ba2+ influx
Figure 4.3.1A shows the Ba2+ or Sr2+ responses in Swiss 3T3 cells after stimulation with lOOnM 
bombesin. Ba2+ induced a small and slow influx in response to bombesin (a). This occurred in 10 
out of 11 experiments. The average increase in ratio340/380 caused by this bombesin-induced 
Baz+ entry is 0.098 ± 0.007 (n=43 cells). The Sr2+ influx to bombesin is much quicker and more 
pronounced (b), and occurred in 46 out of 47 experiments {n=388 cells). More detailed statistical 
analysis of bombesin-induced Sr2+ influx is indicated in figure 4.3.4. In addition, both Ba2+ and Sr2+ 
responses to bombesin in the same cell are displayed (c), which further confirms the difference 
between Ba2+ and Sr2+ influxes after the stimulation by bombesin.
Figure 4.3.1.B shows the control experiments. Addition of ImM Ba2+ (a) or ImM Sr2+(b) did not 
affect the ratio340/380 in un-stimulated Swiss 3T3 cells.
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Figure4.3.1A-Bombesin-induced Baz+ and Sr2+ influxes
3-day-old quiescent Swiss 3T3 cells were 
cultured, unrestricted on glass coverslips 
in SF-DMEM for 16 hours before 
experiments. Responses to lOOnM 
bombesin in Ca2+ free HBS with 
subsequent addition of either Ba2+ (a) or 
Sr2+ (b) are shown. Bombesin (lOOnM) 
was added at 200 seconds and Ba2+(lmM) 
or Sr2t(lmM) was added at 600 seconds.
Both Ba2+ and Sr2+ influxes were tested in
a same cell (c), in which ImM Ba2+ was 
added at 600 seconds and then at 900 
seconds the solution was replaced by a 
solution containing ImM Sr2+. Each figure 
is representative of at least 5 separated 
experiments.
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Figure 4.3.1B-Ba2+ and Sr2+ control
3-day-old quiescent Swiss 3T3 cells were cultured, unrestricted on glass coverslips in SF-DMEM 
for 16 hours before experiments. Ba2+ (a) or Sr2+ (b) were added to give a final concentration of 
ImM in Ca2+ free HBS at 180 seconds. The figure is representative of at least 3 separate 
experiments.
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4.3.2 Thapsigargin-induced Ba2+ influx
Figure 4.3.2 (a) shows the typical Ba2+ influx observed after the stimulation of thapsigargin (2p.M). 
Thapsigargin consistently induced Ba2+ entry, which was seen in 10 out of 11 experiments. The 
average amplitude of such increased ratio340/380 is 0.237 ± 0.02 (n=66 cells), which is much 
greater compared to that induced by bombesin (0.098 ± 0.007) (Section 4.3.1). For comparison, 
two Ba2+ responses to either bombesin or thapsigargin in a same cell are shown in figure 4.3.2 
(b).
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Figure 4.3.2-Thapsigargin-induced Ba2+ influx
3-day-old quiescent Swiss 3T3 cells were cultured, unrestricted on glass coverslips in SF-DMEM 
for 16 hours before experiments. The response in the presence of Ba2+ (a) to thapsigargin was 
shown in Ca2+ free HBS. In figure (a), thapsigargin (2pM) was added at 200 seconds and then Ba2+ 
was added to the final concentration at ImM to the solution at 800 seconds. In figure (b), 
bombesin (lOOnM) was first added to stimulate the cell at 200 seconds and Ba2+ was added at 
500 seconds into the solution in HBS. After that, the solution was replaced with fresh HBS and 
thapsigargin (2pM) was added at 800 seconds and followed the ImM Ba2+ at 1200 seconds. The 
figure is representative of 4 (a) and 6 (b) separate experiments.
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4.3.3 ETYA-induced Ba2+ and Sr2+ influx
Figure 4.3.3A (a) shows an ETYA-evoked Ba2+ influx and a thapsigargin-induced Ba2+ influx that 
occurred in the same cell. Compared to thapsigargin, in most cases, ETYA (lOOnM), which is 
dissolved in ethanol, failed to induce Ba2+ influx (8 in 11 experiments, n=61 cells). Figure 4.3.3A (b) 
shows the ethanol control experiment on the Ba2+ response, in which no Ba2+ influx is observed 
(2 experiments, n=17 cells).
However, an apparent Ba2+ influx after the stimuli of ETYA was seen several times with a low 
incidence (3 in 11 experiments, n=22 cells), and is shown in figure 4.3.3B (a). The increased 
340/380 ratio caused by the influx of Ba2+ after ETYA is 0.418 ± 0.009. At the same period of time, 
Ba2+ passive influxes were observed in 3 of 5 control experiments (n=19 cells), with an increased 
ratio of 0.2176. As shown in figure 4.3.3B (b), an addition of ImM Ba2+ causes an increase in 
ratio340/380 with no stimulation by any agonist, which reveals that the passive influx of Ba2+ 
occurs occasionally in Swiss 3T3 cells.
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Figure 4.3.3A-ETYA-induce Ba2+ response
3-day-old quiescent Swiss 3T3 cells were cultured, unrestricted on glass coverslips in SF-DMEM 
for 16 hours before experiments. Experiments were initiated in Ca2+ free HBS. A typical response 
of Ba2+ (a) to ETVA (lOOnM) is shown. In figure (a), both ETYA and ImM Ba2+ were added to 
solution at 200 seconds and then the solution was replaced with fresh HBS containing ImM EGTA 
at 600 sec with 2pM thapsigargin added at the same time. A further addition of ImM Ba2+ was 
made at 1200 seconds. In figure (b), ethanol (Ipl) was added to the ImM EGTA containing HBS at 
150 seconds as the control of ETYA stimulation and ImM Ba2+ was added at 300 seconds. Each 
figure is representative of at least 2 separate experiments.
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Figure 4.3.3B-ETYA-induced Ba2+ response with Ba2+ passive influx
3-day-old quiescent Swiss 3T3 cells were cultured, unrestricted on glass coverslips in SF-DMEM 
for 16 hours before experiments. Experiments were initiated in Ca2+ free HBS. In figure (a), Ba2+ 
(ImM) show a large and quick influx to lOOnM ETYA at 300 seconds. In figure (b), an addition of 
Ba2+ (ImM) at 400 seconds causes a passive influx. Each figure is representative of at least 3 
separate experiments.
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4.3.4 Bombesin-induced Sr2+ influx in confluent and non-confluent cells
The effect of cell density on bombesin-induced Sr2+ influx has been tested. In the experiment 
cells were first stimulated with lOOnM bombesin. After the initial Caz+ release, ImM Sr2+ was 
added and this resulted in a Sr2+ influx (Figure 4.3.1A). This bombesin-evoked Sr2+ influx was seen 
in all 24 experiments in confluent cells (n=298 cells) and 22 out of 23 experiments in 
non-confluent cells (n=90 cells). In 2 out of these 22 experiments, there are about half the 
non-confluent cells failed to show a Sr2+ influx (n=5 cells). The result is consistent with the 
experiments investigating the effect of cell density on bombesin-induced Ca2+ influx (Section 
3.3.1). Bombesin is more consistent at causing a Sr2+ influx in confluent cells compared with 
non-confluent cells.
The statistical data of the increases of ratio340/380 caused by the bombesin-induced Ca2+ release 
or Sr2+ influx are shown in figure 4.3.4. The results suggested that the bombesin-evoked Sr2+ 
influx is significant bigger in non-confluent cells than in the confluent cells according to the t-test 
(p<0.05). This is consistent to the bombesin-induced Ca2+ influx in confluent and non-confluent 
cells (Section 3.3.1). This implies that although the cell density has an effect on the 
bombesin-evoked Sr2+ influx similar to that on Ca2+ influx.
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Figure 4.3.4-Bombesin-induced Ca2+ release and Sr2+ influx in confluent and non-confluent cells
Quiescent Swiss 3T3 cells were cultured, unrestricted on glass coverslips in SF-DMEM for 16 
hours before experiments. Mean data showing increased ratio340/380 caused by 
bombesin-induced Ca2+ release and Sr2+ influx in either confluent (black) or non-confluent (red) 
cells. The Aratio340/380 is measured as the ratio340/380 at the peak points of Ca2+ release and 
Sr2+ influx minus the baseline value before the addition of bombesin. Error bars shown are ± S.E. 
of (N) number of indicted cells. P<0.05, when Aratio340/380 value of (N) number of cells were 
subjected to t-test.
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4.3.5 Bombesin-induced Baz+ responses in restricted cells
Bombesin-induced Ba2+ responses in shape-restricted cells show great variation. Figure 4.3.5A 
and figure 4.3.5B show three types of Ba2+ responses to bombesin (a-c), and two Ba2+ control 
responses (d) in either large and small islands. The results indicate that there is no significant 
difference between bombesin-evoked Ba2+ responses in cells on either large or small islands. In 
the cells on large islands, a Ba2+ influx with the increase of ratio340/380 ranged from 0.1 to 0.2 
was observed in 8 of 14 cells. Similarly, there were 9 out of 14 cells showed a Ba2+ influx after the 
stimulation of bombesin in cells on small islands. The remaining of the cells presented no 
response to bombesin or Ba2+. On the other hand, passive Ba2+ influxes were observed in cells on 
both sizes of island. In cells on large islands, Ba2+ passive leak occurred in 3 out of 4 cells, and in 
cells on small islands, 2 in 3 cells showed such leak.
Figure 4.3.5C shows the statistical data relating to the increase ratio340/380 caused by Ba2+ 
influxes in restricted cells. The results suggested that there are no significant differences of the 
Ba2+ responses including passive influx and bombesin-evoked influx between large and small 
islands restricted cells.
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Figure 4.3.5A-Ba2+ responses in cells on large islands
3-day-old quiescent Swiss 3T3 cells were cultured and restricted on large islands in SF-DMEM for 
16 hours before experiments. Three Ba2+ responses to bombesin were shown in figure (a-c). 
Bombesin (lOOnM) was added at 180 seconds to Ca2+ free HBS. Ba2+ (ImM) was then added at 
600 seconds in figure (a) & figure (b) and at 400 seconds in figure (c). Figure (d) shows two Ba2+ 
control responses in two single cells, with Ba2+ (ImM) added to Ca2+ free HBS at 180 seconds. 
Each figure is representative of at least 2 separate experiments.
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Figure 4.3.5B-Ba2+ responses in cells on small islands
3-day-old quiescent Swiss 3T3 cells were cultured and restricted on small islands in SF-DMEM for 
16 hours before experiments. Three Ba2+ responses to bombesin were shown in figure 3.4.2a-c. 
Bombesin (lOOnM) was added at 180 seconds to Ca2+free HBS. Then Ba2+ (ImM) was added at 
600 seconds in figure 3.4.2a & figure 3.4.2b, and at 500 seconds in figure 3.4.2c. Figure 3.4.2d 
shows two Ba2+ control responses in two single cells, with Ba2+ (ImM) added to Ca2+ free HBS at 
180 seconds. Each figure is representative of at least 2 separate experiments.
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Figure 4.3.5C-Statistical data of Baz+ responses in restricted cells
3-day-old quiescent Swiss 3T3 cells were cultured and restricted on small islands in SF-DMEM for 
16 hours before experiments. Mean data of increased ratio340/380 due to Ba2+ influx in cells on 
either large or small islands was indicated in solid bars. The grey bars present the data of Ba2+ 
spontaneous influx with no agonist stimulation whereas the blue bars present the data of Ba2+ 
influx after the stimulation of bombesin. The Aratio340/380 was measure as the maximum 
ratio340/380 during the sustained Ba2+ influx phase minus the baseline ratio340/380 level before 
the stimulation. "N" represents the number of cells showed a Ba2+ influx. Error bars shown are ± 
S.E. of (N) number of indicted cells. P>0.05, when Aratio340/380 value of (N) number of cells 
were subjected to t-tests.
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4.3.6 Bombesin-induced Sr2* responses in restricted cells
Similar to Ba2*, bombesin-induced Sr2+ responses in shaped restricted cells various among single 
cells. Figure 4.3.6A and figure 4.3.6B display three types of Sr2+ responses to bombesin (a-c) and 
Sr2+ control responses (d) in cells on either large or small islands. After the stimulation of 
bombesin, the Sr2+ influxes were not consistently observed. In the cells on large islands, 8 cells 
out of 19 showed a Sr2* influx. With a similar frequency, the Sr2* influx occurred in 9 out of 19 
cells on small islands. The Sr2* passive influxes were frequently seen in restricted cells on both 
sizes of islands. In the cells on large islands, Sr2* entered the cells in 4 out of 5 cells without any 
stimulation. In the cells on small islands, Sr2* passive influx occurred in 3 out of 5 cells.
Figure 4.3.6C indicates the statistical data of the increase ratio340/380 caused by Sr2* influxes in 
restricted cells. The results suggested that there are no significant differences of the Sr2* 
responses including passive influx and bombesin-evoked influx between large and small islands 
restricted cells.
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Figure 4.3.6A-Sr2* responses in cells on large islands
3-day-old quiescent Swiss 3T3 cells were cultured and restricted on large islands in SF-DMEM for 
16 hours before experiments. Three Sr2+ responses to bombesin were shown in figure (a-c). 
Bombesin (lOOnM) was added to Ca2+free HBS at 180 seconds. Sr2+ (ImM) was then added at 
600 seconds in figure (a) & figure (b) and at 500 seconds in figure (c). Figure (d) shows a Sr2+ 
control response in a single cell, with Sr2+ (ImM) added to Ca2+ free HBS at 180 seconds. Each 
figure is representative of at least 2 separate experiments.
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Figure 4.3.6B -Sr2* responses in cells on small islands
3-day-old quiescent Swiss 3T3 cells were cultured and restricted on small islands in SF-DMEM for 
16 hours before experiments. Three Sr2+ responses to bombesin were shown in figure (a-c). 
Bombesin (lOOnM) was added to Ca2+free HBS at 180 seconds. Sr2+ (ImM) was then added at 
600 seconds in figure (a) & figure (b) and at 500 seconds in figure (c). Figure (d) shows two Sr2+ 
control responses in two single cells, with Sr2+ (ImM) added to Ca2+ free HBS at 180 seconds. 
Each figure is representative of at least 2 separate experiments.
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Figure 4.3.6C-Statistical data of Sr2+ response in restricted cells
Mean data of increased ratio340/380 due to Sr2+ influx in cells on either large or small islands was 
indicated in solid bars. The grey bars present the data of Sr2+ spontaneous influx with no agonist 
stimulation whereas the blue bars present the data of Sr2+ influx after the stimulation of 
bombesin. The Aratio340/380 was measure as the maximum ratio340/380 during the sustained 
Sr2+ influx phase minus the baseline ratio340/380 level before the stimulation. "N" represents the 
number of cells showed a Sr2+ influx. Error bars shown are ± S.E. of (N) number of indicted cells. 
P>0.05, when Aratio340/380 value of (N) number of cells were subjected to t-test.
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4.4 Discussion
In the study where divalent cations were used as substitutes for Ca2+, it was confirmed that both 
Ba2+ and Sr2+ are able to permeate into Swiss 3T3 cells. At the beginning of this research, similar 
experiments on agonists-induced Ba2+ and Sr2+ responses were performed according to the 
protocol of Foster's {2005} research in our laboratory. It was observed that, in the same cell, 
bombesin-induced a slight and slow Ba2+ influx while thapsigargin is able to evoke a big and quick 
Ba2+ entry. In a same way, no Ba2+ influx occurred after the stimulation of ETYA whereas 
thapsigargin-induced a quick and significant Ba2+ entry response. These observations suggested 
that bombesin acts like ETYA rather than thapsigargin that it activates channels allowing quite 
small amount or no Ba2+ to pass through. This hypothesis is coherent with the Foster's study 
implying that ARC channels are involved in bombesin-evoked Ca2+ influx pathway.
Nevertheless, this hypothesis is subsequently challenged due to the presence of passive Ba2+ and 
Sr2+ influxes in Swiss 3T3 cells observed after further study. For example, Ba2+ enters the cell 
spontaneously when studying the effect of ETYA on Ba2+ responses. Such passive influx is difficult 
to predict or prevent. Besides, it has been argued that both NSOCE and SOCE pathways are 
permeable to Ba2+ while only NSOCE is permeable to Sr2+ (Moneer and Taylor, 2002). 
Consequently, the Ba2+ influx observed after the stimuli of agonists may be an agonist-evoked 
influx or a passive influx or both.
Furthermore, in order to study the effect of cell shape, the Ba2+ and Sr2+ influxes were examined
in cell shape-restricted cells. However, the results were disturbed by high frequency of Ba2+ and
Sr2+ passive influxes as well. Both Ba2+ and Sr2+ are able to enter cells in either large or small
islands spontaneously, which indicates that cell shape has no effect on their passive influx
channels. The Ba2+ and Sr2+ response to bombesin showed great variations among restricted cells.
It was observed that after the stimulation by bombesin, some restricted cells showed a slight Ba2+
influx with a Aratio340/380 less than 0.1 and some cells showed a significant Ba2+ entry with a
Aratio340/380 more than 0.2 while rest of the restricted cells showed no Ba2+ influx. These three
types of responses were seen in either large or small islands restricted cells. The Sr2+ responses to
bombesin could be categorized into similar three types as well. Since 3 distinct types of response
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with either Ba2+ or Sr2+ were observed in both restricted and spread ceils (small and large islands), 
it appears that cell shape does not have a clear effect on the characteristic of the divalent cation 
pathway that can be activated.
Compared to the data in normal spreading cells presented in section 4.3.1, significant Ba2+ 
influxes occurred in restricted cells (Figure 4.3.5Ab & Figure 4.3.5Bb). Flowever, the high 
occurrence of Ba2+ passive influx during the same period of experiments could be the main cause 
of these responses. The role for TRP channels in this effect cannot be ruled out and needs to be 
further investigated. In addition, as the intracellular Ba2+ ([Ba2+]j) concentration is controlled by 
not only the Ba2+ influx but the pumps in plasma membrane and ER should remove Ba2+. The high 
increased [Ba2+]jis probably due to the cells' inability to clear Ba2+ from the cytoplasm (Liu et a!., 
1995). This hypothesis needs to be investigated by further research. On the other hand, the 
frequency of a Sr2+ influx to bombesin was reduced in restricted cells compared to that in normal 
spreading cells. The study on the effect of cell density reveals that bombesin could consistently 
induce a Sr2+ influx in normal spreading cells. However, confluent cells are more likely to show a 
bombesin-evoked Sr2+ influx than non-confluent cells (Figure 4.3.4). These data reconciles with 
the observation that Ca2+ influx appears bigger in non-confluent cells (Section 3.3.1). In the case 
of Sr2+ entry, it could well be that cell density or cell-cell contact influence this cation entry 
pathway.
The mean data of Aratio340/380 cause by Ba2+ or Sr2+ influxes exhibited in figure 4.3.5C and 
figure 4.3.6C suggest that Ba2+ showed a smaller influx in cells on large islands than that in the 
cells on small islands whereas Sr2+ acted in a converse way. However, such differences were not 
as significant as the variation of responses among cells limited the statistical confidence of the 
results. The sample size of each group is small, so the results are not well representative. 
Therefore, more experiments need to be carried out to confirm the conclusion.
In summary, the Ba2+ and Sr2+ responses to bombesin, thapsigargin and ETYA imply a possibility
that Ca2+ enters cell after bombesin stimulation through the AA activated pathways. However,
due to the spontaneous influx of both cations, the involvement of ARC channels cannot be
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confirmed. Ba2+ and Sr2+ investigation contributed less to the study of the cell-shape-dependent
Ca2+ influx pathway than expected. As a result, alternative ways, which are described in the
following chapters, should be applied to carry on the study.
To sum up, the key findings presented in the chapter are:
1. Bombesin induces a slight and slow Ba2+ influx in Swiss 3T3 cells. ETYA induces no Ba2+ influx 
while thapsigargin can consistently evoke a Ba2+ influx.
2. All the three agonist, bombesin, thapsigargin and ETYA can consistently induce a Sr2+ influx.
3. The bombesin-induced Sr2+ influx is not cell density dependent.
4. The bombesin-evoked Ba2+ and Sr2+ responses showed a great variation in adhesive islands 
restricted cells. There is no significant difference according to the statistic analysis between 
the Ba2+/Sr2+ flux in cells on small islands and that in cells on large islands.
5. The Ba2+/Sr2+ spontaneous influxes occurred during the experiment, which disturbed the 
results. As a result, Ba2+ and Sr2+ fluxes were not an ideal approach for the study on 
shape-sensitive Ca2+ influx pathway in Swiss 3T3 cells.
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AA-induced Ca2+ influx: the activation of cPLA2 after the stimulation by
bombesin
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5.1 Introduction
Based on the initial data obtained from the agonist-evoked Ba2+ and Sr2+ influx experiments, we 
suspected that the major Ca2+ influx during the cell proliferation was more likely through the ARC 
channels rather than the CRAC channels. Given that AA is an important regulator of Ca2+ influx, 
the effect of bombesin on the process that led to the generation of AA were first studied. As 
described in section 1.6.3.3, PLA2 enzyme plays a vital role in regulating the release of AA and 
cPLA2 possesses a preference for phospholipids containing AA (Leslie, 1997). Previous studies 
have reported that bombesin increased the activities of cPLA2 and that this was followed by the 
release of AA in Swiss 3T3 cells (Domin and Rozengurt, 1993). Consequently, it is necessary to 
determine if cPLA2 plays a role in the activation of Ca2+influx in response to bombesin. Also the 
translocation of cPLA2 is an important step in its activation. This process may well be susceptible 
to cell shape restriction that is now known to prevent Ca2+ influx.
Cytoplasmic PLA2 is phosphorylated during its activation. The phosphorylation sites of cPLA2 vary 
in response to different stimuli and in different cell types. For instance, it is revealed that there 
are four sites of cPLA2 phosphorylation observed in sf9 cells: Ser437, Ser454, Ser505, and Ser727 (de 
Carvalho et al., 1996). In addition, okadaic acid caused a marked increase in AA release from Sf9 
cells and a selective increase in the phosphorylation of cPLA2 at Ser727 (de Carvalho et al,, 1996). 
Phosphorylation on Ser505 has been shown to be a MAP kinase consensus site in various cell 
types (reviewed by Lin et al., 1993). Evidence indicates that replacement of Ser505 with Ala results 
in a loss in activity of cPLA2 and the decrease of agonist stimulates arachidonate release 
(Abdullah et al., 1995). In macrophages, a transient increase in [Ca2+]j and phosphorylation of 
cPLA2 on Ser505 by MAP kinase can act together to fully activate cPLA2 leading to AA release (Qiu 
et al., 1998). Phosphorylation of cPLA2 on Ser505 also occurs in thrombin- and collagen-stimulated 
platelets and cytokine-stimulated HeLa cells (Borsch-Haubold etal., 1998).
In my research, the activation of cPLA2 induced by bombesin was investigated by testing the
increase of phospho-cPLA2 in the cell. Since bombesin is a mitogen, cPLA2 is more likely to be
phosphorylated on Ser505. Therefore, the phospho-cPLA2 (Ser505) antibody was used to monitor
the phospho-cPLA2 in both normal spreading and cell shape restricted cells. Confocal microscopy
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was used to identify the changes of phospho-cPLA2 in both resting and bombesin stimulated 
cells.
Further experiments were carried out in order to investigate whether the increase of 
phospho-cPLA2 in bombesin-stimulated cells is through phosphorylation of MAP kinase. It is 
known that underlying mechanisms of the cPLA2 phosphorylation are complex (Section 1.6.3.3). 
ERKs, which are members of the MAP kinase family, are reported to responsible for the 
phosphorylation of cPLA2 on Ser505 and the release of AA in many cell types (Chang et ai, 2006). 
It is conceivable that ERK1/ERK2 or MAP kinase p42/44 is the key regulator of cPLA2 
phosphorylation. In this study, two MAP kinase inhibitors were used to block the ERK pathway in 
Swiss 3T3 cells: ERK Inhibitor II (FR180204) and PD98059. FR180204 selectively inhibits ERK1 and 
ERK2 (Ohori et al., 2007) while PD98059 inhibits p42/p44 MAP kinase. If the phosphorylation of 
cPLA2 after stimulation by bombesin is through the ERK/MAPK pathway, no increased 
phospho-cPLA2 would be observed in bombesin-stimulated cells in the presence of FR180204 or 
PD98059.
In addition to the cPLA2 pathway, other possible mechanisms that may generate AA were 
investigated as well. As described in section 1.6.3.3.1, iPLA2 is able to liberate AA (Atsumi et al., 
1998; Akiba et ah, 1999). Moreover, iPLA2 is reported to play a role in SOCEs as an essential 
component of signal transduction from the stores to plasma membrane channels (Singaravelu et 
al., 2006; Boittin et al., 2008). Therefore, the involvement of iPLA2 in the bombesin-evoked Ca2+ 
influx was tested. The inhibitor bromoenol lactone (BEL), which is a widely used iPLA2 inhibitor 
(Balsinde eta!., 1995) was used as BEL substantially reduces SOCEs (Smani etal., 2003).
5.2 Method 
5.2.1 Cell culture
Swiss 3T3 cells and cells on either large or small islands cultured according to standard protocol
as mentioned in section 2.1. For unrestricted cells, 3 day-confluent cells were transferred to glass
coverslips 1 day before the experiment. After an initial 3-4 hours culture in FCS-DMEM on
coverslips, the cells were kept in SF-DMEM for 16 hours prior to experimentation.
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5.2.2 Stimulation by bombesin
The coverslips containing cells were placed in a 6 well plate containing HBS with ImM Ca2+at 
37°C. Cells were divided into two groups: the control group and the bombesin-stimulated group. 
For the stimulated group, bombesin {100nM} was added into 3 distinct wells at 2 minutes, 4 
minutes and 8 minutes before fixing the cells with 100% methanol. In the control group, a sham 
addition was made instead of bombesin.
5.2.3 Pre-treatment of cells with inhibitors
For the immunofluorescence experiments, 12 coverslips with Swiss 3T3 cells were divided into 3 
groups with 4 coverslips in each group. The first group was used as a control pretreated with
DMSO (1:500) in 1ml HBS for 1 hour at 37°C. In the same way, the other two groups are
pre-incubated with inhibitors: FR180204 (lOpM) or PD98059 (20pM) or BEL (20pM). After that, 
each group was stimulated with bombesin as described in section 5.2.2.
For the experiments testing the [Ca2+]i response using Ca2+ PTI imaging system, coverslips were
incubated with either DMSO as a vehicle control or inhibitors during the fura-2 loading at 37°C
for 1 hr. At end of the incubation, the cells were washed with HBS containing ImM Ca2+ and 
placed into chamber for the Ca2+ imaging system.
For the experiments using a Flexstation plate reader, similar protocols to those for the Ca2+ 
imaging system were used. DMSO or inhibitors were added during the fura-2 loading period in 
order to pre-incubate the cells with these agents. The following steps were the same standard 
protocol described in section 2.4.
5.2.4 Antibody staining
The cells were stained with primary antibody {phospho-cPLA2 Sersos-R) following the standard 
protocol described in section 2.5. However, cells on islands were fixed with 100% methanol for 5
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min at room temperature rather than 10 min to order to diminish damage to the polyHEMA. In 
addition, cells on islands were loaded with the secondary antibody for 2 hours instead of 1 hour. 
In these experiments, Alexa Fluor 488 chicken anti-rabbit IgG was used as the secondary antibody. 
Antibody dilution was prepared as described in section 2.5.1. In the experiments testing the 
inhibitors (FR180204, PD98059 and BEL), Alexa Fluor 596 chicken anti-rabbit IgG was used as the 
secondary antibody.
5.2.5 Confocal microscopy
The distribution of phospho-cPLA2 was examined using a Leica SP2 AOBS scanning confocal 
microscope. More details were described in section 2.5.3. After optimizing the confocal settings 
for control slides, the settings were then kept the same during each experiment in order to allow 
the relative staining intensity to be determined.
5.3 Results
5.3.1 Effect of bombesin on phospho-cPLA2 in normal spreading cells
At least 8 separate experiments have been performed to test the effect of bombesin on 
phospho-cPLA2 immunofluorescence in normal spreading cells. Figure 5.3.1A shows 4 confocal 
images of immunofluorescence of phospho-cPLA2 in both resting and bombesin-stimulated cells 
that were selected from the same experiment. Each image was recorded under identical system 
settings. Un-restricted cells were grown on glass coverslips and the control group was 
un-stimulated before fixing with methanol (a). There are three sets of stimulated cells which 
were fixed at 2 minutes, 4 minutes and 8 minutes after stimulation by lOOnM bombesin (c-d).
The immunofluorescence gives an indication of distribution and amount of phospho-cPLA2 in 
each ser of cells. The images show that phospho-cPLA2 was diffuse in the cytosol in both resting 
and stimulated cells. It is apparent that the fluorescence of stimulated cells is brighter than that 
of the resting cells, especially those cells fixed at 2 minutes after bombesin stimulation.
The change of fluorescence intensity of phospho-cPLA2 was examined using the Leica software
by calculating the mean and total intensity of each single cell. The total intensity is the sum
112
Chapter 5
fluorescence in the selected area of interest (one single cell). The mean intensity is the average 
pixel fluorescence in the selected area. In figure 5.3.IB, the statistical data of the fluorescence 
intensity represented in each column was collected from 24 randomly selected cells from 6 
experiments (4 cells from each experiment) using the same system settings. The results indicate 
that there is a significant increase of the phospho-cPLA2 fluorescence intensity in 
bombesin-treated un-restricted cells with the maximum amount in the '2 minutes' stimulated 
group compared to other groups.
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a. un-stimulated cells
22pm ■ 22pm I 22pm
b. 2min after bombesin c. 4min after bombesin d. 8min after bombesin
Figure 5.3.1A-The immunofluorescence of phospho-cPLA2 in normal spreading cells
3-day-old quiescent Swiss 3T3 cells were cultured and unrestricted on glass coverslips in 
SF-DMEM for 16 hours before stained with primary antibody (phospho-cPLA2 Ser505-R) and 
secondary Alexa Fluor 488 chicken anti-rabbit IgG. Images were visualized with a Leica laser 
scanning confocal microscope. The images of resting cells are presented in figure a. Figure b-d are 
three sets of bombesin-stimulated cells that were fixed at 2 min, 4min and 8min respectively 
after the stimulation. Results shown are representative of 6 separate experiments.
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Figure 5.3.1B- The fluorescence intensity of phospho-cPLA2 in normal spreading cells
3-day-old quiescent Swiss 3T3 cells were cultured and unrestricted on glass coverslips in 
SF-DMEM for 16 hours before stained with primary antibody (phospho-cPLA2 Ser505-R) and 
secondary Alexa Fluor 488 chicken anti-rabbit IgG. The solid bars represent the mean (a) or total 
(b) data of phospho-cPLA2 fluorescence intensity in each single cell. Error bars shown are ± S.E. of 
(N) number of indicted cells. *P<0.05, statistical analysis of fluorescence intensity in (N) number 
of cells in each group are compared using one-way ANOVA.
115
Chapter 5
5.3.2 Effect of bombesin on phospho-cPLA^ in shape restricted cells
Following the study in normal spreading cells, the effect of cell shape on bombesin-evoked 
phospho-cPLA2 was examined. In total, 16 separate experiments were conducted to test the 
influence of cell shape. Figure 5.3.2A shows the confocal image of 4 single cells on the large 
islands (a), and another 4 on the small islands (b). Both un-stimulated cells and 
bombesin-stimulated cells at 2, 4 and 8 minutes before fixation are shown. All images were 
recorded under the same system settings. These data are similar to that seen in un-restricted 
cells on the glass coverslips.
Figure 5.3.2B shows the statistical data of mean (a) and total (b) phospho-cPLA2 fluorescence 
intensities from single cells on islands. There is a distinct increase of intensity in 
bombesin-stimulated cells on the large islands, which is confirmed by the one-way ANOVA test 
(p<0.05). Although there is an apparent increase of intensity in stimulated cells at 2min and 4min 
time points in cells on the small islands, the differences are not significant according to ANOVA 
analysis. Figure 5.3.2B also suggests that the resting phospho-cPLA2 immunofluorescence 
intensity (mean data) is higher in cells on small islands than that in the cells on large islands.
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Figure 5.3.2A-The immunofluorescence of phospho-cPLA2 in shape restricted cells
3-day-old quiescent Swiss 3T3 cells were cultured and restricted with either large or small islands 
in SF-DMEM for 16 hours before stained with primary antibody (phospho-cPLA2 Ser505-R) and 
secondary Alexa Fluor 488 chicken anti-rabbit IgG. Images were visualized with a Leica laser 
scanning confocal microscope. The images of resting cells are presented in figure (a). Figure (b-d) 
show three sets of bombesin-stimulated cells that were fixed at 2 min, 4min and 8min 
respectively after the stimulation. Results shown are representative of 16 separate experiments.
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Figure 5.3.2B-The fluorescence intensity of phospho-cPLA2 in shape restricted cells
3-day-old quiescent Swiss 3T3 cells were cultured and restricted with either large or small islands 
in SF-DMEM for 16 hours before stained with primary antibody (phospho-cPLA2 Ser505-R) and 
secondary Alexa Fluor 488 chicken anti-rabbit IgG. The solid bars represent the mean (a) or total 
(b) data of phospho-cPLA2 fluorescence intensity in each single cell. The black bars represent the 
data in cells on large islands while the red bars are for those on the small islands. Error bars 
shown are ± S.E. of (N) number of indicated cells. *P<0.05, statistical analysis of fluorescence 
intensity in (N) number of cells in each group are compared using one-way ANOVA.
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5.3.3 The mechanism of bombesin regulated cPLA2 phosphorylation
The data presented in section 5.3.1 indicates that there is a phospho-cPLA2 intensity increase in 
bombesin-stimulated cells. The mechanism of bombesin-regulated phospho-cPLA2 activation was 
therefore further examined by testing whether the ERK/MAP kinase pathway was involved in the 
phosphorylation of cPLA2. Figure 5A shows the two inhibitors, FR180204 and PD98059 could 
inhibit the phosphorylation of cPLA2 by MAPK. Figure 5.3.3A shows the phospho-cPLA2 
immunofluorescence of 3 cell groups treated with DMSO as a control or treated with one of the 
ERK inhibitors, FR180204 or PD98059. The level of phospho-cPLA2 in either resting or bombesin 
stimulated cells are compared in each group (A-C).
In total, 3 experiments following the same protocol have been performed. Three of experiments 
showed that with the presence of FR180204 (lOpM) or PD98059 (20pM), the phospho-cPLA2 
fluorescence increased in the bombesin stimulated cells, especially in those cells fixed 2 minutes 
after the bombesin addition.
Figure 5.3.3B shows the statistical data of mean (a) and total (b) phospho-cPLA2 fluorescence 
intensity in either DMSO-controlled or inhibitor-treated cells. The statistical analysis indicates 
that the level of phospho-cPLA2 fluorescence intensity in either FR180204- or PD98059- treated 
cells is lower than that in the DMSO-controlled cells, no matter whether the cells were resting or 
bombesin-stimulated. However, according to the t-test analysis, such difference is not significant, 
except difference between control cells and the ones treated by PD98059 at the time point of 
8min after bombesin-stimulation. Moreover, a significant increase of phospho-cPLA2 fluorescence 
intensity was still observed in inhibitor-treated cells according to one-way ANOVA analysis 
(p<0.05). Generally speaking, the ERK inhibitors seem to have no influence on the cPLA2 
activation regulated by bombesin, though they showed a trend to suppress the resting level of 
phospho-cPLA2.
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Figure 5A-lnhibition mechanism of ERK FR180204 and PD98059
The figure shows the inhibition mechanism of ERK FR180204 and PD98059 on cPLA2 activation 
pathway. Both inhibitors could block the phosphorylation of cPLA2 by MAPK.
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Figure 5.3.3A-The effect of ERK inhibitors in bombesin regulated phospho-cPLA2 activation
3-day-old quiescent Swiss 3T3 cells were cultured and unrestricted on glass coverslips in 
SF-DMEM for 16 hours before stained with primary antibody (phospho-cPLA2 Ser505-R) and 
secondary Alexa Fluor 596 chicken anti-rabbit IgG. Images were visualized with a Leica laser 
scanning confocal microscope. The cells in group A were pre-treated with DMSO for 1 hour while 
the other two groups (B&C) were pre-treated with FR180204 or PD98059 respectively. The 
images of resting cells in each group are presented in figure (a). Figure (b-d) show three sets of 
bombesin-stimulated cells that were fixed at 2 min, 4min and 8min respectively after the 
stimulation. Results shown are representative of 3 separate experiments.
121
Chapter 5
(a)
(b)
Figure 5.3.3B-The effect of ERK inhibitors in bombesin regulated phospho-cPLA2 activation
3-day-old quiescent Swiss 3T3 cells were cultured and restricted with either large or small islands 
in SF-DMEM for 16 hours before stained with primary antibody (phospho-cPLA2 Sers05-R) and 
secondary Alexa Fluor 596 chicken anti-rabbit IgG. The solid bars represent the mean (a) or total 
(b) data of phospho-cPLA2 fluorescence intensity in each single cell. The black bars represent the 
data in controlled cells and the red and blue bars represent the data in the FR180204 or PD98059 
treated cells. Error bars shown are ± S.E. of (N) number of indicated cells. *P<0.05, statistic 
analysis of fluorescence intensity in (N) number of cells in each group are compared using 
one-way ANOVA. *P<0.05, when statistical analysis of fluorescence intensity in (N) number of 
cells are subjected to t-test.
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5.3.4 The effect of ERK inhibitors and BEL in bombesin-induced [Ca2*], response
The ERK inhibitors and BEL were further used to test whether the bombesin-induced [Ca2+]j 
response requires either cPLA2 phosphorylation or iPLA2 activity. Figure 5B shows the inhibition 
mechanism of BEL. Experiments were performed either using a PTI Ca2+ imaging system or a 
Flexstation plate reader.
The figure 5.3.4A shows the bombesin-induced [Ca2+]] responses in DMSO-treated control cells or 
inhibitor-treated cells. In figure 5.3.4A (a), the typical [Ca2+]| response to lOOnM bombesin in 
DMSO-treated cells is seen. In total, 4 control experiments were performed (n=14 cells). Figure 
5.3.4A (b) shows the [Ca2+]i responses in the cells treated with all three inhibitors FR180204 
(lOpM), PD98059 {20pM) and BEL (20pM)for 1 hr. The bombesin-induced [Ca2+]| responses were 
inhibited in the cells treated with all 3 inhibitors, which was observed in all the 5 experiments 
(n=15 cells). Figure 5.3.4A (c-e) shows the [Ca2+]i responses in the cells treated with one of the 
three inhibitors. When the cells were treated with the inhibitors separately, the 
bombesin-induced [Ca2+]i response was still seen in FR180204- (n=5 cells) or PD98059- (n=7 cells) 
treated cells, whereas it was blocked in BEL-treated cells (n=6 cells). This indicates that both ERK 
inhibitors FR180204 and PD98059 have little effect on the bombesin-evoked [Ca2+]| responses 
while BEL is effective to inhibit the response. Earlier studies showed BEL has no inhibition on the 
thapsigargin-induced Ca2+ release (Smani et ai, 2003). In this study, BEL suppressed the 
bombesin-evoked Ca2+ release.
To confirm the results, similar experiments were performed with the Flexstation plate readers to 
monitor the [Ca2+]j responses with the presence of inhibitors. Figure 5.3.4B shows the Flexstation 
recorded bombesin-evoked [Ca2+]i responses traces in either DMSO control or inhibitor-treated 
cells. The traces present the typical response seen 1 in 5 replicate wells. The results were quite 
consistent with those obtained from the PTI Ca2+ imaging system. The bombesin-induced [Ca2+]j 
responses, including Ca2+ release and Ca2+ influx were completely inhibited in cells-treated with 
all 3 inhibitors or those treated with BEL alone. The cells incubated with both FR180204 and 
PD98059 showed similar [Ca2+]j responses to the control cells.
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In summary, the results indicated that these two ERK inhibitors: ERK FR180204 and PD98059 
have no inhibition effect on bombesin-induced [Ca2+]| response in 3T3 cells, which suggests the 
phosphorylation of cPLA2 is not required for the bombesin to evoke [Ca2+]i response. On the 
other hand, since the BEL alone is enough to inhibit such [Ca2+]j responses, iPLA2 is possibly 
involved.
Figure 5B-The inhibition mechanism of BEL in Ca2* related responses
This figure shows the inhibition mechanism of BEL in Ca2+ entry pathways. BEL could inhibit the
activity of iPLA2 and the generation of DAG.
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Figure 5.3.4A-The effect of ERK inhibitors and BEL in bombesin-induced [Ca2+]j response
3-day-old quiescent Swiss 3T3 cells were cultured on coverslips in SF-DMEM for 16 hours before 
experiments. A [Ca2+]i response is shown to bombesin (lOOnM) added at 180 seconds in the
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presence of ImM Ca2+ in HBS. The [Ca2+]j was measured using fura-2, at 37°C, using a Ca2+
imaging system. Figure (a) shows a typical [Ca2+]j response in a DMSO control cell. Figure (b) 
shows a typical [Ca2+]j response in cells treated with all 3 inhibitors {FR & PD & BEL). Figures (c-e) 
show three [Ca2+]i responses to bombesin in ceils treated with either FR180204 or PD98059 or 
BEL respectively. Each figure is representative of at least 2 separate experiments.
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Figure 5.3.4B-The effect of ERK inhibitors and BEL in bombesin-induced [Ca2+]j response 
3-day-old quiescent Swiss 3T3 cells were cultured in 96-well plates in SF-DMEM for 16 hours 
before experiments. Each line represents a [Ca2+]i response to bombesin (lOOnM) added at 120 
seconds in the presence of ImM Ca2+ in MBS in each well. The [Ca2+]| was measured using fura-2; 
at 370C, using a Flexstation reader. The cells were pretreated with either DMSO or inhibitors for 1 
hr before reading the [Ca2+]j responses to bombesin. Individual traces are typical of 5 similar 
replicates from a single plate.
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5.4 Discussion
The data presented in this chapter suggests that there is an increase of phospho-cPLA2 following 
the stimulation by bombesin in normal spreading Swiss 3T3 cells. Since the activation of cPLA2 
requires phosphorylation to form phospho-cPLA2, this finding is consistent with the hypothesis 
that the bombesin leads to the generation of AA through cPLA2 resulting in AA-induced Ca2+ 
influx. Another prediction is that activation of cPLA2 requires its translocation to intracellular 
membrane. However, because the distribution of phosphorylated cPLA2 was measured, the 
location of cPLA2 before its phosphorylation is unclear. The cPLA2 has been found to target Golgi, 
ER and the perinuclear membrane (Evans et al., 2001). Due to the abundant 
immunofluorescence signal of phospho-cPLA2 in Swiss 3T3 cells, it was difficult to identify the 
exact location of phospho-cPLA2. It has also been suggested that the cPLA2 is already localized 
within the membrane during the activation of lARC( since no significant Ca2+ dependent cPLA2 
translocation is detected at low agonist concentration (Osterhout and Shuttleworth, 2000). 
Therefore, whether the cPLA2 has been translocated and fully activated after the 
bombesin-stimulation needs to be verified.
The application of two ERK inhibitors: FR180204 and PD98059 suggests that the ERK pathway,
which is known to be the main pathway for cPLA2 phosphorylation (Chang et al., 2006), has no
role in the increase of phospho-cPLA2 after bombesin-stimulation. Furthermore, these two
inhibitors showed little effect on bombesin-induced [Ca2+]| responses as well, which implies that
the phosphorylation of cPLA2 by ERKs is not involved this Ca2+ entry pathway. These findings
challenge our hypothesis. One explanation is that the bombesin-induced cPLA2 phosphorylation is
not mediated by ERKs but by other kinases. Similar results have been reported which underpin
such possibility. For example, it was observed that PD98059 failed to inhibit the phosphorylation
of cPLA2 stimulated by thrombin or collagen. As a result, it is believed that the ERKs are not
involved in the process of AA release from platelets (de Carvalho etaL, 1996). It was also found
that phosphorylation of cPLA2 in lipopolysaccharide- or TNFa-treated neutrophils and
thrombin-stimulated platelets occurred independently on p42/p44 MAP kinase activation (Leslie,
1997). Moreover, PKC and PKA have been reported to phosphorylate cPLA2 in vitro, though the
increase of cPLA2 activity is slight (Qiu and Leslie, 1994). Nevertheless, another possibility is that
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the phosphorylated cPLA2 is the consequence of the bombesin-evoked [Ca2+]i response rather 
than the cause. As described in section 1.6.3.3, a relevant change of [Ca2+]i plays an important 
role in promoting the translocation of cPLA2 to associate with its substrate and become activated 
(Clark et a!., 1991; Leslie, 1997). In another words, the cPLA2 is not required for the [Ca2+]j 
response caused by bombesin.
Although the importance of cPLA2 in the bombesin-evoked [Ca2+]j response is questioned, the 
involvement of AA which could be generated through other pathways cannot be ruled out. Since 
BEL is a typical iPLA2 inhibitor which inhibits the bombesin-induced [Ca2+]j response. It is 
suspected that it is iPLA2 and not cPLA2 that is responsible for the [Ca2+)i response activated by 
bombesin. Evidence has shown that iPLA2 is capable of liberating AA (Balsinde and Dennis, 1997). 
The inhibition of [Ca2+]j response by BEL (Figure 5.3.4A) may block the elevation of [Ca2+]j 
required by cPLA2 activation, since it was observed that BEL prevented the increase of 
phospho-cPLA2 after bombesin stimulation (preliminary data not shown). If this is true, it 
confirms that the increase of phospho-cPLA2 after the bombesin-induced [Ca2+]j elevation is the 
consequence but not the cause of the process. It was also argued that BEL cannot be used as a 
selective iPLA2 inhibitor in whole cell studies since it indirectly inhibits the DAG activation as well 
(Balsinde and Dennis, 1997). It was found that BEL inhibits the activity of Mg2+-dependent PA 
phosphohydrolase (PAP-1) which can convert PA into DAG in the PLD-DAG pathway (Section 
1.6.3.4) (Balsinde and Dennis, 1996) DAG, however, has also been proved demonstrated to 
produce AA (Kennedy etal., 1979). Hence, no matter whether BEL blocks either the activation of 
iPLA2 or DAG, it is capable of hindering the generation of AA after all.
In addition to the function in AA generation, iPLA2 has been reported to be involved in the SOCEs.
For example, it was observed that the impairment of iPLA2 function with BEL leads to irreversible
inhibition of thapsigargin-induced SOCEs in wide variety of cell types (Smani et al., 2003;
Martinez and Moreno, 2005; Singaravelu etal., 2008). The crucial role of iPLA2in SOCE activation
was recently confirmed by the observation that molecular knockdown of the CG6718gene which
is a Drosophila homologue of human iPLA2|3 significantly affected SOCE (Vig et al., 2006). A
relationship among STIM1, Orai, CIF and iPLA2p was reviewed and it was argued that CIF-induced
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activation of iPLA23 can promote the signal transduction between STIM1 and Orail, leading to 
Ca2+ entry (reviewed by Bolotina, 2008). Therefore, although I believe iPLA2 is necessary for the 
bombesin to induce a [Ca2+]j response, which Ca2+ entry pathway is involved is still uncertain.
In this chapter, the influence of cell shape on the cPLA2 phosphorylation was tested. According to 
the results, the increase of the phospho-cPLA2 in the cells on small islands seemed to be partially 
inhibited compared to the increase seen in cells on large islands and the normal unrestricted cells. 
However, since the results of the phospho-cPLA2 immunofluorescence in the restricted cells 
showed a great variation, this conclusion needs to be verified. Based on the speculation 
mentioned above, the augmentation of phospho-cPLA2 as a consequence of bombesin-evoked 
[Ca2+]| response may be restrained due to the inhibition of Ca2+ influx in shape restricted cells.
The key evidence presented in this chapter is listed in following:
1. There is a significant increase of phospho-cPLA2 after the stimulation of bombesin in normal 
spreading Swiss 3T3 cells.
2. The significant increase of phospho-cPLA2 intensity was observed in cells on the large islands 
but not the ones on the small islands.
3. Two ERK inhibitors, FR180204 and PD98059 showed little effect on the increase of 
phospho-cPLA2 intensity and bombesin-evoked [Ca2+]j response in Swiss 3T3 cells.
4. The inhibitor BEL effectively blocked the bombesin-evoked [Ca2+]j response in Swiss 3T3 cells.
In order to confirm which Ca2+ entry pathway is responsible for the bombesin-evoked [Ca2+]i 
elevation, I decided to use inhibitor to distinguish SOCE from NSOCE. The results were presented 
in chapter 6.
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Chapter 6
The effect of diverse inhibitors on bombesin-induced Ca2* influx
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6.1 Introduction
The last chapter provided evidence that the activation of cPLA2 may not be a pre-requisition for 
Ca2+ influx as was expected in the bombesin-induced [Ca2+]i response in Swiss STB cells. In order 
to find out which Ca2+ entry pathway is involved in bombesin-evoked Ca2+ influx, a number of 
inhibitors more specific to the generation of AA were utilized.
A cPLA2a inhibitor was first used to block the activation of cPLA2a, which is the only PLA2 enzyme 
that shows significant selectivity toward phospholipids bearing AA at the sn-2 position 
(Murakami and Kudo, 2002). AACOCF3, a potent slow inhibitor of cPLA2, was applied as well. In 
addition to the cPLA2 pathway, the involvement of DAG pathway was further tested with a DAG 
lipase inhibitor, RHC80267 (Sutherland and Amin, 1982; Trimble et al., 1993). It has been 
demonstrated that DAG lipase pathway is an important alternative way to release AA (Canonico 
etol., 1985; Chuang and Severson, 1990).
In addition, activating influx downstream of AA generation was tested using a non selective 
cation channel blocker LOE908, which has frequently been used to examine the activation of 
NSCCs. It was reported that the non-selective cationic channels (NSCCs) are distinguished from 
SOCCs in terms of their sensitivity to LOE908 but not SK&F96365 (Kawanabe et al., 2001; Niger et 
al., 2004). The participation of SOCCs has been tested with the inhibitor SK&F96365 which is 
widely used to block the thapsigargin-induced store-operated Ca2+ influx (Yoshida etal., 2003).
Generally speaking, in this chapter, the involvement of AA and the mechanism of its generation 
in the shape-dependent Ca2+ influx pathway are studied using various inhibitors.
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6.2 Method
6.2.1 Cell culture
Swiss 3T3 cells were cultured as described in section 2.1. Cells were plated onto glass coverslips 
and culture in FCS-DMEM for 3-4 hours. Subsequently, cells were kept in SF-DMEM for 16 hours 
before the experiments.
6.2.2 Addition of cPLAzand Caz+ influx inhibitors
In order to test the effect of cPLA2a inhibitor {6pM), RHC80267 (20pM) and AAC0CF3 (lOpM), 
cells on coverslips were incubated with either DMSO as control or inhibitors in SF-DMEM at 37°C 
overnight. After that, cells were loaded with fura-2 as described in section 2.3.2. Inhibitors were 
again added into the HBS containing ImM Ca2+ when cells were placed in the chamber for PTI 
Ca2+ imaging system expect for those controlled cells. LOE908 {30pM) and SK&F96365 (30pM) 
were added instantly during the experiment.
6.2.3 Ca2+ imaging
Prior to the experiment, cells on glass coverslips were loaded with 2|iM fura-2 and immersed in 
HBS containing ImM Ca2+or Ca2+free HBS. The photometric traces showing the changes of fura-2 
fluorescence that were monitored from individual cells using PTI Ca2+ imaging system {see section
2.3 for more details).
6.2.4 Flexstation microplate reader
The cells were loaded with fura-2 following the standard protocol described in section 2.4. During 
the reading, inhibitors and bombesin were added sequentially. In the experiments testing the 
Ca2+ influx, the compounds were diluted with ImM Ca2+ containing HSB. In the compound plate, 
the first column was added with control vehicle or one of the inhibitors and the second column 
was added with bombesin. In the experiments testing the Baz+ or Sr2+ influx, compounds were 
diluted with Ca2+ free HBS. In the compound plate, the first two columns were prepared as 
described above while the third column contained Ba2+ or Sr2+.
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6.3 Results
6.3.1 The effect of AA inhibitors on bombesin-induced [Ca2*]; responses
Three inhibitors were used (cPLA2a inhibitor, RHC80267 and AACOCF3) to test the involvement of 
AA in bombesin-induced [Ca2+]j responses. Figure 6 shows the inhibition mechanism of these 
three inhibitors on the AA generation. When the inhibitors were added to cells instantly before 
the bombesin, there was no apparent inhibition (data not presented). As a result and following 
previous studies, cells were then pre-incubated with each of these inhibitors overnight or with 
DMSO as a control. Then during the experiments, the same concentration of each inhibitor was 
added to the FIBS.
Figure 6.3.1A shows a typical [Ca2+]i response evoked by lOOnM bombesin in either control or 
inhibitor-treated cells. In total, 6 similar experiments were performed to confirm the results. 
Figure 6.3.IB exhibits the statistical data relating to the increase of [Ca2+]j caused by bombesin at 
both the peak and plateau points of the response in either control and inhibitor treated cells. A 
t-test was used to compare the responses and small but significant changes were recorded 
(p<0.05). Compared to the response in control cell (n=45 cells), 6pM cPLA2a inhibitor (n=58 cells) 
and 20|iM RFIC80267 (n=37 cells) show some inhibition at the [Ca2+]j response induced by 
bombesin while 10(iM AACOCF3 (n=22 cells) was not very effective. The results indicate that 
the cPLA2a inhibitor somehow increases the A[Ca2+]| at the peak points but that it significantly 
inhibits the Ca2+ influx. The RFIC80267 compound inhibits both the bombesin-evoked Ca2+ release 
and influx. Flowever, AACOCF3 showed no significant influence on the [Ca2+]j response.
In addition, the effect of these inhibitors was tested with a Flexstation plate reader. Figure 6.3.1C 
shows the typical bombesin-evoked [Ca2+]| responses in either vehicle control or inhibitor-treated 
cells monitor by Flexstation in each 96-well plate. "N" represents the number of replicate wells 
that were recorded from 2 plates. Cells were treated with inhibitor at the beginning of the 
experiments followed with the stimulation of lOOnM bombesin. Figure 6.3.1C (a) which shows 
the [Ca2+]j response in control (red) and cPLA2a inhibitor treated cells (black) indicated that 
cPLA2a inhibitor increases the overall [Ca2+]j response. Figure 6.3.1C (b) shows the response in 
control or RFIC80267-treated cells which suggest that RFIC80267 suppresses the
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bombesin-induced Ca2+ influx. Figure 6.3.1C (c) indicates that AACOCF3 has little effect on 
bombesin-evoked [Ca2f]i response. Generally, the results obtained from Flexstation reader are 
consistent with that obtained from the PTI Ca2+ imaging system.
Figure 6-The inhibition mechanisms of three AA generation inhibitors
This figure shows the inhibition mechanisms of three inhibitors on the AA generation pathways. 
The cPLA2a inhibitor and AACOCF3 inhibit the PLA pathway that produces AA. RHC80267 inhibits 
the DAG pathway for AA generation.
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Figure 6.3.1A-The effect of AA inhibitors on bombesin-induced [Ca2+], responses monitored by 
Caz+ imaging system
3-day-old quiescent Swiss 3T3 cells were cultured on coverslips in SF-DMEM with either DMSO or 
inhibitors pretreated for 16 hours before experiments. A [Ca2+]j response is shown to bombesin 
(lOOnM) added at 200 seconds in the presence of ImM Ca2+ in HBS. The [Ca2+]j was measured 
using fura-2, at 370C, using a Ca2+ imaging system. Figure (a) shows the [Ca2+]i response in a 
DMSO control cell. Figure (b) presents a [Ca2+]| response in cells treated with 6pM cPLj^oi 
inhibitor. Figure (c) presents a [Ca2+]j response in cells treated with 20pM RHC80267 while figure 
(d) is a [Ca2+]j response to bombesin in cells treated with 10pM AACOCF3. Each figure is 
representative of 6 experiments.
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Figure 6.3.1B-The effect of AA inhibitors on bombesin-induced [Ca2+]j responses monitored by 
Ca2+ imaging system
Quiescent Swiss 3T3 cells were cultured, unrestricted on glass coverslips in SF-DMEM for 16 
hours before experiments. Mean data of increased [Ca2+]j at both the peak and plateau points of 
the responses caused by the addition of bombesin (lOOnM) are indicated in solid columns. The 
columns in black represent the data in control cells and the columns with other colours show the 
data in cells which were treated with 6pM cPLA2a inhibitor (red) or 20pM RHC80267 (blue) or 
lOpM AACOCF3 (green). The A[Ca2+]| is measured as [Ca2+]j at the peak or plateau, which is 300 
seconds after the peak, minus the baseline Ca2+ concentration before the addition of bombesin. 
Error columns shown are ± S.E. of (N) number of indicted cells. *P<0.05, when A[Ca2+]| value of (N) 
number of cells were subjected to t-test comparing to the control group.
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Figure 6.3.1C-The effect of AA inhibitors on bombesin-induced [Ca2+]j responses monitored by 
Flexstation plate reader
3-day-old quiescent Swiss 3T3 cells were 
cultured in a 96-well plate in SF-DMEM for 
16 hours before experiments. Cells were 
first stimulated with DMSO as vehicle 
control or inhibitors at 20 seconds. A 
[Ca2+]j response is shown to bombesin 
(lOOnM) added at 120 seconds in the 
presence of ImM Ca2+ in HBS. The [Ca2+]j 
was measured using Fura-2, at 37 °C, 
through a Flexstation reader. Figure (a) 
shows two [Ca2+]j responses in either 
DMSO control (black) and 6pM cPLA2oi 
inhibitor treated cells (red). Figure (b) 
presents two [Ca2+]i responses with or 
without the presence of RHC80267 at a 
final concentration of 20pM. Figure (c) 
shows the [Ca2+]| responses in control and 
lOpM AACOCF3 treated cells. "N" 
represents the number of similar replicate
wells read by the Flexstation reader from 2 
plates.
DMSO/cPLA,q inhibitor
------- control(N=5)
+CPLA2 inhibitor(N=15)
Time (s)
DMSO/RHC control(N=3)
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-------AACOCF3(N=9)DMSO/ AACOCF3
Time (s)
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6.3.2 The effect of cPLA2 inhibitors on [Ca2+]i responses and Sr2+ influx
Sr2+was further used to mimic the Ca2+ influx in order to test the effect of these AA inhibitors on 
both Ca2+ release and influx. The same protocol was applied to examine the function of 
inhibitors.
Figure 6.3.2A shows the typical bombesin-evoked Ca2+ release and Sr2+ influx in either control or 
inhibitor treated cells. In total, more than 10 similar experiments were performed to confirm the 
results. Figure 6.3.2B shows the statistical data of the increase in ratio340/380 caused by 
bombesin at both the peak of Ca2+ release and Sr2+ influx points of the response in either control 
or inhibitor-treated cells. A t-test was used to compare the responses {p<0.05). Compared to the 
response in control cell (n=87 cells), 6pM cPLA2a inhibitor (n=42 cells) showed a significant 
influence on bombesin-evoked Ca2+ release and Sr2+ influx. However, rather than showing an 
inhibition function, the cPLA2a inhibitor enhanced both the Ca2+ release and Sr2+ influx. Similarly, 
lOpM AACOCF3 (n=15 cells) significantly increased Sr2+ influx. AACOCF3 showed no influence on 
the bombesin-induced Ca2+ release. The results indicate that 20pM RHC80267 (n=84 cells) has 
little inhibition on both Ca2+ release and Sr2+ influx induced by bombesin (lOOnM).
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Figure 6.3.2A-The effect of AA inhibitors on bombesin-induced Ca2+ release and Sr2+ influx
3-day-old quiescent Swiss 3T3 cells were cultured on coverslips in SF-DMEM with either DMSO or 
inhibitors pretreated for 16 hours before experiments. A Ca2+ release is shown to bombesin 
(lOOnM) added at 120 seconds in Ca2+ free HBS. Sr2+ (ImM) was added at 400 seconds which 
results in a Sr2+ influx. The [Ca2+]j and Sr2+ concentration was measured using fura-2, at 37°C, 
using a Ca2+ imaging system. Figure (a) shows the Ca2+ release and Sr2+ influx to bombesin in a 
DMSO control cell. Figure (b) presents the response in cells treated with 6pM cPLA2a inhibitor. 
Figure (c) presents the response in cells treated with 20pM RHC80267 while figure (d) is the 
response in cells treated with lOpM AACOCF3. Each figure is representative of 10 experiments.
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Figure 6.3.2B-The effect of AA inhibitors on bombesin-induced Ca2+ release and Sr2+ influx 
Quiescent Swiss 3T3 cells were cultured, unrestricted on glass coverslips in SF-DMEM for 16 
hours before experiments. Mean data of the change in ratio340/380 at both the Ca2+ release and 
Sr2+ influx peak points of the responses caused by the addition of bombesin (lOOnM) are 
indicated in solid columns. The columns in black represent the data in control cells and the 
columns with other colours show the data in cells which were treated with 6pM cPLA2a inhibitor 
(red) or 20pM RHC80267 (blue) or lOpM AACOCF3 (green). The Aratio340/380 is measured as 
the ratio340/380 at the peak points minus the baseline ratio340/380 before the addition of 
bombesin. Error columns shown are ± S.E. of (N) number of indicted cells. *P<0.05, when 
Aratio340/380 value of (N) number of cells were subjected to t-test.
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6.3.3 The effect of inhibitor LOE908 on the bombesin-induced [Caz+]i responses
The inhibitor LOE908 was used to test the participation of NSSCs in bombesin-evoked Ca2+ influx.
The effect of LOE908 was first examined with the PTI Ca2+ imaging system. In each experiment, 
the cells were treated with DMSO as vehicle control or 30pM LOE908 before stimulation with 
lOOnM bombesin.
Figure 6.3.3A shows the typical bombesin-evoked [Ca2+]i responses in either control or LOE908 
treated cells (n>34 cells). The responses in both confluent (n=102 cells) and non-confluent cells 
(n=54 cells) were presented in either (a & b) or (c & d) respectively. There were little differences 
in the effect of LOE908 on either confluent or non-confluent cells. However, the Ca2+ influx was 
suppressed in LOE908-treated cells compared to that in the control cells. In addition, it was found 
that the [Ca2+]i baseline consistently dropped immediately after the addition of LOE908 (Figure d). 
LOE908 also efficiently ceased the Ca2+ oscillations (Figure b).
Figure 6.3.3B shows the statistical data of the increase [Ca2+]j caused by bombesin at both the 
peak and plateau points of the response in either control and LOE908-treated cells. The data is 
collected from 17 control experiments and 17 LOE908-treated experiments in both confluent and 
non-confluent cells. From each experiment, the responses in 2 individual cells were randomly 
selected for the statistical analysis (n=34 cells). T-tests were used to compare the responses. The 
results indicated that the LOE908 significantly decreased the A[Ca2+]j during the plateau 
compared with the control (p<0.05), especially from 5min after the peak. However, the 
suppression at the peak point is not significant.
The Flexstation plate reader was then utilized to confirm the results obtained from the PTI Ca2+ 
imaging system. Figure 6.3.3C shows two representative bombesin-induced [Ca2+]j response 
traces in either DMSO control or LOE908-treated cells. It was confirmed that the 
bombesin-evoked Ca2+ influx is suppressed in LOE908-treated ceils. Both Ba2+ and Sr2+ were used 
to test whether LOE908 is able to inhibit the channels that are permeable to Ba2+ or Sr2+. Figure 
6.3.3D shows the bombesin-induced Ba2+ or Sr2+ influx in either controlled (black) or 
LOE908-treated cells (red). The figure represents a typical response read from 1 of 6 replicate
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wells in 1 plate. The results indicate that LOE908 can block the Ba2+ and Sr2+ entry channels.
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Figure 6.3.3A-The effect of inhibitor LOE908 on the bombesin-induced [Ca2+]j responses
Quiescent Swiss 3T3 cells were cultured on coverslips in SF-DMEM. Cells were pretreated with 
either DMSO or inhibitors for 16 hours before experiments. A Ca2+ release is shown to bombesin 
(lOOnM) in HBS containing ImM Ca2+. Figures (a) & (b) present two bombesin-induced [Ca2+]| 
responses in confluent cells with or without the addition of LOE908 (30|iM) before the bombesin. 
Similarly, figures (c) & (d) show the [Ca2+]j response in non-confluent cells. At least 17 similar 
experiments were performed.
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Figure 6.3.3B-The effect of LOE908 on bombesin-induced [Ca2+]j response
Quiescent Swiss 3T3 cells were cultured, unrestricted on glass coverslips in SF-DMEM for 16 
hours before experiments. Mean data of increased [Ca2+]| at the peak and plateau of the 
responses caused by the addition of bombesin (lOOnM) are indicated in solid columns. The black 
columns represent the data of controlled cells and the red columns show the data of LOE908 
(30pM) treated cells. The A[Ca2t]j is measured as [Ca2+]j at the peak or a series time points of 
plateau, which are from 1 minute to 9 minutes after the peak, minus the baseline [Ca2+]j before 
the addition of bombesin. Error columns shown are ± S.E. of (N) number of indicated cells. 
*P<0.05, when A[Ca2+]i value of (N) number of cells were subjected to t-test.
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Figure 6.3.3C-The effect of LOE908 on the bombesin-induced [Ca2+]i response as monitored by 
the Flexstation plate reader
3-day-old quiescent Swiss 3T3 cells were cultured in a 96-well plate in SF-DMEM for 16 hours 
before experiments. Cells were first stimulated with DMSO (black) as vehicle control or 30pM 
LOE908 (red) at 20 seconds. A [Ca2+]j response is shown to bombesin (lOOnM) added at 100 
seconds in the presence of ImM Ca2+ in HBS. The [Ca2+]| was measured using fura-2, at 37°C, 
through a Flexstation reader. "N" represents the number of similar replicate wells read by the 
Flexstation reader from 2 plates.
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Figure 6.3.3D-The effect of LOE908 on bombesin-induced Ba2+ and Sr2+ as monitored by the 
Flexstation plate reader
3-day-old quiescent Swiss 3T3 cells were cultured in a 96-well plate in SF-DMEM for 16 hours 
before experiments. Cells were first stimulated with DMSO (black) as vehicle control or 30pM 
LOE908 (red) at 20 seconds. A Ca2+ release is shown to bombesin (lOOnM) added at 100 seconds 
in the presence of Ca2+ free HBS. Either ImM Ba2+ (a) or ImM Sr2+ (b) was then added at 400 
seconds. The ratio340/380 was measured using fura-2, at 37°C, through a Flexstation plate 
reader. "N" represents the number of similar replicate wells read by the Flexstation reader from 1 
plate.
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6.3.4 The effect of the inhibitor SK&F 96365 on the bombesin-induced [Ca2*]j responses
Since SOCE is a very important and widely spread Ca2+ entry pathway, its involvement in the
bombesin-evoked [Ca2+]j responses was tested. In addition, according to the data presented in 
chapter 5, iPLA2 which is believed to be important to SOCEs may play a role in the 
bombesin-evoked [Ca2+]i response. Therefore, the role of SOCEs needed to be tested. A widely 
used SOCE inhibitor, SK&F96365, was used to investigate the Ca2+ entry pathway.
Figure 6.3.4A presents two typical [Ca2+]| responses evoked by bombesin in either control {n=48 
cells) or 30|iM SK&F96365 treated (n=57 cells) cells. In total 10 similar experiments were 
conducted. The bombesin-induced [Ca2+]i response was reduced by SK&F96365. Figure 6.3.4B 
shows the statistical data of the [Ca2+]i increase caused by bombesin at both the peak and plateau 
points of the response in either control or SK&F96365-treated cells. A t-test was used to compare 
the responses. The results indicate that the SK&F96365 significantly decreases the A[Ca2+]i during 
the plateau.
In addition to the PTI Ca2+imaging system, the Flexstation plate reader was used to confirm the 
results. Figure 6.3.4C shows two representative bombesin-induced [Ca2+]i response traces in 
either DMSO controlled or SK&F96365-treated cells. It was confirmed that the bombesin-evoked 
Ca2+ influx is suppressed by SK&F96365. Both Ba2+ and Sr2+ were used to test the whether 
SK&F96365 is able to inhibit the channels that are permeable to Ba2+ or Sr2+. Figure 6.3.3D shows 
the bombesin-induced Ba2+ or Sr2+ influx in either control (black) or SK&F96365-treated cells 
(red). The figure represents a typical response read from 1 of 6 replicate wells in 1 plate. The 
results indicate that SK&F96365 could block the Ba2+ and Sr2+ entry channels.
The function of SK&F96365 was also tested on thapsigargin-evoked [Ca2+]| responses in Swiss 3T3 
cells. Figure 6.3.4E shows two typical [Ca2+]| responses after the stimulation of 2pM thapsigargin 
in either control (n=22 cells) or 30p.M SK&F96365-treated (n=16 cells) cells. More than 3 
experiments were conducted. The results were consistent showing that SK&F96365 strongly 
abolishes the thapsigargin-evoked [Ca2+]j response. After the addition of SK&F96365, thapsigargin 
only induced very slow and sluggish increase in [Ca2+]|, which indicates a small Ca2+ release from
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stores. This is in contrast with some other cell types where a substantial Ca2+ release can still be 
seen in the presence of SK&F96365 (Merritt et al., 1990).
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Figure 6.3.4A- The effect of the inhibitor SK&F96365 on the bombesin-induced [Ca2+]j responses 
monitored with the PTI Ca2+ imaging system
3-day old quiescent Swiss 3T3 cells were cultured on coverslips in SF-DMEM with either DMSO or 
inhibitors pretreated for 16 hours before experiments. A Ca2+ release is shown to bombesin 
(lOOnM) in HBS containing ImM Ca2+. Figure (a) shows a bombesin-induced [Ca2+]i response in 
control cells. Figure (b) shows a bombesin-evoked [Ca2+]| response with the addition of 
SK&F96365 (30|iM) before the bombesin. At least 10 experiments were performed.
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Figure 6.3.4B- The effect of the inhibitor SK&F96365 on the bombesin-induced [Ca2+]j responses 
monitored with the Ca2* imaging system
Quiescent Swiss 3T3 cells were cultured, unrestricted on glass coverslips in SF-DMEM for 16 
hours before experiments. Mean data of increased [Ca2+]| at the peak and plateau of the 
responses caused by the addition of bombesin (lOOnM) are indicated in solid columns. The black 
columns represent the data of controlled cells and the red columns show the data of SK&F96365 
(30pM) treated cells. The A[Ca2+]iis measured as the [Ca2+]| at the peak and plateau, which is 300 
seconds after the peak, minus the baseline [Ca2+]i before the addition of bombesin. Error bars 
shown are ± S.E. of (N) number of indicated cells. *P<0.05, when A[Ca2+]i value of (N) number of 
cells were subjected to t-test. At least 10 experiments were performed.
153
Chapter 6
DMSO/SK&F
------- control(N=3)
--------+SK&F(N=3)600-
500-
400-
200-
200
Time (s)
Figure 6.3.4C- The effect of inhibitor SK&F96365 on the bombesin-induced [Ca2+], responses as 
monitored by the Flexstation plate reader
3-day-old quiescent Swiss 3T3 cells were cultured in a 96-well plate in SF-DMEM for 16 hours 
before experiments. Cells were first stimulated with DMSO (black) as vehicle control or 30pM 
SK&F96365 (red) at 20 seconds. A [Ca2+]| response is shown to bombesin (lOOnM) added at 120 
seconds in the presence of ImM Ca2+ in HBS. The [Ca2+]j was measured using Fura-2, at 37°C, 
through a Flexstation reader. "N" represents the number of similar replicate wells read by the 
Flexstation reader from 1 plate.
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Figure 6.3.4D-The effect of SK&F96365 on bombesin-induced Ba2+ and Sr2+ responses as 
monitored by the Flexstation plate reader
3-day-old quiescent Swiss 3T3 cells were cultured in a 96-well plate in SF-DMEM for 16 hours 
before experiments. Cells were first stimulated with DMSO (black) as vehicle control or 30pM 
SK&F96365 (red) at 20 seconds. A Ca2+ release is shown to bombesin (lOOnM) added at 100 
seconds in the presence of in Ca2+ free HBS. Then either ImM Ba2+ (a) or ImM Sr2+ (b) was added 
at 400 seconds. The ratio340/380 was measured using Fura-2, at 37°C, through a Flexstation 
reader. "N" represents the number of wells read by the Flexstation reader. "N" represents the 
number of similar replicate wells read by the Flexstation reader from 1 plate.
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Figure 6.3.4E- The effect of inhibitor SK&F96365 on the thapsigargin-induced [Ca2+]j responses 
3-day old quiescent Swiss 3T3 cells were cultured on coverslips in SF-DMEM with either DMSO or 
inhibitors pretreated for 16 hours before experiments. A Ca2+ release is shown to thapsigargin 
(2pM) in HBS containing ImM Ca2+. Figure (a) represents a typical thapsigargin-induced [Ca2+]i 
response in control cells. Figure (b) shows a bombesin-evoked [Ca2+]i response with the addition 
of SK&F96365 (30pM) before the bombesin. At least 3 experiments were performed.
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6.4 Discussion
In this chapter, the effect of Ca2+ influx inhibitors on the bombesin-induced Ca2+ influx was 
investigated. The results gained by either using a PTI Ca2+ imaging system when the cells were 
pre-treated with inhibitor or a Flexstation plate reader when the cell were treated with inhibitors 
instantly turned out to be similar. This increases the confidence of the data presented in this 
chapter.
According to the statistical analysis, it was suggested that the cPLA2a inhibitor was more 
influential than AACOCF3 on the bombesin-evoked [Ca2+]i response. The results indicate that 
cPLA2a inhibitor suppressed the Ca2+ influx, which in turn suggests that the cPLA2a may be 
involved in the bombesin-induced Ca2+ influx pathway. Flowever, it was found that the cPLA2a 
inhibitor caused a significant increase in the Ca2+ release and Sr2+ influx, which questions the 
effectiveness of this inhibitor. AACOCF3 also tends to cause a bigger bombesin-evoked [Ca2+]i 
response and it significantly increased Sr2+influx compared to that in the control cells. Such a side 
effect of AACOCF3 has been observed by others, and is attributed to the property of AACOCF3 
acting as an analogue of AA (Riendeau et al, 1994). This finding could reinforce the notion that 
AA is important in the bombesin-induced [Ca2+]i response.
According to the results obtained from the experiments using the PTI Ca2+ imaging system, it was 
revealed that the RHC80267 significantly decreases the bombesin-evoked [Ca2+]| response, 
especially the Ca2+ entry (Figure 6.3.IB). However, the bombesin-evoked Ca2+ release was not 
suppressed by the RHC80267 when the responses were monitored using a Flexstation plate 
reader. This might because the cells were treated with RHC80267 for a longer time in 
experiments with the Ca2+ imaging system compared with the cell used in the Flexstation 
microplate reader.
RHC80267 is a potent and specific in vitro DAG lipase inhibitor (Canonico et al., 1985). As 
described in sectionl.6.3.4, the DAG pathway is an important alternative to release AA 
(Watanabe-Tomita etai, 1997). Therefore, the inhibition by RHC80267 suggests that DAG may be 
required for the bombesin-evoked Ca2+ influx, and this supports the supposition described in
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chapter 5. However, some caution must be applied to this interpretation since RHC80267 did not 
appear to affect Sr2+ influx (Figure 6.3.2B). It was observed that RHC80267 failed to inhibit 
AVP-evoked Sr2+ entry in A7r5 cells, which was suggested to be mediated through DAG-AA 
pathway (Broad et al., 1999). On the other hand, results confirmed that both LOE908 and 
SK&F96365 are able to suppress the bombesin-induced Ca2+ influx. Since LOE908 is regarded to 
block the NSCCs while the SK&F96365 is well known for its function on SOCCs (Kawanabe et al., 
2001), it is believed that both the NSCCs and SOCCs have been activated by bombesin in order to 
conduct Ca2+ entry in the Swiss 3T3 cells. However, neither of the inhibitors could fully abolish 
the bombesin-evoked [Ca2+]i response, although both of them are able to block most of the Ba2+ 
or Sr2+ influx. These finding suggests that other Ca2+ channels which are neither sensitive to 
LOE908 and SK&F96365 nor selective to Ba2+ and Sr2+ participate in the bombesin-evoked Ca2+ 
entry pathway. However, this conclusion is challenged by several observations. The first problem 
is the specificity of both inhibitors. Although LOE908 and SK&F96365 are widely used to inhibit 
NSCCs or SOCCs respectively, both inhibitors were found to block a variety of ion channels. It has 
been shown that LOE908 (10pm or 30pm) has no effect on thapsigargin-induced SOCEs in A7r5 
cell and that LOE908 and SK&F96365 can be used to distinguish NSCCEs and SOCEs (Miwa et al., 
2000; Moneer and Taylor, 2002). However, another study found that LOE908 (~2pM) is a potent 
blocker of a Ca2+ conductance activated by thapsigargin-induced depletion of intracellular Ca2+ 
stores in endothelial cells (Encabo et al., 1996). Based on this evidence, the specificity of LOE908 
seems to be concentration- and cell type-dependent. Therefore, despite the fact that LOE908 was 
reported to inhibit endothelin-l-induced AA release in Chinese hamster ovary (CHO) cells 
(Kawanabe et al., 2003), it remains questionable whether the reduced bombesin-induced Ca2+ 
influx by LOE908 observed in this thesis is due to the inhibition of the NSCCEs, such as lARC.
Another explanation for the observation that neither LOE908 or SK&F96365 fully blocked the
bombesin-evoked Ca2+ influx while Ba2+ and Sr2+ influxes were inhibited may be related to the
reciprocal regulation between lSoc and IArc (Mignen et al., 2001). ARC channels are indeed
specifically activated by low agonist concentrations and provide the predominant route of Ca2+
entry under these conditions while SOCCs provides the predominant route of Ca2+ entry at high
agonist concentrations. It was reported that at high concentrations of agonist, the prolonged
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depletion of intracellular Ca2+ stores and following activation of SOCCs that cause a sustained 
elevation of [Ca2+]j could, in turn, inhibit the activity of the ARC channels (Mignen et al., 2001). 
Therefore, when the SOCEs have already been fully activated in cells, the IArc is likely to be under 
suppression. In this thesis, when the SOCEs were inhibited by SK&F96365, it might in turn 
remove such reciprocal inhibition of lSOc on IArc- This consequently may result in the activation of 
ARC channels conducting the Ca2+ influx. The reciprocal regulation is believed to be dependent on 
the global [Ca2+]i, rather than a local effect of the Ca2+ actually entering through the channels. AA 
has also been reported to inhibit SOCEs in some cells (Moneer and Taylor, 2002). Hence, such 
switch in the predominant mode of Ca2+ entry from lARC to lSoc might occur when LOE908 was 
applied in order to avoid the change in global [Ca2+]j. However, since there is no reciprocal 
regulation in the Ba2+ or Sr2+ influx, when either LOE908 or SK&F96365 was added, no alternative 
entry pathways was activated. Therefore, the Ba2+ or Sr2+ entry is more likely to be fully blocked 
by these inhibitors.
In summary, these experiments showed that:
1. The cPLA2a inhibitor suppressed the bombesin-evoked Ca2+ influx. However, it appears to 
increase the Ca2+ release and Sr2+ influx by a mechanism that remains unclear.
2. The inhibitor AACOCF3 has little influence on the bombesin-induced [Ca2+]| responses. 
However, the Ca2+ influx tends to be bigger in the cells with the presence of AACOCF3 than 
that in the control cells. AACOCF3 significantly increased bombesin-evoked Sr2+ influx.
3. The inhibitor RHC80267 significantly reduced bombesin-evoked Ca2+ influx. The 
bombesin-evoked Ca2+ release is seen to be suppressed in the RHC80267 pre-treated cells 
using a PTI Ca2+ imaging system while no such suppression is seen in cells treated with 
RHC80267 instantly using a Flexstation plate reader. In addition, RHC80267 has little effect on 
the Sr2+ influx.
4. Both LOE908 and SK&F96365 significantly blocked the bombesin-evoked Ca2+ influx. They are 
very effective at inhibiting the Ba2+ and Sr2+ fluxes.
5. The involvement of the SOCEs in the bombesin-evoked [Ca2+]j response is confirmed, 
although a role of AA in this [Ca2+]j response cannot be ruled out.
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The activation of STIM1 in bombesin-evoked Ca2+ influx
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7.1 Introduction
Based on the findings from the previous chapters, the SOCEs appear to be involved in the 
bombesin-induced [Ca2+]i responses in Swiss 3T3 cells. The role of SOCE in bombesin-evoked Ca2+ 
influx and its relation to cell shape was therefore examined. In particular, it was decided to focus 
on the translocation of STIM1, since this represents a key step in SOCE activation and may be 
sensitive to alterations in the cytoskeleton.
As mentioned in section 1.6.2.2, it is now clear that STIM1 is a necessary component for the 
activation of SOCCs {Liou et al., 2005). Although the precise mechanism of how STIMl acts in 
SOCE is still not fully understood, a widely accepted model is that STIMl proteins need to form 
puncta for the activation of SOCCs (Wu et al., 2006; Smyth et al., 2007). Based on this theory, the 
STIMl oligomerization and translocation for puncta formation have become two criteria to 
identify the activation of SOCEs.
It is difficult to examine STIMl by immunofluorescence due to its relative low level of expression, 
though they were observed in Swiss 3T3 cells in a previous study in our laboratory. For a similar 
reason, it is difficult to investigate STIMl using western blotting. Although blots can be obtained 
from cells expressing endogenous STIMl, no spatial information can be obtained relating to the 
location of STIMl and puncta formation. Consequently, it was decided to investigate STIMl 
activation by transfection with yellow fluorescent protein (YFP)-chimeric STIMl plasmids 
(Burgoyne et al., 2010). However, Swiss 3T3 cells were found to be difficult to transfect 
(transfection rate < 10%) with the YFP-STIM1. Therefore, it was decided initially to use HeLa cells 
as an alternative. HeLa cells have been widely used for the study of STIMl, where STIMl 
oligomerization and the formation of puncta were observed (Liou et al., 2007).
The activation of STIMl in response to the stimulation by either bombesin or thapsigargin in 
normal spreading HeLa cells on coverslips was investigated first. It has been widely observed that 
thapsigargin can lead to STIMl puncta formation in HeLa cells (Liou et al., 2007). Therefore, 
thapsigargin was used as a standard positive control to compare with bombesin.
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The influence of cell shape on STIM1 was examined using large and small adhesive islands. The 
cell cytoskeleton including actin, microtubules, intermediate filaments are required for 
maintenance of the cell shape (reviewed by Hay, 2005). The localization and movements of 
intracellular signaling proteins are often controlled by the cytoskeleton, especially the actin 
filaments and microtubules (reviewed by Smyth et a!., 2007). When the cell shape is restricted by 
islands, the distribution of the cytoskeleton is altered. It has been observed in our laboratory that 
the actin cytoskeleton was re-organized in the cells on small islands and formed a ring of actin 
which is reminiscent of that induced by jasplakinolide (Foster, 2005). Jasplakinolide is also known 
to block Ca2+ entry as it was observed to inhibit the SOCEs in both DDT1MF-2 cells and A7r5 cells 
(Patterson et al., 1999). Based on all these findings, the hypothesis is that STIM1 puncta 
formation may be inhibited due to the re-organization of actin cytoskeleton in cells on small 
islands. This then may account for the absence of bombesin-induced Ca2+ influx in 
shape-restricted cells.
In summary, the primary aim is to exam the activation of STIM1 in experiments by transfecting 
HeLa cells with YFP-STIM1 in order to establish STIM1 localization using confocal microscopy. In 
addition, a fluorescence-activated ceil sorter (FACS) was used to enrich the transfected cell 
population. Another objective is to determine the localization of STIM1 in cells on large and small 
islands.
In the experiments, HeLa cells expressing YFP-STIM1 were restricted from spreading by plating 
onto adhesive islands as described in previous chapters. They were then stimulated with either 
bombesin or thapsigargin. As with previous experiments, there was a loss of cells when 
transferring cells onto islands. In order to obtain a good occupancy of YFP-STIM1 expressing cells, 
the population needed to be enriched. To achieve this, a FACS was applied to sort the YFP 
expressing cells.
Although Swiss 3T3 cells were difficult to transfect, if Jet Prime transfection reagent along with
mCherry-STIMl was used, the transfection rate was enhanced to 30%-50%. Consequently, the
distribution of STIM1 in normal spreading Swiss 3T3 cells could be investigated. Since the FACS
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increased the density of transfected cells, the STIM1 distribution in the shape restricted Swiss 
3T3 cells could also be examined.
7.2 Method
7.2.1 Cell culture
HeLa cells were cultured according to standard protocol for Swiss 3T3 cells as described in 
section 2.1. The shape-restricted cells were transferred to coverslips containing either large or 
small islands using the same protocol described for Swiss 3T3 cells.
7.2.2 Transfection
HeLa cells were grown to 50% confluent for YFP-STIM1 transfection in a 10cm2 cell culture dish. 
For each dish, 6pg DNA was added into 500pl Optimem and incubated for 5min. Following that, 
24|i! reagent Gene juice was added allowing 20min before transferring the mixture onto the cells.
Cells were then cultured for at least 24 hrs before the experiments at 37°C.
Swiss 3T3 cells were grown to 50% confluency for mCherry-STIMl and YFP-STIM1 transfection. 
For a 6-well plate, 2pg DNA was first added into 200pl Jet prime buffer, mixed and incubated for 
5min. After that, 4pl Jet prime reagent was added and incubated for lOmin. Then the mixed 
complex was added into each well where cells were cultured in 2ml FCS-DMEM. The media
needed to be replaced with fresh FCS-DMEM after 4 hours culture at 37°C. Cells were then 
cultured for at least 24 hrs before the experiments.
7.2.3 FACS analysis
Transfected cells were first washed with PBS and resuspended with Trypsin-EDTA following the 
standard protocol described in section 2.1. They were then centrifuged for 5min at 400xg. After 
that, cells were suspended in 0.1%BSA in PBS with a density of IxlO6 cells/ml for sorting by FACS. 
Meanwhile, untransfected cells were suspended in the same way and used as a control group. 
Approximately, 10% of the transfected cells can be sorted.
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7.2.4 Stimulation of transfected cells
Unstimulated transfected cells were kept in MBS containing ImM Ca2+ before being fixed with 3% 
paraformaldehyde (PFA). For the stimulated cells, they were treated with lOOnM bombesin in 
MBS containing 1 mM Ca2+ or with 2|iM thapsigargin in Ca2+ free HBS. The agonist-treated HeLa
cells were incubated at 37°C for 2min/ 4min and Smin before being fixed with 3% PFA. The Swiss
3T3 cells were treated with bombesin in the same way, however those cells on adhesive islands 
were only incubated for 4min before fixation.
7.2.5 Confocal microscopy
The distribution of STIM1 was examined using a Leica AOBS scanning confocal microscope as 
described in section2.5.3. Images of YFP- and mCherry-STIMl were acquired using 488nm and 
561nm laser line excitation, respectively.
7.3 Results
7.3.1 The effect of bombesin and thapsigargin on STIM1 in normal spreading HeLa cells
The results show the distribution and density of STIM1 in the YFP-STIM1 expressing normal
spreading HeLa cells, which were either stimulated with bombesin or thapsigargin. Figure 7.3.1a 
shows the confocal microscope images for a single un-stimulated cell scanned at 2 different 
planes. The figure 7.3.1b-d show the confocal images of 3 single cells which were treated with 
lOOnM bombesin at 2min, 4min and Smin before fixation. For each cell, 4 scanned images at 
different planes from the bottom to the top of the cell are presented. In a same way, figure 
7.3.1e-g show the images of 3 thapsigargin-treated (2pM) cells.
From this figure, puncta can be clearly seen in thapsigargin-stimulated cells. There was no distinct 
increase of puncta formation in the bombesin-treated cells, compared to the un-stimulated cells. 
Most of the puncta are located at the base of the cell, especially in those that have been 
bombesin-treated. Both bombesin- and thapsigargin-stimulated cells show most puncta at the 4 
minute time point.
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a. control
b. +bombesin 2min
??pm |___________________ |____________________ 2?nm I 22pm
c. +bombesin 4min
2£pm|____________________ 22pm |________ 22pm I 22pm
d. -tbombesin 8min
22pm| 22pm I 22pm I 22pm
167
Chapter 7
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Figure 7.3.1-The effect of bombesin and thapsigargin on STIM1 distribution in normal spreading 
HeLa cells
YFP-STIM1 over expressing HeLa cells were cultured, unrestricted on glass coverslips. Images 
were visualized with a Leica SP2 AOBS laser scanning confocal microscope. The images of one 
single cell scanned in different planes, from the bottom (left) to the top (right), are presented in 
each figure from (a)-(g). The two images in figure (a) shows the distribution of STIM1 in an 
un-stimulated cell in ImM Ca2+ containing HBS. Figure (b)-(d) show the distribution of STIM1 in 
three lOOnM bombesin treated cells in ImM Ca2+ containing HBS for 2min (b), 4min (c) and 8min 
(d) respectively. Figure (e)-(g) present the distribution of STIM1 in three cells treated with 2pM 
thapsigargin for 2min (e), Amin (f) and 8min (g) consequently. Results shown are representative 
of 3 separate experiments.
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7.3.2 The effect of bombesin and thapsigargin on STIM1 in cell shape restricted HeLa cells
Since it was observed that the STIM1 can be at least partially activated by bombesin in HeLa cells,
the effect of cell shape on activation was investigated. Both large (045pm) and small (022pm) 
islands were utilized to restrict the HeLa cell shape.
Figure 7.3.2A and figure 7.3.2B show the distribution of STIM1 in cells on either large or small 
adhesive islands. The confocal images for two un-stimulated cells are presented in figure 7.3.2A 
(a) and figure 7.3.2B (a). Figure 7.3.2A (b)-(d) and figure 7.3.2B (b)-{d) are confocal images for 
lOOnM bombesin-treated cells on large and small islands at different time points (2min & 4min & 
8min), in which four confocal images scanned at different planes are presented for each single 
cell.
Thapsigargin (2pM) was also used to stimulate the shape restricted HeLa cells. In the same way, 
figure 7.3.2C and figure 7.3.2D show the distribution of STIM1 in control and thapsigargin-treated 
restricted cells. In total, 3 similar experiments were performed to confirm the results. Each ceil in 
the figure is representative at least 3 different cells.
Both bombesin and thapsigargin are able to induce the STIM1 puncta formation in the shape 
restricted cells, whether they were on the large or small islands. As a result, it appears that the 
formation of STIM1 puncta is not affected by the cell shape in the HeLa cells.
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a. large island: control
22um 22pm I 22pm I 22pm
b. large island: +bombesin 2min
22pm 22pm I 22pm I 22pm
c. large island: +bombesin 4min
22pm I 22pm I 22pm I 22pm
d. large island: -fbombesin 8min
22pm I 22pm I 22pm I 22pm
Figure 7.3.2A-The effect of bombesin on STIM1 in the HeLa cells on large islands
YFP-STIM1 over expressing HeLa cells were cultured and restricted with large islands. Images
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were visualized with a Leica SP2 ABOS laser scanning confocal microscope. The images of one 
single cell scanned at different planes, from the bottom (left) to the top (right), are presented in 
each figure from (a)-(d). Figure (a) shows the distribution of STIM1 in an un-stimulated cell in 
ImM Ca2+ containing HBS. Figure (b)-(d) show the distribution of STIM1 in three lOOnM 
bombesin-treated cells in ImM Ca2+ containing FIBS for 2min (b), 4min(c) and 8min(d) 
respectively. Results shown are representative of 3 separate experiments.
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a. small island: control
|____________________ 22pm | 22pm I 22pm
b. small island: -fbombesin 2min
22pm |____________________ 22pm | 22pm I 22pm
c. small island: +bombesin 4min
22pm |___________ 22pm I 22pm I 22pm
d. small island: -fbombesin 8min
2?pm I 22pm I 22pm I 22pm
Figure 7.3.2B-The effect of bombesin on STIM1 in the HeLa cells on small islands
YFP-STIM1 over expressing HeLa cells were cultured and cell spreading restricted using small
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adhesive islands. Images were visualized with a Leica SP2 ABOS laser scanning confocal 
microscope. The images of one single cell scanned at different planes, from the bottom (left) to 
the top (right), are presented in each figure from (a)-(d). Figure (a) shows the distribution of 
STIMl in an un-stimulated ceil in ImM Ca2+ containing HBS. Figure (b)-(d) show the distribution 
of SUM 1 in three lOOnM bombesin-treated cells in ImM Caz+ containing HBS for 2min (b), 4min(c) 
and 8min(d) respectively. Results shown are representative of 3 separate experiments.
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a. large island: control
22pm |___________________ 22pm I 22pm I 22pm
b. large island: +Tg 2min
22pm I 22pm I 22pm I 22pm
c. large island: +Tg 4min
22pm I 22pm I 22pm I 22pm
d. large island: +Tg 8min
22pm I 22pm I 22pm I 22pm
Figure 7.3.2C-The effect of thapsigargin on STIM1 in the HeLa cells on large islands
YFP-STIM1 over expressing HeLa cells were cultured and placed on large adhesive islands. Images were 
visualized with a Leica SP2 ABOS laser scanning confocal microscope. The images of one
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single cell scanned at different planes, from the bottom (left) to the top (right), are presented in 
each figure from (a)-(d). Figure (a) shows the distribution of STIM1 in an un-stimulated cell in Ca2+ 
free HBS. Figure (b)-(d) show the distribution of STIM1 in three 2pM thapsigargin-treated cells in 
Ca2+free HBS for 2min (b), 4min(c) and 8min(d) respectively. Results shown are representative of 
3 separate experiments.
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a. small island: control
22Mm|____________________ 22pm |________ 22pm I 22pm
b. small island: +Tg 2min
22pm I_____________ 22pm I 22pm I 22pm
c. small island:-fig 4min
22pm I____________________ 22pm | 22pm I 22pm
d. small island:+Tg 8min
22pm I 22pm I 22pm I 22pm
Figure 7.3.2D-The effect of thapsigargin on STIM1 in the HeLa cells on small islands
YFP-STIM1 over expressing HeLa cells were cultured and placed on small adhesive islands. Images were
visualized with a Leica SP2 ABOS laser scanning confocal microscope. The images of one
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single cell scanned at different planes, from the bottom (left) to the top (right), are presented in 
each figure from (a)-(d). Figure (a) shows the distribution of SUM 1 in an un-stimuiated cell in Ca2+ 
free HBS. Figure (b)-(d) show the distribution of STIM1 in three 2pM thapsigargin-treated cells in 
Ca2+ free FiBS for 2min (b), 4min(c) and 8min(d) respectively. Results shown are representative of 
3 separate experiments.
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7.3.3 The effect of bombesin and thapsigargin on STIM1 in normal spreading Swiss 3T3 cells
With a new transfection reagent Jet prime, the mCherry- or YPF-STIM1 transfection rate was 
increased up to 30% in Swiss 3T3 cells (GeneJuice showed a transfection rate at 1-2%). As a result, 
the activation of STIM1 to either bombesin or thapsigargin was first examined in normal 
spreading cells.
Figure 7.3.3A shows the distribution of mCherry-STIMl in either control or stimulated cells. Two 
un-stimulated cells (left) in ImM Ca2+ HBS are presented in figure 7.3.3A (a), which are 
representative of 17 out of 25 investigated un-stimulated cells shown no puncta formation. In the 
remaining cells, some degree of puncta formation was observed as shown in the image (right) in 
figure 7.3.3A (a). In other words, 8 out of 25 cells (32%) un-stimulated cells show STIM1 puncta. 
Figure 7.3.3A (b)-(d) show bombesin (lOOnM) treated cells at 2min, 4min and 8min after the 
stimulation. Two different cells are presented in each figure (b)-(d). For the stimulated cells at the 
2 minute time point (b), 17 out of 21 cells (81%) clearly show STIM1 puncta. At the 4 minute time 
point (c), there are 14 out of 18 (78%) bombesin-treated cells showing STIM1 puncta. Similarly, 
the proportion of cells that possess STIM1 puncta in stimulated cells at the 8 minute (d) time 
point was 3 out of 4 (75%). The results indicate that bombesin is able to cause STIM1 puncta 
formation in most cases. In a same way, figure 7.3.3A (e)-(g) shows 2pM thapsigargin-stimulated 
cells at different time points. At the 2 minute time point, there are 12 out of 14 (86%) 
thapsigargin-treated cells with STIM1 puncta (e). Similarly, STIM1 puncta were observed in 5 out 
of 7 (71%) cells stimulated with thapsigargin at 4min (f) after the stimulation. All the 
thapsigargin-treated cells (n=2 cells) at the 8 minute time point showed the STIM1 puncta (g).
Followed the above, the STIM1 formation in cell shape restricted Swiss 3T3 cells was investigated. 
In order to sort the cells by FACS, YFP-STIM1 was transfected into Swiss 3T3 cells. The transfected 
cells were sorted before being placed onto islands. Figure 7.3.3B shows 3 YFP-STIM1 expressing 
Swiss 3T3 cells that are either normal spreading (a) or restricted by islands (b) & (c). These data 
show that YFP-STIMl expressing Swiss 3T3 can be sorted and cultured on islands for analysis of 
STIM1 puncta formation.
Furthermore, the activation of STIM1 by either bombesin or thapsigargin in restricted Swiss 3T3
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cells was examined. All the stimulated cells were treated with either bombesin in ImM Ca2+ 
containing HBS or thapsigargin in Caz+ free HBS for 4min before the fixation. Figure 7.3.3C shows 
the distribution of STIM1 in either control (a) or agonist treated (b & c) normal spreading Swiss 
3T3 cells. Clear STIMl puncta can be seen in the thapsigargin-treated cells but not in the 
bombesin-stimulated ones. Figure 7.3.3D & figure 7.3.3E show the distribution of STIMl in either 
large or small islands restricted cells. Similarly, the STIMl puncta is only observed in 
thapsigargin-stimulated cells.
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a. Control
22nm I 22\vr\ I 22\xm
b. -t-bombesin 2min
c. +bombesin 4min
d. -t-bombesin 8min
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f. +Tg 4m in
g. +Tg 8min
Figure 7.B.3A- The effect of bombesin and thapsigargin on STIM1 in normal spreading Swiss 3T3 
cells
The mCherry-STIMl expressing Swiss 3T3 cells were cultured, unrestricted on glass coverslips. 
Images were visualized with a Leica SP2 ABOS laser scanning confocal microscope. The images of 
two different single cells are presented in each figure from (a)-(g). Figure (a) shows the 
distribution of STIM1 in the un-stimulated cells in ImM Ca2+ containing HBS. Figure (b)-(d) show 
the distribution of STIM1 in lOOnM bombesin treated cells in ImM Ca2+ containing HBS for 2min 
(b), 4min(c) and 8min(d) respectively. Figure (e)-(g) present the distribution of STIM1 in cells 
treated with 2pM thapsigargin for 2min(e), 4min(f) and 8min(g) consequently. Results shown are 
representative of 3 separate experiments.
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a. Control: normal spreading
22nm I 22nm I 22[im I 22Mm
b. Control: large islands
22pm I 22pm I 22pm I 22pm
c. Control: small islands
22pm I 22pm I 22pm I 22pm
Figure 7.3.3B-The distribution in normal spreading and shape restricted Swiss 3T3 cells
YFP-STIM1 expressing Swiss 3T3 cells were cultured unrestricted on the glass coverslips (a) or on 
the large (b) and small (c) islands. Cells were cultured in FCS-DMEM before fixation. The images 
were visualized with a Leica SP2 ABOS laser scanning confocal microscope. Images of one single 
cell scanned at different planes, from the bottom (left) to the top (right), are presented in each 
figure from (a)-(c). The result is 5 experiments. These data were obtained in collaboration with Dr 
Alex Laude.
182
Chapter 7
a. Normal spreading: control
22pm 22pm I 22pm I 22pm
b. Normal spreading: -t-bombesin
22pm I 22pm I 22pm I 22pm
c. Normal spreading: -fig
22pm I 22pm I 22pm I 22pm
Figure 7.3.3C- The effect of bombesin and thapsigargin on STIM1 in normal spreading Swiss 3T3 
cells
YFP-STIM1 expressing Swiss 3T3 cells were cultured unrestricted on the glass coverslips. Cells 
were sorted by FACS and then cultured in FCS-DMEM for 16 hrs before fixation. The images were 
visualized with a Leica SP2 ABOS laser scanning confocal microscope. Images of one single cell 
scanned at different levels, from the bottom (left) to the top (right), are presented in each figure 
from (a)-(c). Figure (a) presents an un-stimulated cell while figure (b) & (c) present cells 
stimulated by bombesin (lOOnM) and thapsigargin (2pM) for 4min, respectively. The result is 
representative of 5 experiments. These data were obtained in collaboration with Dr Alex Laude.
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b. Large islands: + bombesin
22|jm I 22|am I 224m I 22|im
c. Large islands: +Tg
22|im I 224m I 224m I 224m
Figure 7.3.3D- The effect of bombesin and thapsigargin on STIM1 in Swiss 3T3 cells on the large 
islands
YFP-STIM1 expressing Swiss 3T3 cells were cultured unrestricted on the large islands. Cells were 
sorted by FACS and then cultured in FCS-DMEM for 16 hrs before fixation. The images were 
visualized with a Leica SP2 ABOS laser scanning confocal microscope. Images of one single cell 
scanned at different levels, from the bottom (left) to the top (right), are presented in each figure 
from (a)-(c). Figure (a) presents an un-stimulated cell while figure (b) & (c) present cells 
stimulated by bombesin (lOOnM) and thapsigargin (24M) for Amin, respectively. The result is 
representative of 5 experiments. These data were obtained in collaboration with Dr Alex Laude.
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a. Small islands: control
22nm I 22|im I 22pim I 22nm
b. Small islands: +bombesin
22|am I 22pm I 22pm I 22pm
c. Small islands: +Tg
22pm I 22pm I 22pm I 22pm
Figure 7.3.3E-The effect of bombesin and thapsigargin on STIM1 in Swiss 3T3 cells on the small 
islands
YFP-STIM1 expressing Swiss 3T3 cells were cultured unrestricted on the small islands. Cells were 
sorted by FACS and then cultured in FCS-DMEM for 16 hrs before fixation. The images were 
visualized with a Leica SP2 ABOS laser scanning confocal microscope. Images of one single cell 
scanned at different levels, from the bottom (left) to the top (right), are presented in each figure 
from (a)-(c). Figure (a) presents an un-stimulated cell while figure (b) & (c) present cells 
stimulated by bombesin (lOOnM) and thapsigargin (2pM) for 4min, respectively. The result is 
representative of 5 experiments. These data were obtained in collaboration with Dr Alex Laude.
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7.4 Discussion
It is agreed that STIM1 puncta formation always precedes the induction of SOCE, and this is 
consistent with a causal role for STIM1 redistribution in activating SOCCs (Baba et ai, 2006). In 
this chapter, the location of STIM1 redistribution in response to the stimulation by bombesin or 
thapsigargin in normal spreading Hela cells and Swiss 3T3 cells was investigated using confocal 
microscopy.
Some STIM1 puncta were occasionally observed in un-stimulated cells (Figure 7.3.3Aa & 7.3.3Ba). 
Similar findings were reported by Baba et al. (2006), and they argued that at any one time at least 
a small fraction of STIM1 distributions in the ER occur as small puncta.
The results demonstrate that thapsigargin is very effective at inducing the formation of STIM1 
puncta in both HeLa and Swiss 3T3 cells. This is entirely consistent with its property to deplete 
Ca2+ stores and trigger SOCE. The result shows that: in Hela cells, STIM1 puncta formed as early 
as 2 min after addition of thapsigargin, and the amount of puncta increased at 4min followed by a 
decrease at 8min. The time course corresponds with the time dependence of SOCE after 
thapsigargin-stimulated release from stores in this cell type (Gamberucci et al., 1994; Missiaen et 
al., 1994). Similarly, the thapsigargin-treated Swiss 3T3 cells when treated for 4min possess more 
puncta than the cells at other two time points.
Fewer STIM1 puncta were seen in the bombesin-treated FleLa or Swiss 3T3 cells compared to the 
thapsigargin-treated ones (Figure 7.3.1 &7.3.3A). Since STIM1 puncta was also seen in resting 
cells, whether the stimulation by bombesin facilitates the formation of STIM1 puncta is difficult 
to confirm without quantitative analysis. However, in this case, it is quite likely that the limited 
amount of STIM1 puncta is insufficient to fully active SOCCs and lead to a large Ca2+ influx. In 
other words, the partially activated SOCCs may not be fully responsible for the bombesin-induced 
Ca2+ influx although they certainly participate. This conclusion explains the observation that 
SK&F96365, rather than fully blocking, merely reduced the amount of bombesin-induced Ca2+ 
influx, which is presented in chapter 6.
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An interesting observation in the experiments is that most of the puncta were based or adjacent 
to the bottom of the cells. Since cells were attached to the coverslips, shaped as a "bell", the 
bottom is where the most area of plasma membrane can be seen under confocal microscope. 
Therefore, the accumulation of puncta at the base of the cells suggest that most of them are 
close to or even located at the plasma membrane, which agrees with the common definition of 
puncta that it is a structure near or within the plasma membrane (Liou et al., 2005; Zhang et al., 
2006).
Following the examination in normal spreading cells, the dependence of the redistribution of 
STIM1 on the ceil shape was investigated. The result indicated that the thapsigargin-induced 
formation of STIMl puncta is not impaired by the restriction of cell shape in either HeLa or Swiss 
STB cells (Figure 7.3.2C-D & 7.3.3D-E). This is consistent with the observation in our laboratory 
that the thapsigargin-evoked Ca2+ influx can be activated in the Swiss 3T3 cell on the small islands 
(Foster, 2005). In addition, this finding supports the conclusion that the actin cytoskeleton does 
not play an obligate role in the SOCE pathway as argued by other researchers. For example, it was 
reported that depolymerization of the actin cytoskeleton with cytochalasin D does not negatively 
impact SOCEs in NIFI 3T3 cells (Ribeiro et al.r 1997).
Fiowever, the formation of STIMl puncta evoked by bombesin in restricted cells seemed to be 
different from that induced by thapsigargin. Although the STIMl puncta was seen in the 
restricted HeLa cells, STIMl puncta were not observed in the restricted Swiss 3T3 cells. The 
differences between HeLa and Swiss 3T3 cells may due to the difference of their original cell sizes. 
The original size of HeLa cell is much smaller than that of the Swiss 3T3 cell. As a result, the
022[im small adhesive island may not be small enough to have the HeLa cell shape intensively
restricted. The bombesin-evoked [Ca2+]j response in HeLa cells was not measured, therefore it is 
not known whether bombesin is able to evoke a cell shape-dependent Ca2+ influx in this cell line. 
For the Swiss 3T3 cells, as long as the absence of bombesin-induced STIMl puncta in restricted 
cells can be confirmed, it may account for the loss of the bombesin-evoked Ca2+ influx in cells on 
small islands (Figure 3.3.4).
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Although the actin cytoskeleton may have little effect on the thapsigargin-induced SOCEs, it was 
found that disruption of the actin cytoskeleton with cytochalasin D inhibits agonist-evoked Ca2+ 
influx (Ribeiro et al., 1997). The relationship between PLC and IP3 receptors might be altered 
when the skeleton was disrupted. This may further impair PLC-dependent Ca2+ signaling (Ribeiro 
et al., 1997). We know that activated PLC stimulates hydrolysis of PIP2 into DAG and IP3(Lee and 
Rhee, 1995). The latter triggers Ca2+ release via IP3Rs on the ER (Berridge et al., 2003). STIM1 as 
an ER depletion sensor is translocated and formed the puncta at the ER-PM junction as 
consequence of IP3-induced ER depletion. Based on this evidence, it may be suspected that the 
bombesin-induced STIM1 puncta formation observed in normal spreading Swiss 3T3 cells is 
through the PLC-IP3 pathway. As a result, when the actin cytoskeleton is disrupted by restriction 
the cell shape using adhesive islands, this might alter the activation of PLC and IP3, and the 
bombesin-induced STIM1 puncta formation is prevented. However, such hypothesis is challenged 
by a observation that the Ca2+ release from ER which is normally controlled by IP3 is not inhibited 
by the restriction of cell shape by islands in Swiss 3T3 cells (Pennington et al., 2007). This finding 
suggests that the activity of IP3 is not cell shape dependent.
Another possible explanation for the absence of bombesin-induced STIM1 formation in the
restricted Swiss 3T3 cells is the effect of microtubular cytoskeleton on STIM1. The microtubular
cytoskeleton is known to be a major regulator of ER structure and function (Terasaki et al., 1986).
Some evidence has suggested that microtubules might play a facilitative role in organizing STIM1
to communicate with Orai channels (Smyth etai, 2007). Restriction of the cell shape with islands
might cause a re-arrangement of the microtubular structure which consequently alters the
activation of STIM1. According to a previous finding in our laboratory, microtubular structure was
observed in small adhesive islands restricted Swiss 3T3 cells (Foster, 2005). However, the
distribution of microtubules in shape restricted-cells differs from that in the normal spreading
cells (see Appendix 2). Therefore, microtubules are possible to affect the distribution and
translocation of STIM1 in restricted cells. Although no clear STIM1 puncta was observed in
bombesin-stimulated Swiss 3T3 cells, the distribution of STIM1 tended to be more condensed
than that in un-stimulated cells. The condensed distribution of STIM1 is similar to an observation
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in a study measuring the structure of ER microtubule network during cell division. It is found that 
the ER displays a reticular network of convolved cisternae linked to tubules in the interphase 
while it undergoes a transformation and is organized as extended cisternae from prometaphase 
to telophase (Lu et al., 2009). Hence, the condensed STIM1 seen in bombesin-stimulated cells 
might be due to the change of ER microtubule structure. Furthermore, because Swiss 3T3 cells 
are difficult to be transfect with mCherry- or YFP-STIM1, limited data were obtained from the 
experiments.
In conclusion, the study clearly indicates STIM1 puncta can form in shape-restricted cells. In 
addition to STIMl, STIM2 should be studied. It was reported that STIM2 may already be partially 
active at basal ER Ca2+ concentrations and be fully activated by small reductions of ER Ca2+ 
concentration, while STIMl may require much larger receptor-triggered reductions in ER Ca2+ to 
be activated (Brandman et al., 2007). Since the result in my research imply that the [Ca2+]i 
response in restricted cells is smaller than that in normal spreading cells, SUM2 which is more 
sensitive to smaller Ca2+ release might play a more important role in this bombesin-induced Ca2+ 
influx than STIMl. More studies on STIM2 in Swiss 3T3 cells are therefore needed.
In summary, the key findings presented in this chapter are:
1. Thapsigargin is effective at inducing STIMl puncta formation in normal spreading HeLa and 
Swiss 3T3 cells.
2. The thapsigargin-induced STIMl puncta formation in HeLa and Swiss 3T3 cells is not affected 
by cell restriction using adhesive islands.
3. Bombesin is not very effective in generating STIMl puncta and there was not a noticeable 
increase in STIMl puncta compared with control cells. Less STIMl puncta were observed in 
bombesin-stimulated cells than in thapsigargin-stimulated cells.
4. STIMl puncta were observed in bombesin-stimulated cell shape-restricted HeLa cells. 
However, no bombesin-evoked STIMl puncta was seen in restricted Swiss 3T3 cells.
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8.1 General discussion
It has been demonstrated that restricting cell shape leads to inhibition of cell cycle progression. 
(Folkman and Moscona, 1978; Ireland et aL, 1987; Watt et al., 1988; Huang et al., 1998) In 
particular, Swiss 3T3 cells failed to enter S phase under the stimulation of FCS when they are 
cultured on small (022pm) adhesive islands (Ireland eta/., 1987; Pennington eta/., 2007). More 
recently, it has been demonstrated that bombesin-induced Ca2+ influx was inhibited in such small 
island restricted cells (Pennington et al., 2007). Similar results are presented here in chapter 3, 
which confirms the existence of this cell-shape-dependent Ca2+ influx. It is known that Ca2+ 
signals, derived from mitogen-evoked signaling pathways, play a critical role in regulating the cell 
cycle. Ca2+ and various Ca2+ binding proteins regulate a number of cell cycle regulatory factors, 
such as cyclinD-CDK4 complex, p21 and p27 to control the cell cycle (Kahl and Means, 2003). 
Consequently, the absence of the bombesin-induced Ca2+ influx would be expected to inhibit cell 
cycle progression in Swiss 3T3 cells restricted by small adhesive islands. The main aim of this 
research is to investigate the mechanisms underlying bombesin-induced cell shape-dependent 
Ca2+ influx.
Previous work in our laboratory proposed a possibility that AA may be involved in this 
bombesin-induced Ca2+ influx. It has been seen that bombesin acts like the AA analogue ETYA 
that stimulates Ca2+ and Sr2+ entry but not Ba2+ entry. Nevertheless, thapsigargin evokes both Sr2+ 
and Ba2+ influx (Foster, 2005). As a result, the role of AA in the bombesin-evoked Ca2+ influx was 
first examined.
Following the same protocol, I tested the effect of agonists, bombesin, ETYA and thapsigargin, on 
the influx of Ba2+ and Sr2+. The data is presented in chapter 4. Although similar results, that are 
consistent to Foster's study, were obtained, the reliability of the effects is questioned due to the 
occurrence of spontaneous Ba2+ and Sr2+ influxes. Whether the influx of Ba2+ or Sr2+ is due to the 
stimulation of agonists or a passive leaking is unclear. Ba2+ influxes were seen after the addition 
of ETYA, with a bigger amplitude of Aratio340/380 than the spontaneous influx observed during 
the same period of time (Figure 4.3.3B). This observation implied that ETYA is able to evoke a Ba2+
influx, which is in agreement with the model proposed by Foster (Foster, 2005). However, rather
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than no response; bombesin showed a tendency to evoked a slight Ba2+ influx according to my 
data (Figure 4.3.1A). Whether ETYA as well as bombesin induce a small Ba2+ influx and a big Sr2+ 
entry is still an issue to be resolved. Furthermore; the experiments in shape restricted cells 
indicated that, in more than half the cases, cells showed a Ba2+ influx with or without the 
stimulation of bombesin. In addition, no significant difference was seen in either Ba2+ or Sr2+ 
influx in the cells on large or small adhesive islands. Collectively speaking, the model based on 
the specific responses of Ba2+ and Sr2+ to agonists is challenged since a Ba2+ influx was seen after 
the stimulation of bombesin or ETYA. Due to the occasional spontaneous influx of Baz+ and Sr2+, 
both cations were not able to distinguish particular activation by either SOCE or NSOCE. 
Consequently, other approaches to determine the nature of the bombesin-evoked influx were 
adopted.
In order to characterize the involvement of AA in this shape-dependent Ca2+ influx, the cPLA2 
pathway which is primarily responsible for the liberation of AA was examined. The 
immunofluorescence experiments presented in chapter 5 indicate that there was an increase of 
phospho-cPLA2 after the addition of bombesin in normal spreading Swiss STB cells. This 
bombesin-induced phospho-cPLA2 expression was suppressed in small island-restricted cells 
according to the data, although there were increases of immunofluorescence intensity of 
phospho-cPLA2 occasionally seen in those restricted cells (Section 5.3.2). However, whether the 
bombesin-regulated phospho-cPLA2 increase occurred in the upstream or downstream of the 
cPLA2-AA pathway is questionable, since the ERK/MAPK inhibitors, ERK FR182040 and PD98Q59 
failed to inhibit the Ca2+ influx evoked by bombesin (Figure 5.3.5 A & B). In addition, the increase 
of phospho-cPLA2 intensity was still seen in ERK FR182040 and PD98059 treated cells. All these 
findings suggested that the ERK/MAPK pathway is not participating in the pathway that activates 
the Ca2+ influx after the stimulation of bombesin. Therefore, the cPLA2, which is activated through 
the phosphorylation by ERK/MAPK, may be not required for the bombesin-evoked Ca2+ influx.
The importance of cPLA2 to the bombesin-evoked [Ca2+]i responses was further questioned when 
two cPLA2 inhibitors were utilized. Although the cPLA2a inhibitor caused a moderate suppression 
on Ca2+ influx, it somehow increased the bombesin-evoked Ca2+ release and also Sr2+ influx.
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Another inhibitor AACOCF3 showed no inhibition but rather slightly increased both 
bombesin-induced Ca2+ release and influx (Section 6.3.1 & 6.3.2). These data are not consistent 
with cPLA2 playing a major role in controlling bombesin-induced Ca2+ entry. Although the 
involvement of cPLA2 is challenged, the importance of AA in this Ca2+ entry pathway cannot be 
ruled out. One piece of evidence is that the inhibitor AACOCF3, as an analogue of AA, 
(Riendeau et al., 1994) increased the bombesin-induced Ca2+ release and Ca2+ influx (Section 
6.3.1&6.3.2). In addition to cPLA2, AA is generated through other phospholipases, such as iPLA2 
or PLC/PLD-DAG pathway.
The data in chapter 5 indicate that an iPLA2 inhibitor BEL blocks the bombesin-evoked [Ca2+]j 
response. This suggests that iPLA2 rather than cPLA2 is more likely to contribute to the activation 
of Ca2+ entry. Ca2+-independent phospholipase A2 is able to generate AA along with other fatty 
acids and lysophospholipids. In addition, it is regarded as an essential component of signal 
transduction from the stores to plasma membrane in SOCEs (reviewed by Bolotina, 2008). 
Besides, no increase of phospho-cPLA2 intensity in bombesin-stimulated cells was observed 
when the cells were treated with BEL together with ERK FR182040 and PD98059 (preliminary 
data not shown) which might be due to the absence of Ca2+ responses inhibited by BEL. This 
observation implies that the activation of cPLA2 requires the bombesin-evoked [Ca2+]i responses, 
which means it occurs downstream rather than upstream of this Ca2+ influx.
Other than iPLA2, BEL has been reported to inhibit the action of DAG by suppressing the 
generation of DAG from PA in the PLD-DAG pathway (Balsinde and Dennis, 1997). Therefore, the 
DAG pathway might account for the generation of AA in this bombesin-evoked Ca2+ influx. This 
possibility is supported by the application of a DAG lipase inhibitor RHC80267. It significantly 
inhibits the bombesin-induced [Ca2+]j responses, especially the influx, which indicated that DAG is 
necessary for the bombesin to induce [Ca2+]| responses (Section 6.3.1 & 6.3.2).
Although the data has not ruled out a role of AA in bombesin-evoked Ca2+ influx, the involvement
of SOCE is supported by other data. It was observed that a widely used SOCE inhibitor SK&F96365
suppressed this bombesin-induced Ca2+ influx (Section 6.3.4). At the same time, another inhibitor
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LOE 908 showed a similar inhibition effect on the Ca2+ influx (Section 6.3.3). However, whether 
LOE 908 inhibits a SOCE or a NSCCE is still controversial. Its actions seem to be cell type and 
concentration dependent (Encabo et a!., 1996; Miwa etal., 2000; Moneer and Taylor, 2002). In 
addition, both inhibitors failed to fully block the Ca2+ influx but partially suppressed although they 
are able to inhibit most of the Ba2+ or Sr2+ influxes. Such difference between Ca2+ and Ba2+ or Sr2+ 
might be explained by the reciprocal regulation between lSoc and 1Arc theory (Mignen etal., 2001). 
Based on these findings and the ability of thapsigargin to evoke [Ca2+]j responses, the 
involvement of SOCEs in this bombesin-induced Ca2+ influx is convincing. However, whether it 
co-exists with other Ca2+ entry pathways or is fully responsible for bombesin-evoked Ca2+ influx is 
unclear. Also, it is unclear as to whether SOCE can be regulated by cell shape.
In order to answer these questions, the activation of STIM1 was studied in both HeLa and Swiss 
3T3 cells. The STIM1 puncta was seen in either bombesin or thapsigargin stimulated HeLa and 
Swiss 3T3 cells (Section 7.3.1 & 7.3.3). However, the amount of bombesin-induced STIM1 puncta 
is less than that induced by thapsigargin. This limited amount of STIMl puncta in 
bombesin-treated cells implies that the SOCCs might not be fully activated. Consequently, SOCEs 
may not fully account for the bombesin-induced Ca2+ influx.
In addition, the data in chapter 7 show that restricting the cell shape with adhesive islands has 
little effect on the formation of STIMl induced by thapsigargin in either HeLa or Swiss 3T3 cells. 
These observations indicate that the thapsigargin-evoked STIMl puncta formation is not cell 
shape dependent which is consistent with the finding that the thapsigargin-evoked Ca2+ influx is 
not inhibited in cells restricted with small islands (Foster, 2005). A recent study in epithelial cells, 
in which cells are plated in hard and soft substrate, suggested that it is the substrate but not the 
cell size that affects the STIMl translocation (Chiu et ai, 2007), which is in general agreement 
with my observation that STIMl can translocate in shape-restricted cells.
Bombesin-induced STIMl puncta formation seems to be absent when restricting cell shape with
islands in Swiss 3T3 cells. No clear STIMl puncta was seen in bombesin stimulated Swiss 3T3 cells
on small islands (Figure 7.3.3E). Such inhibition might due to the re-arrange of cytoskeleton
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caused by cell shape restriction. It was reported that disruption of actin cytoskeleton with 
cytochaiasin D alters the PLC-IP3 pathway (Ribeiro et al.t 1997). Such altered PLC-IP3 pathway may 
lead to an absence of STIM1 puncta. The actin cytoskeleton was seen be re-arranged into a ring 
shape in small island restricted cells (Foster, 2005). However, it was found that low concentration 
of cytochaiasin D could disrupt the ring shape actin cytoskeleton without inhibiting the Ca2+ entry 
(Foster, 2005). In addition, there was no difference between the Ca2+ release induced by IP3 in the 
cells on either large or small islands (Foster, 2005), which suggests the PLC-IP3 pathway is not 
affected when the actin cytoskeleton is altered by small islands. Another possible link between 
actin cytoskeleton and SOCE is a plasma membrane anchored protein, annexin A6. Annexin A6 
was found to be a key player linking the actin cytoskeleton with SOCEs, and its interaction with 
plasma membrane and subsequent stabilization of cortical actin might contribute to attenuation 
of Ca2+ entry in HEK293 cells (Monastyrskaya et al., 2009). Whether the localization of annexin A6 
is altered in small adhesive island-restricted Swiss 3T3 cells need to examined.
Rather than the actin cytoskeleton, microtubules are more likely to affect the distribution of 
STIM1 (Smyth et al., 2007). According to previous research in our laboratory, restricting the cell 
shape with islands changed the distribution of microtubules (Foster, 2005; Appendix 2). Therefore, 
there is a possibility that microtubule re-arrangement is responsible for the absence of STIM1 
puncta in islands restricted cells.
Consequently, the mechanism that leads to the apparent absence of STIM1 puncta in 
shape-restricted bombesin-stimulated cells is still unclear. Due to the limited data obtained from 
the experiments on STIM1, whether STIMl forms puncta in bombesin-stimulated 
shape-restricted cells needs to be confirmed by further research.
8.2 Conclusion
In my research, the bombesin-induced cell-shape-dependent Ca2+ influx is confirmed by the
utilization of small and large adhesive islands. The mechanism of such influx was investigated.
Previous studies pointed out the possibility of ARC channels involved in this
cell-shape-dependent Ca2+ influx based on experiments on Ba2+ and Sr2+. However these two
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divalent cations proved not to be useful in studying the Ca2+ entry pathways due to the presence 
of spontaneous influxes. The presence of spontaneous fluxes means that characterization of the 
influx pathway by divalent cations permeability is difficult to achieve. Consequently, other 
approaches were adopted.
The experiments on the activity of cPLA2 showed that although the cPLA2 is phosphorylated after 
the stimulation of bombesin, such phosphorylation is not necessary for the activation of 
bombesin-evoked Ca2+ influx. Since in the cells on small islands, there is increased phospho-cPLA2, 
but under the condition there was no Ca2+ influx. In addition, the ERK inhibitors failed to prevent 
the increase of phospho-cPLA2 or bombesin-evoked Ca2+ influx. On the other hand, the 
application of inhibitors BEL and RHC80267 indicates that, rather than cPLA2, the DAG or iPLA2 
pathways which are able to generate AA may still participate in the bombesin-evoked Ca2+ influx.
In addition to the participation of ARC channels, the SOCCs may account for this 
cell-shape-dependent Ca2+ influx as well. The most convincing evidence is that the SK&F96365 
suppressed the bombesin-evoked Ca2+ influx. In addition, it was observed that the STIM1 forms 
puncta in bombesin treated Swiss 3T3 cells. However, the amount of puncta is much less than 
that formed after the stimulation of thapsigargin. Whether the limited amount of STIM1 puncta is 
sufficient to fully activate the SOCCs and generate a Ca2+ influx is doubtful. In addition, no 
bombesin-induced STIM1 puncta was seen in adhesive islands restricted Swiss 3T3 cells.
Collectively, data in my research show that both ARC entry pathway and the SOCE pathway are 
likely to account for the bombesin-induced Ca2+ influx. Cytosolic phospholipase A2 does not 
appear to be important in the regulation of cell-shape-dependent Ca2+ influx. The analysis of 
STIM1 localization proved interesting, since STIM1 puncta were seen in HeLa and Swiss 3T3 cells 
even when the cells spreading was restricted with small islands.
8.3 Future research
Based on the data presented here, there are several aspects that require further research to
identify the mechanism that underlies the bombesin-induced cell-shape-dependent Ca2+ influx.
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Whether these two entry pathways: the ARC entry pathway and the SOCE pathway co-exist or 
only one of them participates in this process still needs to be studied in more detail. Besides, the 
mechanism that leads to the inhibition of this bombesin-evoked Ca2+ influx in small island 
restricted cells also requires more investigations.
In order to confirm the involvement of AA, the DAG pathway should be studied. Whether cell 
shape restriction has any effect on the DAG pathway could be investigated. The liberation of AA 
after the stimulation by bombesin could be examined by labeling with [3H] AA.
The activation of iPLA2 is another interesting aspect to study. Is iPLA2 able to generate AA to 
induce an ARC entry or another fatty acid to cause a SOCE that result in the bombesin-evoked 
Ca2+ entry?
Whether the SOCE is responsible for the shape-dependent Ca2+ influx needs to be confirmed. If 
the bombesin-induced STIM1 puncta formation does not occur in the shape restricted cells, this 
may explain how cell shape influences Ca2+ influx. In addition, rather than STIM1, STIM2 which is 
sensitive to a small amount of Ca2+ release, might play an important role in this Ca2+ influx 
(Brandman et al., 2007). Therefore, it is worth studying the activation of STIM2 in Swiss 3T3 cells. 
Moreover, recent reports suggest that STIM puncta formation may be influenced by processes 
other than Ca2+ store depletion. For example, it is found that Golii-BG21, a member of the MBP 
(myelin basic protein) family of proteins, regulates SOCE in T-cells and oligodendrocyte precursor 
cells (Burgoyne et al., 2010). A novel EF-hand protein, CRAC regulator 2A, regulates SOCEs by 
interacting directly with Orail and STIM1, forming a ternary complex that dissociates at elevated 
[Ca2+]j (Srikanth et al., 2010). Therefore, cell shape may exert an effect on puncta formation and 
Ca2+ entry by one of these routes.
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1.1 Transformation of Bacteria E.coli with the Plasmid
To transform E.coli with the GFP-cPLA2 plasmid, 3pl plasmid was mixed with 50pJ E.coli, incubated 
on ice for 5 minutes, heated at 42°C for 40 seconds and then incubated on ice for another 2 
minutes. The transformation mixture was then added with 300pl SOC medium (provided with the 
kit) and shaked for 1 hour at 37°C. The mixture was plated onto LB agar containing lOOmg/L 
kanamycin. The transformation mixture was allowed to absorb into LB agar on room temperature 
for 20 minutes before incubated at 37°C overnight. The colonies containing plasmid DNA were 
subsequently seen after 1 night growing.
1.2 Preparation of Plasmid DNA
Six colonies of bacteria that contained plasmid DNA were picked by sterile techniques and grown 
in 6 tubes with 6ml LB medium containing 0.25% kanamycin at 37°C with shaking system 
overnight under sterile conditions. The bacteria were then pelleted by centrifuged at 4000xg for 
lOmin. Subsequently, the bacteria were kept in a -20°C freezer before used.
The GFP-cPLA2 plasmid was isolated from bacteria following the QJAgen minipreparation protocol. 
The bacteria were thoroughly re-suspended with 250pl Buffer PI containing RNase by pipetting. 
Then 250pl Buffer P2 was added and gently mixed by inversion of the tube 4-6 times. 
Subsequently, 350|il Buffer N3 was added and gently mixed by inversion of the tube 4-6 times 
and then pelleted by centrifuged at 3000xg for 10 minutes. The supernatant containing plasmid 
DNA was transferred to QIAprep spin column sitting in a clean collecting tube, then centrifuged at 
3000xg for 1 minute. The pin column, which contained plasmid DNA, was then added with 750p.l 
Buffer PE and centrifuged twice at 3000xg. Finally, place the QIAprep column in a clean 1.5 ml 
microcentrifuge tube. To elute DNA, add 50pl Buffer EB to the center of each QIAprep spin 
column, let stand for 1 minute, and centrifuge at 6000xg for 1 minute to elute plasmid DNA 
containing cPLA2.
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Unrestricted
Figure appendix 2- The effect of restricting cell spreading on microtubule distribution
5-dya-old quiescent Swiss 3T3 cells were maintained either unrestricted on glass or restricted on 
palladium islands in SF-DMEM then stained using primary anti-tubulin and secondary FITC 
antibodies. Images were visualized using a Leica SP2 AOBS laser scanning confocal microscope. 
Scale bars represent SOpm (Foster, 2005).
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